Finex logo
Finex Intelligence

Market Signal Briefing

Real-time pulse of financial headlines curated from 2 premium feeds.

Last news saved at Mar 20, 19:12 53m ago Cron last ran Mar 20, 19:12 53m ago 2 sources live
Switch language
86,866 Stories ingested Auto-fetched market intel nonstop.
260 Distinct tickers Symbols referenced across the feed
crypton... Trending sources cryptonews • stocknewsapi
Hot tickers
BTC XRP ETH SOL DOGE ADA
Surfacing from current coverage
Details Saved Published Title Source Tickers
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026 stocknewsapi
BKRRF
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2026) - Blackrock Silver Corp. (TSXV: BRC) (OTCQX: BKRRF) (FSE: AHZ0) ("Blackrock" or the "Company") is pleased to announce that Andrew Pollard, President & Chief Executive Officer of the Company, will present live at the Precious Metals & Critical Minerals Virtual Investor Conference hosted by VirtualInvestorConferences.com, on February 10th, 2026 at 2PM ET

Blackrock invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com.

DATE: February 10th
TIME: 2:00PM ET
LINK:https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5226511/blackrock-silver-corp-otcqx-bkrrf-tsxv-brc

This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Marketing Agreement

The Company also announces that that it has entered into a marketing agreement (the "Agreement") with Epstein Research ("ER"), led by Peter Epstein, pursuant to which Mr. Epstein will provide investor relations services to the Company for a six (6) month term beginning on February 6, 2026 and ending on August 6, 2026 in consideration for a cash fee of US$2,500 per month, payable by way of a one time aggregate payment of US$15,000, paid in advance, subject to approval by the TSX Venture Exchange.

In accordance with the terms of the Agreement, ER will work with the Company on posting on social media and producing articles, interviews and commentary designed to increase awareness of the Company.

There are no performance factors contained in the Agreement and ER will not receive any securities of the Company as compensation.

Mr. Epstein does not beneficially own, directly or indirectly, any securities of the Company or any right to acquire securities of the Company. Mr. Epstein operates www.epsteinresearch.com, is an arm's-length party to the Company, and has over 20 years experience in buy-side analyst roles.

Epstein Research is a research and analysis firm operated by Peter Epstein, located in the state of New Jersey, USA, specializing in investor relations and market awareness for public companies.

About Blackrock Silver Corp.

Blackrock Silver Corp. is an American-focused emerging primary silver developer systematically advancing the high-grade Tonopah West Project, situated in the historic "Queen of the Silver Camps" in a jurisdiction consistently ranked as one of the top mining regions globally. The Company is backstopped by a veteran board and technical team with a proven track record of discovering, financing, and building major precious metal mines in Nevada and globally. Blackrock is committed to establishing a secure, high-margin, domestic supply of silver and gold.

Additional information on Blackrock Silver Corp. can be found on its website at www.blackrocksilver.com and by reviewing its profile on SEDAR+ at www.sedarplus.ca.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282934

Source: Blackrock Silver Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Net Lease Office Properties Announces Tax Treatment of 2025 Distributions stocknewsapi
NLOP
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Net Lease Office Properties (NYSE: NLOP) announced the income tax treatment of distributions reported on Form 1099-DIV for 2025. Shareholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of Net Lease Office Properties distributions. 

CUSIP 64110Y108 

FORM 1099-DIV 

Box 1a

Box 2a

Box 3

Box 1b

Box 2b

Box 2f

Box 5

Record 

Date

Payment
Date

Distribution
Per Share

Ordinary
Dividends

Capital Gain
Distributions

Nondividend
Distributions

Qualified
Dividends(1)

Unrecaptured
Section 1250 Gain(2)

Section 897
Capital Gain(3)

Section 199A
Dividends(4)

Section 1061 One-Year
Amounts Disclosure(5)

Section 1061 Three-Year
Amounts Disclosure(5)

8/18/2025

9/3/2025

$3.1000000

$0.0000000

$0.0000000

$3.1000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

12/4/2025

12/19/2025

$4.1000000

$0.0000000

$0.0000000

$4.1000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

$0.0000000

Qualified Dividends is a subset of, and included in, the Taxable Ordinary Dividends amount. Unrecaptured Section 1250 Gain is a subset of, and included in, the Taxable Capital Gain Distributions amount. Section 897 Capital Gain is a subset of, and included in, the Taxable Capital Gain Distributions amount. Section 199A Dividends is a subset of, and included in, the Taxable Ordinary Dividends amount. For the purposes of Section 1061 of the Internal Revenue Code, the "one-year amounts disclosure" and "three-year amounts disclosure" related to the capital gain distributions reported in box 2a are generally applicable to direct and indirect holders of "applicable partnership interests". Net Lease Office Properties

Net Lease Office Properties (NYSE: NLOP) is a publicly traded real estate investment trust that owns a portfolio of high-quality, primarily single-tenant office properties located in the U.S. and net leased to corporate tenants operating across a variety of industries.

www.nloproperties.com 

Institutional Investors:
1-212-492-1140
[email protected]

Individual Investors:
1-844-NLO REIT (656-7348)
[email protected]

Press Contact:
Anna McGrath
1-212-492-1166

SOURCE Net Lease Office Properties

Also from this source
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Cboe Global Markets Reports Results for Fourth Quarter 2025 and Full Year stocknewsapi
CBOE
Fourth Quarter and Full Year Highlights*

Record Diluted EPS for the Quarter of $2.97, Up 60 percent; Record Diluted EPS for the Full Year of $10.42, Up 45 percent Record Adjusted Diluted EPS1 for the Quarter of $3.06, Up 46 percent; Record Adjusted Diluted EPS1 for the Full Year of $10.67, Up 24 percent Record Net Revenue for the Quarter of $671.1 million, Up 28 percent; Record Net Revenue for the Full Year of $2.4 billion, Up 17 percent Establishing 2026 Organic Total Net Revenue Growth Target2 of 'mid single-digit' and Cboe Data Vantage3 Organic Net Revenue Growth Target2 of 'mid to high single-digit' Establishing 2026 Adjusted Operating Expense Guidance2 of $864 to $879 million , /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE) today reported financial results for the fourth quarter of 2025 and full year.

"Cboe delivered an exceptional fourth quarter, marking the culmination of a year characterized by record growth – including 17 percent net revenue growth, 45 percent diluted EPS growth, and 24 percent adjusted diluted EPS1 growth," said Craig Donohue, Chief Executive Officer of Cboe Global Markets. "Our recent strategic realignment is enabling us to allocate more resources toward growth and value creation in our core businesses, while also better positioning Cboe to capitalize on emerging opportunities. We are starting 2026 with a very strong foundation – a focused growth strategy, a highly seasoned and impressive leadership team, and continued strong secular trends in our core businesses."

"Cboe produced another quarter of record net revenue, diluted EPS, and adjusted diluted EPS1 to conclude an extraordinary year," said Jill Griebenow, Cboe Global Markets Executive Vice President, Chief Financial Officer. "In our Derivatives business, record volumes across our index and multi-listed options products drove robust net revenue growth of 38 percent versus the fourth quarter of 2024. Cash and Spot Markets net revenue rose 27 percent, and Data Vantage net revenue increased 9 percent on a year-over-year basis. Moving forward, we anticipate 2026 total organic net revenue growth2 will be in the 'mid single-digit' range, and we anticipate 2026 Data Vantage organic net revenue growth2 will be in the 'mid to high single-digit' range. In addition, we are introducing our full year 2026 adjusted operating expense guidance2 range of $864 million to $879 million. We are pleased with the record results we achieved in 2025, and we remain focused on driving durable shareholder returns in the year ahead."

 *  All comparisons are fourth quarter 2025 or full year compared to the same period in 2024.

(1)

A full reconciliation of our non-GAAP results to our GAAP ("Generally Accepted Accounting Principles") results is included in the attached tables. See "Non-GAAP Information" in the accompanying financial tables.

(2)

Specific quantifications of the amounts that would be required to reconcile the company's organic net revenue growth guidance and adjusted operating expenses guidance are not available. The company believes that there is uncertainty and unpredictability with respect to certain of its GAAP measures, primarily related to acquisition-related revenues and costs that would be required to reconcile to GAAP revenues less cost of revenues, GAAP operating expenses and GAAP effective tax rate, which preclude the company from providing accurate guidance on certain forward-looking GAAP to non-GAAP reconciliations. The company believes that providing estimates of the amounts that would be required to reconcile the range of the company's organic net revenue growth guidance and adjusted operating expenses would imply a degree of precision that would be confusing or misleading to investors for the reasons identified above.

(3)

Cboe Data Vantage refers to the company's Cboe Data Vantage business (formerly known as Data and Access Solutions). Cboe Data Vantage is subsequently referred to as Data Vantage throughout this press release.

Consolidated Fourth Quarter Results 

Table 1 below presents summary selected unaudited condensed consolidated financial information for the company as reported and on an adjusted basis for the three months ended December 31, 2025 and 2024.

Table 1

Consolidated Fourth Quarter Results
($ in millions except per share
amounts and percentages)

4Q25

4Q24

Change

4Q25
Adjusted¹

4Q24
Adjusted¹

Change

Total Revenues Less Cost of
Revenues

$        671.1

$        524.5

28 %

$        671.1

$        524.5

28 %

Total Operating Expenses                                                

$        267.3

$        226.0

18 %

$        220.6

$        204.8

8 %

Operating Income

$        403.8

$        298.5

35 %

$        450.5

$        319.7

41 %

Operating Margin %

60.2 %

56.9 %

       3.3 pp

67.1 %

61.0 %

       6.1 pp

Net Income Allocated to Common
Stockholders

$        312.2

$        195.6

60 %

$        321.0

$        221.2

45 %

Net Income Allocated to Common
Stockholders Margin %

46.5 %

37.3 %

       9.2 pp

47.8 %

42.2 %

       5.6 pp

Diluted Earnings Per Share

$          2.97

$          1.86

60 %

$          3.06

$          2.10

46 %

Operating EBITDA1

$        435.1

$        330.6

32 %

$        464.7

$        331.2

40 %

Operating EBITDA Margin %1

64.8 %

63.0 %

       1.8 pp

69.2 %

63.1 %

       6.1 pp

EBITDA1

$        479.6

$        316.6

51 %

$        464.1

$        331.6

40 %

EBITDA Margin %1

71.5 %

60.4 %

         11.1 pp

69.2 %

63.2 %

       6.0 pp

Total revenues less cost of revenues (referred to as "net revenue"2) of $671.1 million increased 28 percent, compared to $524.5 million in the prior-year period, a result of increases across all net revenue2 captions. Total operating expenses were $267.3 million versus $226.0 million in the fourth quarter of 2024, an increase of $41.3 million. This increase was primarily due to the impairment of assets and higher compensation and benefits, driven by an increase in accrued bonuses as a result of strong company performance in the fourth quarter of 2025. Adjusted operating expenses1 of $220.6 were up $15.8 million compared to $204.8 million in the fourth quarter of 2024. This increase was primarily due to higher compensation and benefits, driven by an increase in accrued bonuses as a result of strong company performance. The effective tax rate for the fourth quarter of 2025 was 30.6 percent as compared with 29.7 percent in the fourth quarter of 2024. The higher effective tax rate in 2025 is primarily related to remeasuring deferred tax assets and liabilities due to changes in state and local filing positions. The effective tax rate on adjusted earnings1 was 28.9 percent, down 0.6 percentage points when compared with 29.5 percent in last year's fourth quarter. The change was primarily due to benefits recognized by filing 2024 tax returns. Diluted EPS for the fourth quarter of 2025 increased 60 percent to $2.97 compared to the fourth quarter of 2024. Adjusted diluted EPS1 of $3.06 increased 46 percent compared to 2024 fourth quarter results. Business Segment Information

Table 2

Total Revenues Less Cost of Revenues by Business Segment (in millions)                                 

4Q25

4Q24

Change

Options

$           433.1

$           324.3

34 %

North American Equities

110.7

94.9

17 %

Europe and Asia Pacific

69.9

56.2

24 %

Futures

33.7

30.2

12 %

Global FX

23.7

19.4

22 %

Digital3



(0.5)

*

Total

$           671.1

$           524.5

28 %

(1)

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See "Non-GAAP Information" in the accompanying financial tables.

(2)

See the attached tables on page 10 for "Net Revenue by Revenue Caption."

(3)

The Digital segment results are prospectively included in the Futures segment beginning in the first quarter of 2025. Digital results from 2024 have been retained in the former Digital segment for comparative purposes.

*Not meaningful

Discussion of Results by Business Segment1:

Options:

Record Options net revenue of $433.1 million was up $108.8 million, or 34 percent, from the fourth quarter of 2024. Net transaction and clearing fees2 increased primarily as a result of a 24 percent increase in total options average daily volume ("ADV") versus the fourth quarter of 2024. Access and capacity fees increased 13 percent as compared to the fourth quarter of 2024. Net transaction and clearing fees2 increased $112.4 million, or 40 percent, reflecting a 35 percent increase in index options ADV and a 20 percent increase in multi-listed options ADV. Total options revenue per contract ("RPC") increased 13 percent compared to the fourth quarter of 2024. The increase in total options RPC was primarily due to a mix shift, with index options representing a higher percentage of total options volume, and a 17 percent increase in multi-listed options RPC. Cboe's Options exchanges had total market share of 29.2 percent for the fourth quarter of 2025 compared to 30.4 percent in the fourth quarter of 2024. North American (N.A.) Equities:

Record N.A. Equities net revenue of $110.7 million increased $15.8 million, or 17 percent, from the fourth quarter of 2024, reflecting higher net transaction and clearing fees2, access and capacity fees, and market data fees. Net transaction and clearing fees2 increased by $5.4 million, or 18 percent, compared to the fourth quarter of 2024. The increase was driven by stronger industry volumes, partially offset by lower market share in on-exchange U.S. Equities as compared to the fourth quarter of 2024. Cboe's U.S. Equities exchanges had market share of 9.4 percent for the fourth quarter of 2025 compared to 10.8 percent in the fourth quarter of 2024. Cboe's U.S. Equities off-exchange market share was 17.0 percent, up 0.5 percentage points from 16.5 percent in the fourth quarter of 2024. Canadian Equities market share decreased to 12.7 percent as compared to 14.3 percent in the fourth quarter of 2024. Europe and Asia Pacific (APAC):

Europe and APAC net revenue of $69.9 million increased $13.7 million, or 24 percent, from the fourth quarter of 2024, reflecting growth in net transaction and clearing fees2 and non-transaction revenues. On a constant currency basis3, net revenues were $65.8 million, up 17 percent compared to the fourth quarter of 2024. European Equities average daily notional value ("ADNV") traded on Cboe European Equities was €12.2 billion, up 17 percent compared to the fourth quarter of 2024 given a 16 percent increase in industry market volumes. Cboe Clear Europe net settlement volume reached 3,603.7 thousand shares, up 22 percent from the fourth quarter of 2024. Australian Equities ADNV was 28 percent higher than the fourth quarter of 2024. For the fourth quarter of 2025, Cboe European Equities had 24.8 percent market share, up compared to 24.6 percent in the fourth quarter of 2024. Cboe Australia had 20.6 percent market share for the fourth quarter of 2025, down from 20.8 percent in the fourth quarter of 2024. Futures:

Futures net revenue of $33.7 million increased $3.5 million, or 12 percent, from the fourth quarter of 2024 driven by a 13 percent increase in net transaction and clearing fees2. Net transaction and clearing fees2 increased $3.1 million, reflecting a 16 percent increase in ADV during the quarter. Global FX:

Record Global FX net revenue of $23.7 million increased $4.3 million, or 22 percent, from the fourth quarter of 2024. The increase was due to higher net transaction and clearing fees2. ADNV traded on the Cboe FX platform was $53.3 billion for the quarter, up 17 percent compared to last year's fourth quarter, and net capture rate per one million dollars traded was $2.95 for the quarter, up 8 percent compared to $2.72 in the fourth quarter of 2024. (1)

The Digital segment results are prospectively included in the Futures segment beginning in the first quarter of 2025. Digital results from 2024 have been retained in the former Digital segment for comparative purposes.

(2)

See the attached tables on page 10 for "Net Transaction and Clearing Fees by Business Segment."

(3)

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See "Non-GAAP Information" in the accompanying financial tables.

2026 Fiscal Year Financial Guidance1

Cboe provided guidance for the 2026 fiscal year as noted below.

Organic total net revenue growth2 is expected to be in the 'mid single-digit' range in 2026. Organic net revenue growth2 from Data Vantage is expected to be in the 'mid to high single-digit' range in 2026. Adjusted operating expenses2 in 2026 are expected to be in the range of $864 to $879 million. The guidance excludes the expected amortization of acquired intangible assets of $63 million; the company adjusts for this amount in its non-GAAP reconciliation. Depreciation and amortization expense for 2026 is expected to be in the range of $56 to $60 million, excluding the expected amortization of acquired intangible assets. The effective tax rate on adjusted earnings2 for the full year 2026 is expected to be in the range of 27.5 to 29.5 percent. Significant changes in trading volume, expenses, tax laws or rates, and other items could materially impact this expectation. Capital expenditures for 2026 are expected to be in the range of $73 to $83 million. (1)

2026 guidance includes the anticipated impacts from discontinuing U.S. and European Corporate Listings, CEDX, and Cboe's Japanese equities business, as well as the planned cost reductions in U.S. and European ETP Listings businesses and several of Cboe's smaller Risk and Market Analytics businesses, as announced in 2025 and early 2026. 2026 guidance also includes the anticipated business-as-usual financial contribution from Cboe Canada and Cboe Australia, which Cboe announced divestiture plans for in October 2025. 2026 guidance will be updated as further actions are announced.

(2)

Specific quantifications of the amounts that would be required to reconcile the company's organic and inorganic growth guidance, adjusted operating expenses guidance, and the effective tax rate on adjusted earnings guidance are not available. Acquisitions are considered organic after 12 months of closing. The company believes that there is uncertainty and unpredictability with respect to certain of its GAAP measures, primarily related to acquisition-related revenues and costs that would be required to reconcile to GAAP revenues less cost of revenues, GAAP operating expenses and GAAP effective tax rate, which preclude the company from providing accurate guidance on certain forward-looking GAAP to non-GAAP reconciliations. The company believes that providing estimates of the amounts that would be required to reconcile the range of the company's organic growth, adjusted operating expenses, and the effective tax rate on adjusted earnings would imply a degree of precision that would be confusing or misleading to investors for the reasons identified above.

Capital Management

At December 31, 2025, the company had cash and cash equivalents of $2,216.5 million and adjusted cash3 of $2,216.8 million. Total debt as of December 31, 2025 was $1,442.9 million.

The company paid cash dividends of $75.8 million, or $0.72 per share, and there were no share repurchases in the fourth quarter of 2025. As of December 31, 2025, the company had approximately $614.5 million of availability remaining under its existing share repurchase authorizations.

Earnings Conference Call

Executives of Cboe Global Markets will host a conference call to review its fourth quarter financial results today, February 6, 2026, at 8:30 a.m. ET/7:30 a.m. CT. The conference call and any accompanying slides will be publicly available via live webcast from the Investor Relations section of the company's website at www.cboe.com under Events & Presentations. Participants may also listen via telephone by dialing (800) 715-9871 (toll-free) or (646) 307-1963 (toll) and using the Conference ID 6775785. Telephone participants should place calls 10 minutes prior to the start of the call. The webcast will be archived on the company's website for replay.

(3)

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See "Non-GAAP Information" in the accompanying financial tables.

About Cboe Global Markets

Cboe Global Markets (Cboe: CBOE), the world's leading derivatives and securities exchange network, delivers cutting-edge trading, clearing and investment solutions to people around the world. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, and FX, across North America, Europe, and Asia Pacific. Above all, Cboe is committed to building a trusted, inclusive global marketplace that enables people to pursue a sustainable financial future. To learn more about Cboe, visit www.cboe.com. 

Cautionary Statements Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. You can identify these statements by forward-looking words such as "may," "might," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential", or "continue," and the negative of these terms and other comparable terminology. All statements that reflect our expectations, assumptions or projections about the future other than statements of historical fact are forward-looking statements. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements.

We operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Some factors that could cause actual results to differ include: the loss of our right to exclusively list and trade certain index options and futures products; economic, political and market conditions; compliance with legal and regulatory obligations; price competition and consolidation in our industry; decreases in trading or clearing volumes, market data fees or a shift in the mix of products traded on our exchanges; legislative or regulatory changes or changes in tax regimes; our ability to protect our systems and communication networks from security vulnerabilities and breaches; our ability to attract and retain skilled management and other personnel; increasing competition by foreign and domestic entities; our dependence on and exposure to risk from third parties; factors that impact the quality and integrity of our and other applicable indices; our ability to manage our global operations, growth, and strategic acquisition, wind-downs, divestitures or alliances effectively; increases in the cost of the products and services we use; our ability to operate our business without violating the intellectual property rights of others and the costs associated with protecting our intellectual property rights; our ability to minimize the risks, including our credit, liquidity, market, investment, counterparty, and default risks, associated with operating our clearinghouses; our ability to accommodate trading and clearing volume and transaction traffic, including significant increases, without failure or degradation of performance of our systems; misconduct by those who use our markets or our products or for whom we clear transactions; challenges to our use of open source software code; our ability to meet our compliance obligations, including managing our business interests and our regulatory responsibilities; the loss of key customers or a significant reduction in trading or clearing volumes by key customers; separate from and not integrated with our registered national securities exchanges; damage to our reputation; the ability of our compliance and risk management methods to effectively monitor and manage our risks; restrictions imposed by our debt obligations and our ability to make payments on or refinance our debt obligations; our ability to maintain an investment grade credit rating; impairment of our goodwill, long-lived assets, investments, or intangible assets; the accuracy of our estimates and expectations; and litigation risks and other liabilities. More detailed information about factors that may affect our actual results to differ may be found in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings made from time to time with the SEC.

We do not undertake, and we expressly disclaim, any duty to update any forward-looking statement whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

The condensed consolidated statements of income and balance sheets are unaudited and subject to revision.

Cboe Media Contacts:

Analyst Contact:

Angela Tu

Tim Cave

Kenneth Hill, CFA

(646) 856-8734

+44 (0) 7593 506 719

(312) 786-7559

[email protected]

[email protected]

[email protected]

CBOE-F

Trademarks:

Cboe®, Cboe Global Markets®, Cboe Volatility Index®, Cboe Clear®, Cboe Datashop®, BIDS Trading®, BZX®, BYX®, Cboe Clear®, EDGX®, EDGA®, MATCHNow®, and VIX® are registered trademarks and Cboe Data VantageSM is a service mark of Cboe Global Markets, Inc. and its subsidiaries. All other trademarks and service marks are the property of their respective owners.

Cboe Global Markets, Inc.

Key Performance Statistics by Business Segment

4Q 2025

3Q 2025

2Q 2025

1Q 2025

4Q 2024

Options

Total industry ADV (in thousands)

66,608

60,798

57,203

58,444

51,635

Total Company Options ADV (in thousands):

19,419

18,775

17,301

18,183

15,673

Multi-listed options

13,965

13,911

12,615

13,412

11,633

Index options

5,454

4,864

4,686

4,771

4,040

Total Options market share:

29.2 %

30.9 %

30.2 %

31.1 %

30.4 %

Multi-listed options

22.9 %

24.9 %

24.0 %

25.0 %

24.5 %

Total Options RPC:

$        0.317

$        0.281

$        0.300

$        0.287

$        0.281

Multi-listed options

$        0.075

$        0.055

$        0.068

$        0.066

$        0.064

Index options

$        0.938

$        0.926

$        0.923

$        0.908

$        0.905

North American Equities

U.S. Equities - Exchange:

Total industry ADV (shares in billions)

18.6

17.6

18.4

15.7

13.6

Market share %

9.4 %

9.8 %

10.5 %

10.5 %

10.8 %

Net capture (per 100 touched shares)

$        0.018

$        0.015

$        0.012

$        0.014

$        0.018

U.S. Equities - Off-Exchange:

ADV (touched shares, in millions)

197.0

202.3

125.5

90.6

80.0

Off-Exchange ATS Block Market Share %

17.0 %

17.9 %

14.9 %

17.1 %

16.5 %

Net capture (per 100 touched shares)

$        0.064

$        0.064

$        0.082

$        0.117

$        0.126

Canadian Equities:

ADV (matched shares, in millions)

195.9

163.8

150.6

159.6

157.4

Total market share %

12.7 %

12.5 %

12.7 %

13.8 %

14.3 %

Net capture (per 10,000 shares, in Canadian Dollars)

$        3.962

$        4.142

$        4.222

$        4.250

$        4.008

Europe and Asia Pacific

European Equities:

Total industry ADNV (Euros - in billions)

€          49.1

€          46.1

€          54.5

€          55.8

€          42.3

Market share %

24.8 %

25.4 %

25.1 %

24.8 %

24.6 %

Net capture (per matched notional value (bps), in Euros)

€        0.278

€        0.288

€        0.261

€        0.252

€        0.261

Cboe Clear Europe:

Trades cleared (in thousands)

322,339.2

329,293.1

400,935.8

412,072.2

328,976.1

Fee per trade cleared (in Euros)

€        0.010

€        0.010

€        0.008

€        0.008

€        0.008

Net settlement volume (shares in thousands)

3,603.7

3,541.9

3,289.3

3,200.7

2,962.6

Net fee per settlement (in Euros)

€        1.113

€        1.015

€        0.956

€        0.951

€        1.002

Australian Equities:

ADNV (Australian dollars - in billions)

$            1.0

$            1.0

$            1.0

$            0.8

$            0.8

Market share - Continuous

20.6 %

20.6 %

20.0 %

19.4 %

20.8 %

Net capture (per matched notional value (bps), in Australian Dollars)                                 

$        0.207

$        0.206

$        0.160

$        0.156

$        0.154

Futures

ADV (in thousands)

239.2

200.7

220.5

249.4

206.4

RPC

$        1.717

$        1.745

$        1.691

$        1.740

$        1.765

Global FX

ADNV ($ - in billions)

$          53.3

$          49.9

$          55.9

$          51.9

$          45.6

Net capture (per one million dollars traded)

$          2.95

$          2.89

$          2.81

$          2.77

$          2.72

*In the second quarter of 2025, Digital futures products were transitioned to Cboe Futures Exchange. Futures metrics prior to the second quarter of 2025 exclude Digital futures products.

ADV = average daily volume; ADNV = average daily notional value.

RPC, average revenue per contract, for options and futures, represents total net transaction fees recognized for the period divided by total contracts traded during the period.

Touched volume represents the total number of shares of equity securities and ETFs internally matched on our exchanges or routed to and executed on an external market center.

Matched volume represents the total number of shares of equity securities and ETFs executed on our exchanges.

U.S. Equities - Exchange, "net capture per 100 touched shares" refers to transaction fees less liquidity payments and routing and clearing costs divided by the product of one-hundredth ADV of touched shares on BZX, BYX, EDGX and EDGA and the number of trading days. U.S. Equities – Off-Exchange data reflects BIDS Trading. For U.S. Equities – Off-Exchange, "net capture per 100 touched shares" refers to transaction fees less order and execution management system (OMS/EMS) fees and clearing costs divided by the product of one-hundredth ADV of touched shares on BIDS Trading and the number of trading days for the period.

Canadian Equities, "net capture per 10,000 shares" refers to transaction fees divided by the product of one-ten thousandth ADV of shares for Cboe Canada and the number of trading days. Total market share represents Cboe Canada volume divided by the total volume of the Canadian Equities market.

European Equities, "net capture per matched notional value" refers to transaction fees less liquidity payments in Euros divided by the product of ADNV in Euros of shares matched on Cboe Europe Equities and the number of trading days. "Trades cleared" refers to the total number of non-interoperable trades cleared, "Fee per trade cleared" refers to clearing fees divided by number of non-interoperable trades cleared, "Net settlement volume" refers to the total number of settlements executed after netting, and "Net fee per settlement" refers to settlement fees less direct costs incurred to settle divided by the number of settlements executed after netting.

Australian Equities data reflects data from Cboe Australia. Australian Equities, "net capture per matched notional value" refers to transaction fees less liquidity payments in Australian dollars divided by the product of ADNV in Australian dollars of shares matched on Cboe Australia and the number of Australian Equities trading days.

Global FX, "net capture per one million dollars traded" refers to transaction fees less liquidity payments, if any, divided by the Spot and SEF products of one-thousandth of ADNV traded on the Cboe FX Markets and the number of trading days, divided by two, which represents the buyer and seller that are both charged on the transaction.

Average transaction fees per contract can be affected by various factors, including exchange fee rates, volume-based discounts and transaction mix by contract type and product type.

Cboe Global Markets, Inc. and Subsidiaries

Condensed Consolidated Statements of Income (Unaudited)

Three and Twelve Months Ended December 31, 2025 and 2024

Three Months Ended December 31,

Twelve Months Ended December 31,

(in millions, except per share amounts)

2025

2024

2025

2024

Revenues:

Cash and spot markets

$         431.3

$         468.6

$      1,834.8

$      1,670.0

Data Vantage

162.6

148.7

635.5

576.6

Derivatives markets

610.1

490.3

2,243.9

1,847.9

Total Revenues

1,204.0

1,107.6

4,714.2

4,094.5

Cost of Revenues:

Liquidity payments

443.6

365.7

1,709.7

1,329.1

Routing and clearing

20.1

18.3

80.4

68.3

Regulatory fees cost of revenues

0.3

142.1

238.7

391.4

Royalty fees and other cost of revenues

68.9

57.0

256.3

233.3

Total Cost of Revenues

532.9

583.1

2,285.1

2,022.1

Revenues Less Cost of Revenues

671.1

524.5

2,429.1

2,072.4

Operating Expenses:

Compensation and benefits

127.5

111.9

500.8

462.4

Depreciation and amortization

31.3

32.1

122.4

133.0

Technology support services

28.7

28.5

107.6

102.8

Professional fees and outside services

24.3

25.6

91.5

94.8

Travel and promotional expenses

15.5

16.4

42.1

45.8

Facilities costs

6.6

6.1

26.2

24.6

Acquisition-related costs

(0.1)

0.1

0.3

1.3

Impairment of assets

25.1



46.7

81.0

Other expenses

8.4

5.3

24.4

28.3

Total Operating Expenses

267.3

226.0

962.0

974.0

Operating Income

403.8

298.5

1,467.1

1,098.4

Non-operating Income (Expenses):

Interest expense

(13.3)

(12.9)

(52.3)

(51.5)

Interest income

15.4

7.2

49.4

27.3

Earnings (loss) on investments, net

44.5

(0.2)

92.8

29.0

Other income (expense), net

1.3

(12.9)

9.6

(19.4)

Total Non-operating Income (Expenses)

47.9

(18.8)

99.5

(14.6)

Income Before Income Tax Provision

451.7

279.7

1,566.6

1,083.8

Income tax provision

138.2

83.2

466.6

318.9

Net Income

313.5

196.5

1,100.0

764.9

Net income allocated to participating securities

(1.3)

(0.9)

(5.2)

(3.9)

Net Income Allocated to Common Stockholders

$          312.2

$          195.6

$      1,094.8

$          761.0

Net Income Per Share Allocated to Common Stockholders:

Basic earnings per share

$            2.98

$            1.87

$         10.46

$            7.24

Diluted earnings per share

2.97

1.86

10.42

7.21

Weighted average shares used in computing income per share:                                        

Basic

104.7

104.8

104.7

105.1

Diluted

105.0

105.1

105.1

105.5

Cboe Global Markets, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

December 31, 2025 and December 31, 2024

(in millions)

December 31,
2025

December 31,
2024

Assets

Current assets:

Cash and cash equivalents

$         2,216.5

$            920.3

Financial investments

36.1

110.3

Accounts receivable, net

391.4

444.6

Margin deposits, clearing funds, and interoperability funds

1,618.2

845.5

Income taxes receivable

67.9

73.8

Other current assets (includes restricted cash of $34.1 at December 31, 2025 and $— at
December 31, 2024)

91.3

84.6

Total current assets

4,421.4

2,479.1

Investments

32.4

383.7

Property and equipment, net

133.1

118.0

Operating lease right of use assets

111.0

124.5

Goodwill

3,150.5

3,124.2

Intangible assets, net

1,297.2

1,376.9

Other assets, net

159.7

182.7

Total assets

$         9,305.3

$         7,789.1

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued liabilities

$            686.9

$            359.7

Section 31 fees payable

0.2

182.0

Deferred revenue

6.9

6.4

Margin deposits, clearing funds, and interoperability funds

1,618.2

845.5

Income taxes payable

50.1

1.6

Total current liabilities

2,362.3

1,395.2

Long-term debt

1,442.9

1,441.0

Non-current unrecognized tax benefits

15.8

305.0

Deferred income taxes

185.3

186.8

Non-current operating lease liabilities

120.9

138.4

Other non-current liabilities

39.8

43.1

Total liabilities

4,167.0

3,509.5

Stockholders' equity:

Preferred stock





Common stock

1.0

1.0

Treasury stock, at cost

(1.5)

(1.4)

Additional paid-in capital

1,565.1

1,512.5

Retained earnings

3,543.6

2,815.9

Accumulated other comprehensive income (loss), net                                                                                                                                      

30.1

(48.4)

Total stockholders' equity

5,138.3

4,279.6

Total liabilities and stockholders' equity

$         9,305.3

$         7,789.1

Table 3

Net Transaction and Clearing
Fees by Business Segment
Three Months Ended December
31, 2025 and 2024 (in millions)

Consolidated

December 31,

Options

December 31,

N.A. Equities

December 31,

Europe and APAC

December 31,

Futures

December 31,

Global FX

December 31,

Digital1

December 31,

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

2025

2024

Transaction and clearing fees

$ 977.4

$ 762.6

$ 559.7

$ 418.0

$ 316.3

$ 260.6

$   52.7

$   41.4

$  27.8

$  25.9

$  20.9

$  16.6

$     —

$    0.1

Liquidity payments

(443.6)

(365.7)

(160.7)

(131.7)

(272.6)

(222.2)

(8.8)

(8.5)

(1.5)

(2.7)







(0.6)

Routing and clearing

(20.1)

(18.3)

(4.6)

(4.3)

(9.0)

(9.1)

(6.0)

(4.5)





(0.5)

(0.4)





Net transaction and clearing fees

$ 513.7

$ 378.6

$ 394.4

$ 282.0

$  34.7

$  29.3

$   37.9

$   28.4

$  26.3

$  23.2

$  20.4

$  16.2

$     —

$  (0.5)

Table 4

Net Revenue by Revenue Caption Three Months Ended                           
December 31, 2025 and 2024 (in millions)

Cash and Spot Markets

December 31,

Data Vantage

December 31,

Derivatives Markets

December 31,

Total

December 31,

2025

2024

2025

2024

2025

2024

2025

2024

Transaction and clearing fees

$   390.0

$   318.6

$         —

$         —

$   587.4

$   444.0

$   977.4

$   762.6

Access and capacity fees





105.8

95.0





105.8

95.0

Market data fees

16.7

14.3

56.0

53.0

10.0

8.3

82.7

75.6

Regulatory fees

3.0

114.2





12.0

37.0

15.0

151.2

Other revenue

21.6

21.5

0.8

0.7

0.7

1.0

23.1

23.2

Total revenues

$   431.3

$   468.6

$   162.6

$   148.7

$   610.1

$   490.3

$ 1,204.0

$ 1,107.6

Liquidity payments

$   280.6

$   229.7

$         —

$         —

$   163.0

$   136.0

$   443.6

$   365.7

Routing and clearing

15.5

14.1





4.6

4.2

20.1

18.3

Regulatory fees cost of revenues

0.3

114.1







28.0

0.3

142.1

Royalty fees and other cost of revenues

9.3

11.8

3.1

2.8

56.5

42.4

68.9

57.0

Total cost of revenues

$   305.7

$   369.7

$        3.1

$        2.8

$   224.1

$   210.6

$   532.9

$   583.1

Net revenue

$   125.6

$     98.9

$   159.5

$   145.9

$   386.0

$   279.7

$   671.1

$   524.5

(1)

The Digital segment results are prospectively included in the Futures segment beginning in the first quarter of 2025. Digital results from 2024 have been retained in the former Digital segment for comparative purposes.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, Cboe Global Markets has disclosed certain non-GAAP measures of operating performance. These measures are not in accordance with, or a substitute for, GAAP, and may be different from or inconsistent with non-GAAP financial measures used by other companies. The non-GAAP measures provided in this press release include adjusted revenues less cost of revenues, adjusted operating expenses, adjusted operating income, adjusted operating margin, adjusted net income allocated to common stockholders, adjusted diluted earnings per share, effective tax rate on adjusted earnings, adjusted income before income taxes, operating EBITDA, operating EBITDA margin, adjusted operating EBITDA, adjusted operating EBITDA margin, EBITDA, EBITDA margin, adjusted EBITDA, adjusted EBITDA margin, adjusted cash, and net revenues in constant currency.

Management believes that the non-GAAP financial measures presented in this press release provide additional and comparative information to assess trends in our core operations and a means to evaluate period-to-period comparisons. Non-GAAP financial measures disclosed by management are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results.

The tables below show the reconciliation of each financial measure from GAAP to non-GAAP. The non-GAAP financial measures exclude the impact of those items detailed below and are referred to as adjusted financial measures. 

Reconciliation of GAAP and Non-GAAP Information

Three Months Ended

Twelve Months Ended

Table 5

December 31,

December 31,

(in millions, except percentages and per share amounts)

2025

2024

2025

2024

Reconciliation of Net Income Allocated to Common
Stockholders to Non-GAAP (As shown on Table 1)

Net income allocated to common stockholders

$          312.2

$          195.6

$       1,094.8

$          761.0

Non-GAAP adjustments

Acquisition-related costs (1)

(0.1)

0.1

0.3

1.3

Amortization of acquired intangible assets (2)

17.1

20.6

69.9

88.7

Business realignment costs (3)

4.0

0.5

7.0

2.1

Cboe Digital syndication wind down (4)







(1.0)

Change in contingent consideration (5)







2.1

Non-operating investment adjustments, net (6)

(45.1)

14.4

(96.8)

31.4

Executive compensation adjustment (7)

0.6



1.6



Gain on Cboe Digital non-recourse notes and warrants wind                                            
down (8)







(1.4)

Gain on sale of property held for sale (9)







(1.0)

Impairment of assets (10)

25.1



46.7

81.0

Total Non-GAAP adjustments

1.6

35.6

28.7

203.2

Income tax expense related to the items above

(0.5)

(7.9)

(8.2)

(52.2)

Deferred tax re-measurements (11)

14.3



13.3



Tax reserves (11)

(6.6)

(2.5)

(6.6)

(8.1)

Valuation allowances (12)



0.6



5.0

Net income allocated to participating securities - effect on
reconciling items



(0.2)

(0.3)

(0.9)

Adjusted earnings

$          321.0

$          221.2

$       1,121.7

$          908.0

Reconciliation of Diluted EPS to Non-GAAP

Diluted earnings per common share

$            2.97

$            1.86

$          10.42

$            7.21

Per share impact of non-GAAP adjustments noted above

0.09

0.24

0.25

1.40

Adjusted diluted earnings per common share

$            3.06

$            2.10

$          10.67

$            8.61

Reconciliation of Operating Margin to Non-GAAP

Revenues less cost of revenue

$          671.1

$          524.5

$       2,429.1

$       2,072.4

Non-GAAP adjustments noted above







(1.0)

Adjusted revenues less cost of revenue

$          671.1

$          524.5

$       2,429.1

$       2,071.4

Operating expenses (13)

$          267.3

$          226.0

$          962.0

$          974.0

Non-GAAP adjustments noted above

46.7

21.2

125.5

175.2

Adjusted operating expenses

$          220.6

$          204.8

$          836.5

$          798.8

Operating income

$          403.8

$          298.5

$       1,467.1

$       1,098.4

Non-GAAP adjustments noted above

46.7

21.2

125.5

174.2

Adjusted operating income

$          450.5

$          319.7

$       1,592.6

$       1,272.6

Adjusted operating margin (14)

67.1 %

61.0 %

65.6 %

61.4 %

Reconciliation of Income Tax Rate to Non-GAAP

Income before income taxes

$          451.7

$          279.7

$       1,566.6

$       1,083.8

Non-GAAP adjustments noted above

1.6

35.6

28.7

203.2

Adjusted income before income taxes

$          453.3

$          315.3

$       1,595.3

$       1,287.0

Income tax expense

$          138.2

$            83.2

$          466.6

$          318.9

Non-GAAP adjustments noted above

(7.2)

9.8

1.5

55.3

Adjusted income tax expense

$          131.0

$            93.0

$          468.1

$          374.2

Adjusted income tax rate

28.9 %

29.5 %

29.3 %

29.1 %

(1)

This amount includes acquisition-related costs primarily from the company's Cboe Digital, Cboe Canada, and Cboe Asia Pacific acquisitions, which are included in acquisition-related costs on the condensed consolidated statements of income.

(2)

This amount represents the amortization of acquired intangible assets related to the company's acquisitions, which is included in depreciation and amortization on the condensed consolidated statements of income.

(3)

This amount represents certain business realignment costs related to announced business realignment initiatives. For the three and twelve months ended December 31, 2025, the costs included $2.1 million and $5.1 million in compensation and benefits, respectively, $0.5 million in professional fees and outside services, and $1.4 million in other expenses, respectively, on the condensed consolidated statements of income. For the three and twelve months ended December 31, 2024, the costs included $0.5 million and $2.1 million in compensation and benefits, respectively, on the condensed consolidated statements of income.

(4)

This amount represents the contra-revenue that was reversed as a result of the Cboe Digital syndication wind down, which is included in transaction and clearing fees on the condensed consolidated statements of income.

(5)

This amount represents the gains and losses related to contingent consideration liabilities achieved related to the acquisitions of Cboe Canada and Cboe Asia Pacific, which is included in other expenses on the condensed consolidated statements of income.

(6)

This amount represents the net gains associated with the partial sale of PYTH token intangible assets and from the company's various minority investments, as well as the gain associated with the completion of the investment transaction within the company's investment in the 7Ridge Fund (which owned Trading Technologies International Inc.), which included $45.1 million, and $96.8 million in earnings on investments, net on the condensed consolidated statements of income, for the three and twelve months ended December 31, 2025, respectively, and the net impairments related to the company's minority investments, which included $14.4 million and $31.6 million in other income (expense), net on the condensed consolidated statements of income, for the three and twelve months ended December 31, 2024, respectively, and $0.2 million in earnings on investments, net on the condensed consolidated statements of income for the twelve months ended December 31, 2024.

(7)

This amount represents the CEO sign-on long-term equity awards with a grant date value of $6.0 million (comprised of a mixture of time and performance-based awards) and subject to a 3-year cliff vesting requirement associated with the hiring of Craig Donohue as Chief Executive Officer, which is included in compensation and benefits on the condensed consolidated statements of income. This amount does not include the CEO's annual long-term equity incentive awards that were prorated for 2025.

(8)

This amount represents the revaluation and the gain associated with the wind down of the Cboe Digital non-recourse notes and warrants, which is included in other income (expense), net on the condensed consolidated statements of income.

(9)

This amount represents the net gain on the sale of the company's former headquarters, which is included in other income (expense), net on the condensed consolidated statements of income.

(10)

This amount represents the impairment of assets related to Cboe Canada, Cboe European Derivatives ("CEDX"), and Cboe Japan in 2025, as well as the impairment of assets related to the Cboe Digital wind down in 2024, which are included in impairment of assets on the condensed consolidated statements of income.

(11)

These amounts represent the tax impact related to changes in state and local filing positions for the three and twelve months ended December 31, 2025 and the tax reserves related to Section 199 matters for the three and twelve months ended December 31, 2024, respectively.

(12)

This amount represents the valuation allowances related to the impairments of the company's minority investments in Globacap Technology Limited and StratiFi Technologies Inc.

(13)

The company sponsors deferred compensation plans held in a trust. The expenses or income related to the deferred compensation plans are included in compensation and benefits ($1.9 million and $1.4 million in expense for the three months ended December 31, 2025 and 2024, respectively, and $4.5 million and $3.6 million in expense for the twelve months ended December 31, 2025 and 2024, respectively), and are directly offset by deferred compensation income, expenses and dividends included within other income (expense), net ($1.9 million and $1.4 million in income, expense and dividends in the three months ended December 31, 2025 and 2024, respectively, and $4.5 million and $3.6 million in income, expense and dividends in the twelve months ended December 31, 2025 and 2024, respectively), on the condensed consolidated statements of income. The deferred compensation plans' expenses are not excluded from adjusted operating expenses and do not have an impact on income before income taxes.

(14)

Adjusted operating margin represents adjusted operating income divided by revenues less cost of revenues.

EBITDA Reconciliations

EBITDA (earnings before interest, income taxes, depreciation and amortization) and Adjusted EBITDA are widely used non-GAAP financial measures of operating performance. These metrics are presented as supplemental information that the company believes are useful to investors to evaluate the company's results because they exclude certain items that are not directly related to the company's core operating performance. Operating EBITDA is calculated by adding back to operating income depreciation and amortization. Adjusted Operating EBITDA is calculated by adding back to Operating EBITDA relevant adjustments. Operating EBITDA margin represents Operating EBITDA divided by revenues less cost of revenues. Adjusted Operating EBITDA margin represents Adjusted Operating EBITDA divided by revenues less cost of revenues. EBITDA is calculated by adding back to net income interest (income) expense, net, income tax expense, and depreciation and amortization. EBITDA margin represents EBITDA divided by revenues less cost of revenues. Adjusted EBITDA is calculated by adding back to EBITDA relevant adjustments. Adjusted EBITDA margin represents Adjusted EBITDA divided by revenues less cost of revenues. Relevant adjustments are detailed in the reconciliations that follow. Operating EBITDA, Adjusted Operating EBITDA, EBITDA, and Adjusted EBITDA should not be considered as substitutes either for net income, as an indicator of the company's operating performance, or for cash flow as a measure of the company's liquidity. In addition, because Operating EBITDA, Operating EBITDA margin, Adjusted Operating EBITDA, Adjusted Operating EBITDA margin, EBITDA, EBITDA margin, Adjusted EBITDA, and Adjusted EBITDA margin may not be calculated identically by all companies, the presentation here may not be comparable to other similarly titled measures of other companies.

Table 6

Three Months Ended

Twelve Months Ended

(in millions, except percentages)

December 31,

December 31,

Reconciliation of Operating Income to Operating EBITDA and
Adjusted Operating EBITDA (Per Table 1)

2025

2024

2025

2024

Operating income

$         403.8

$         298.5

$      1,467.1

$      1,098.4

Depreciation and amortization

31.3

32.1

122.4

133.0

Operating EBITDA

$         435.1

$         330.6

$      1,589.5

$      1,231.4

Operating EBITDA Margin

64.8 %

63.0 %

65.4 %

59.4 %

Non-GAAP adjustments not included in above line items                                           

Acquisition-related costs

(0.1)

0.1

0.3

1.3

Business realignment costs

4.0

0.5

7.0

2.1

Cboe Digital syndication wind down







(1.0)

Change in contingent consideration







2.1

Executive compensation adjustment

0.6



1.6



Impairment of assets

25.1



46.7

81.0

Adjusted Operating EBITDA

$         464.7

$         331.2

$      1,645.1

$      1,316.9

Adjusted Operating EBITDA Margin

69.2 %

63.1 %

67.7 %

63.5 %

Reconciliation of Net Income Allocated to Common Stockholders
to EBITDA and Adjusted EBITDA (Per Table 1)

2025

2024

2025

2024

Net income allocated to common stockholders

$         312.2

$         195.6

$      1,094.8

$         761.0

Interest expense, net

(2.1)

5.7

2.9

24.2

Income tax provision

138.2

83.2

466.6

318.9

Depreciation and amortization

31.3

32.1

122.4

133.0

EBITDA

$         479.6

$         316.6

$      1,686.7

$      1,237.1

EBITDA Margin

71.5 %

60.4 %

69.4 %

59.7 %

Non-GAAP adjustments not included in above line items

Acquisition-related costs

(0.1)

0.1

0.3

1.3

Business realignment costs

4.0

0.5

7.0

2.1

Cboe Digital syndication wind down







(1.0)

Change in contingent consideration







2.1

Non-operating investment adjustments, net

(45.1)

14.4

(96.8)

31.4

Executive compensation adjustment

0.6



1.6



Gain on Cboe Digital non-recourse notes and warrants wind down







(1.4)

Gain on sale of property held for sale







(1.0)

Impairment of assets

25.1



46.7

81.0

Adjusted EBITDA

$         464.1

$         331.6

$      1,645.5

$      1,351.6

Adjusted EBITDA Margin

69.2 %

63.2 %

67.7 %

65.2 %

Table 7

(in millions)

December 31,

Reconciliation of Cash and Cash Equivalents to Adjusted Cash

2025

2024

Cash and cash equivalents

$        2,216.5

$            920.3

Financial investments

36.1

110.3

Less deferred compensation plan assets                                                                                                                                               

(35.8)

(40.3)

Less cash collected for Section 31 Fees



(110.8)

Adjusted Cash

$        2,216.8

$            879.5

Table 8

Three Months Ended

Twelve Months Ended

(in millions)

December 31,

December 31,

Reconciliation of GAAP Net Revenue to Net Revenue in
Constant Currency

2025

2024

2025

2024

Europe and Asia Pacific net revenue                                                                                        

$              69.9

$              56.2

$            273.5

$            220.2

Constant currency adjustment

(4.1)



(8.4)



Europe and Asia Pacific net revenue in constant currency1

$              65.8

$              56.2

$            265.1

$            220.2

(1)

Net revenue in constant currency is calculated by converting the current period GAAP net revenue in local currency using the foreign currency exchange rates that were in effect during the previous comparable period.

SOURCE Cboe Global Markets, Inc.
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
AGF Management Limited - Normal Course Issuer Bid stocknewsapi
AGFMF
February 06, 2026 07:30 ET  | Source: AGF Management Ltd.

TORONTO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- AGF Management Limited (“AGF”) announced today that the Toronto Stock Exchange (“TSX”) has approved AGF’s notice of intention to renew its normal course issuer bid in respect of its Class B Non-Voting Shares (AGF.B).

As at January 26, 2026, there were 64,472,5331 Class B Non-Voting Shares issued and outstanding and the public float consisted of 46,938,306 Class B Non-Voting Shares.

Under the announced normal course issuer bid, AGF is permitted to purchase up to 4,693,830 Class B Non-Voting Shares, representing approximately 10% of the public float for such shares as of January 26, 2026. Purchases under the normal course issuer bid may commence on February 10, 2026 and continue until February 9, 2027, when the bid expires. Pursuant to the Articles of AGF, the Class B Non-Voting Shares may not be purchased by AGF at a price which exceeds more than 15% of the weighted average price at which the Class B Shares traded on the TSX during the ten trading days immediately preceding the date of any such purchase.

AGF announced that it will be entering into an automatic purchase plan (the “Plan”) with a broker during the normal course issuer bid. The Plan is effective as of February 10, 2026 and should terminate together with the normal course issuer bid. The Plan allows for purchases by AGF of its Class B Non-Voting Shares, subject to certain parameters.

Under the announced normal course issuer bid, purchases may be made through the facilities of TSX, alternative Canadian trading systems /other designated exchanges, or as otherwise permitted by the Canadian Securities Administrators or Ontario Securities Commission. The average daily trading volume (“ADTV”) of the Class B Non-Voting Shares (for the six-month period ended January 31, 2026) on the TSX was 107,502. Under the rules of the TSX, AGF is entitled to repurchase during the same trading day on the TSX up to 25% of the ADTV of its Class B Non-Voting Shares, being 26,875 except where reliance is placed on the TSX’s block purchase exemption.

Class B Non-Voting Shares purchased under the NCIB will be canceled or purchased and held by the AGF Employee Benefit Trust for the settlement of equity settled incentive plans by AGF. The directors believe that the purchase for cancellation of Class B Non-Voting Shares represents a desirable use of capital when, if in the opinion of management, the value of the Class B Non-Voting shares is attractive relative to the trading price of said shares.  Purchase for cancellation by AGF of outstanding Class B Non-Voting Shares may also be used to offset the dilutive effect of treasury stock released for the employee benefit trust and of shares issued through AGF’s stock option plans and dividend reinvestment plan.

Under its existing normal course issuer bid, which expires on February 9, 2026, AGF sought and received approval from the TSX to purchase 4,750,792 Class B Non-Voting Shares. During the period from February 10, 2025, to February 4, 2026, AGF acquired 2,757,313 Class B Non-Voting Shares at a weighted average price of $13.30.

About AGF Management Limited

Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. Our companies deliver excellence in investing in the public and private markets through three business lines: AGF Investments, AGF Capital Partners and AGF Private Wealth.

AGF brings a disciplined approach, focused on incorporating sound, responsible and sustainable corporate practices. The firm’s collective investment expertise, driven by its fundamental, quantitative and private investing capabilities, extends globally to a wide range of clients, from financial advisors and their clients to high-net worth and institutional investors including pension plans, corporate plans, sovereign wealth funds, endowments and foundations.

Headquartered in Toronto, Canada, AGF has investment operations and client servicing teams on the ground in North America and Europe. With over $59 billion in total assets under management and fee-earning assets, AGF serves more than 820,000 investors. AGF trades on the Toronto Stock Exchange under the symbol AGF.B.

Media Contact

Amanda Marchment
Director, Corporate Communications
416-865-4160
[email protected]  

1 Includes treasury stock in the amount of 403,336
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Papa Johns Canada Launches Pizza My Heart for Valentine's Day stocknewsapi
PZZA
EDMONTON, Alberta, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Papa Johns Canada is launching Pizza My Heart, a new limited-time heart pizza available nationwide for Valentine’s Day.

On menus from February 9 through February 15, Pizza My Heart is a one-topping heart pizza on thin crust, made with Papa Johns’ signature fresh, never frozen dough, vine-ripened tomato sauce, and real mozzarella cheese. Priced at $17.99, the limited-time offering gives customers a festive way to mark Valentine’s Day at home.

Whether it’s a date night in, a family dinner, or something in between, Pizza My Heart brings a Valentine’s Day twist to a familiar favourite—one that people already love to share.

“Valentine’s Day and good food tend to go hand in hand,” said Michael Prentice, Senior Franchise Growth Director at Papa Johns Canada. “Pizza My Heart is one of those items people get genuinely excited about, and we’re excited to bring it to Canada for the first time.”

The limited-time Pizza My Heart will be available for carryout and delivery at participating Papa Johns locations across Canada, while supplies last.

About Papa Johns
Papa John’s International, Inc. (Nasdaq: PZZA) opened its doors in 1984 with one goal in mind: BETTER INGREDIENTS. BETTER PIZZA.® Papa Johns believes that using high-quality ingredients leads to superior quality pizzas. Its original dough is made of only six ingredients and is fresh, never frozen. Papa Johns tops its pizzas with real cheese made from mozzarella, pizza sauce made with vine-ripened tomatoes that go from vine to can in the same day and meat free of fillers. It was the first national pizza delivery chain to announce the removal of artificial flavors and synthetic colors from its entire food menu. Papa Johns is co-headquartered in Atlanta, Ga. and Louisville, Ky. and is the world’s third-largest pizza delivery company with approximately 6,000 restaurants in approximately 50 countries and territories. For more information about the company or to order pizza online, visit www.PapaJohns.ca or download the Papa Johns mobile app for iOS or Android.

Media:

Michelle Philippe
Communications Manager, Brand PR & Campaigns
Papa John’s International
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/68142719-8a2c-4895-b28e-8940dd5a64c2

Papa Johns Canada - Pizza My Heart Pizza My Heart is a one-topping heart pizza on thin crust, made with Papa Johns’ signature fresh, ne...
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) stocknewsapi
NTLA
February 06, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc.

CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on February 1, 2026, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment.

The inducement grants consisted of time-based restricted stock units (“RSUs”) for an aggregate of 30,600 shares of Intellia’s common stock, with one-third of such RSUs vesting annually over three years. All equity vesting is subject to each employee’s continued service as an employee of, or other service provider to, Intellia through the applicable vesting dates.

All of the above-described awards were granted outside of Intellia’s stockholder-approved equity incentive plans pursuant to Intellia’s 2024 Inducement Plan, which was adopted by the board of directors in June 2024. These awards were approved by Intellia’s compensation committee as a material inducement to entering into employment with Intellia in accordance with Nasdaq Listing Rule 5635(c)(4).

About Intellia Therapeutics

Intellia Therapeutics, Inc. (Nasdaq: NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia’s deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing and delivery technologies. Learn more at intelliatx.com and follow us @intelliatx.

Intellia Contact:

Jason Fredette
Vice President, Investor Relations and Corporate Communications
[email protected]
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Wrap Technologies Highlights Clinton County Probation Services' Adoption of WrapReality™ to Advance Non-Lethal Response Training in Corrections stocknewsapi
WRAP
MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in non-lethal response and public safety technology, today highlighted the successful implementation of its WrapReality™ virtual reality platform by Clinton County Probation Services (“Clinton County”), a Pennsylvania-based corrections agency.

Led by Ed Hosler, a 20-year probation professional and certified instructor across defensive tactics, firearms, and other tools for law enforcement, Clinton County adopted WrapReality with the goal to enhance realism, improve decision-making under stress, and support consistent Non-Lethal Response training across probation officers, jail staff, and partner agencies. Clinton County initially evaluated WrapReality VR as part of a grant-funded initiative focused on expanding training realism beyond legacy laser-based simulators. According to Hosler, traditional 2D systems failed to fully immerse officers or reflect real-world positioning, movement, and decision-making challenges commonly encountered in corrections, probation, and reentry settings.

Clinton County reported that WrapReality’s immersive 360-degree environments, instructor-controlled avatars, and dynamic scenario flow enabled officers to physically move, seek cover, and engage in realistic verbal and tactical interactions. The capabilities of WrapReality were described as “unsurpassed” in terms of realism and officer engagement.

Clinton County integrated WrapReality VR into its 3,000-square-foot training facility, where the system is used not only by probation officers, but also by jail staff, local law enforcement agencies, and first responders. The platform is designed to support pre-certification exposure for firearms, scenario-based training, and after-action review, allowing instructors to pause, reset, and replay scenarios to reinforce learning and review their own decision-making under stress. Clinton County’s use of WrapReality extends beyond traditional patrol scenarios to corrections-specific and reentry-focused use cases, including verbal de-escalation, crisis intervention, and community reintegration encounters, which is an area where many agencies have reportedly struggled to establish consistent non-lethal training models.

Hosler emphasized that the instructor-driven functionality of WrapReality allows training to be tailored to agency-specific realities, including rural environments, custody settings, and probation encounters. In Clinton County’s experience, instructors can dynamically adapt avatar behavior, alter starting positions, and test decision-making across multiple force options, including verbal skills, OC spray, conducted electrical weapons, firearms, and BolaWrap®. Clinton County emphasized that it incorporated the WrapReality system to drive continuous education for firearms training and recruit onboarding, enabling officers to safely make mistakes, receive immediate feedback, and re-enter scenarios with improved tactics and mentality.

Integration into a Non-Lethal Response Program

Clinton County’s experience reinforces Wrap’s broader Non-Lethal Response strategy, which emphasizes the integration of technology, training, and policy with the aim to drive safer, more consistent outcomes. WrapReality is designed to enable agencies to train not just on individual tools, but on when, why, and how non-lethal options should be deployed within the totality of circumstances, particularly in correctional and custodial environments where de-escalation and containment are critical.

“We believe non-lethal tools are only effective if they are integrated into a well-structured training program,” said Ed Hosler, Deputy Chief Probation Officer. “WrapReality allows us to test judgment, reinforce verbal skills, and build confidence across different force options. In less than a year, we have seen improvements in awareness, de-escalation, and more deliberate decision-making.”

Strategic Value

Clinton County Probation Services represents a compelling example of how immersive training can support corrections, probation, jail operations, and community reentry programs, expanding the addressable use cases for non-lethal response solutions beyond traditional patrol environments. We believe Clinton County’s success in utilizing WrapReality underscores the importance of realistic training, instructor control, and integrated policy in driving sustainable adoption of non-lethal solutions.

About Wrap Technologies, Inc.

Wrap Technologies, Inc. (Nasdaq: WRAP) a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations.

Wrap's complete public safety portfolio includes the non-lethal BolaWrap® 150 device, WrapReality™ immersive training platform, WrapVision™ body-worn camera system, WrapTactics™ training programs, and next-generation CUAS solutions like PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company's mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets. Wrap's BolaWrap® 150 solution leads in pre-escalation intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption that leverages sight, sound and sensation to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap® 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap® is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap's commitment to public safety through cutting-edge technology and expert training.

WrapReality™ VR is a fully immersive training simulator to enhance decision-making under pressure.

As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality™ is intended to equip officers with the skills and confidence to navigate high-stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve.

WrapVision is an all-new body-worn camera and evidence management system built for efficiency.

Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view.

The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with country-of-origin (COO) United States. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks.

Trademark Information

Wrap, the Wrap logo, BolaWrap®, WrapReality™ and Wrap Training Academy are trademarks of Wrap Technologies, Inc., some of which are registered in the U.S. and abroad. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements - Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "anticipate," "should", "believe", "target", "project", "goals", "estimate", "potential", "predict", "may", "will", "could", "intend", and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control and include, but are not limited to, statements relating to Wrap's planned future products, technologies, integration, intended product designs and expected benefits therefrom, expected market opportunities and outcomes related to Wrap's products to increase officer and public safety. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ability to maintain compliance with the Nasdaq Capital Market's listing standards; the Company's ability to successfully implement training programs for the use of its products; the Company's ability to manufacture and produce products for its customers; the Company's ability to develop sales for its products; the market acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company's product solutions; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the impact resulting from geopolitical conflicts and any resulting sanctions; the ability to obtain export licenses for counties outside of the United States; the ability to obtain patents and defend intellectual property against competitors; the impact of competitive products and solutions; and the Company's ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company's most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and other Securities and Exchange Commission filings. These forward-looking statements are made as of the date of this release and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investor Relations Contact:

(800) 583-2652
[email protected]
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum stocknewsapi
TGTX
NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual forum, being held in San Diego, California. Links to each presentation are included below.

Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, “We are pleased to share data at this year’s ACTRIMS annual meeting, including updates from the ENABLE real world study evaluating patients with RMS on BRIUMVI. Our presentations reflect our continued focus on advancing the clinical understanding of BRIUMVI and supporting the MS community with meaningful data.”

TG PRESENTATIONS:

Poster Presentation Title: Real-World Infusion Experience with Ublituximab in ENABLE: the First Phase 4 Observational Study for Patients with Relapsing Multiple Sclerosis Initiating Ublituximab

Lead Author: Carrie Hersh, DO, MSc, FAAN - Cleveland Clinic Lou Ruvo Center for Brain Health (CCLRCBH) (MS) & Neuroimmunology Specialist – Assoc. Professor of Neurology at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Poster Presentation Title: Study Design of a Phase 2 Ublituximab Dose Confirmation Study in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS I

Lead Author: K. Mok, PhD – VP Clinical Development, Global Operations TG Therapeutics
Poster Presentation Title: Study Design of a Phase 3, Randomized, Double-Blind Study of Ublituximab Versus Fingolimod in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS II

Lead Author: K. Mok, PhD – VP Clinical Development, Global Operations TG Therapeutics
The above TG presentations are available on the Publications page, located within the Pipeline section, of the Company’s website at www.tgtherapeutics.com/publications.cfm.

OTHER PRESENTATIONS OF BRIUMVI DATA: 

Poster Presentation Title: Multi-protein Biomarker Test Results for Participants Treated with Ublituximab from the Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab (ENHANCE)

Lead Author: S. McCurdy - Octave Bioscience, Menlo Park, CA
All presentations are available via the ACTRIMS ePoster gallery available at www.forum.actrims.org.

ABOUT THE ULTIMATE I & II PHASE 3 TRIALS
ULTIMATE I & II are two randomized, double-blind, double-dummy, parallel group, active comparator-controlled clinical trials of identical design, in patients with RMS treated for 96 weeks. Patients were randomized to receive either BRIUMVI, given as an IV infusion of 150 mg administered in four hours, 450 mg two weeks after the first infusion administered in one hour, and 450 mg every 24 weeks administered in one hour, with oral placebo administered daily; or teriflunomide, the active comparator, given orally as a 14 mg daily dose with IV placebo administered on the same schedule as BRIUMVI. Both studies enrolled patients who had experienced at least one relapse in the previous year, two relapses in the previous two years, or had the presence of a T1 gadolinium (Gd)-enhancing lesion in the previous year. Patients were also required to have an Expanded Disability Status Scale (EDSS) score from 0 to 5.5 at baseline. The ULTIMATE I & II trials enrolled a total of 1,094 patients with RMS across 10 countries. These trials were led by Lawrence Steinman, MD, Zimmermann Professor of Neurology & Neurological Sciences, and Pediatrics at Stanford University. Additional information on these clinical trials can be found at www.clinicaltrials.gov (NCT03277261; NCT03277248).

ABOUT BRIUMVI® (ublituximab-xiiy) 150 mg/6 mL Injection for IV
BRIUMVI is a novel monoclonal antibody that targets a unique epitope on CD20-expressing B-cells. Targeting CD20 using monoclonal antibodies has proven to be an important therapeutic approach for the management of autoimmune disorders, such as RMS. BRIUMVI is uniquely designed to lack certain sugar molecules normally expressed on the antibody. Removal of these sugar molecules, a process called glycoengineering, allows for efficient B-cell depletion at low doses.

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in several countries outside of the U.S. for the treatment of adult patients with RMS with active disease defined by clinical or imaging features.

A list of authorized specialty distributors can be found at www.briumvi.com.

IMPORTANT SAFETY INFORMATION
Contraindications: BRIUMVI is contraindicated in patients with:

Active Hepatitis B Virus infectionA history of life-threatening infusion reaction to BRIUMVI WARNINGS AND PRECAUTIONS

Infusion Reactions: BRIUMVI can cause infusion reactions, which can include pyrexia, chills, headache, influenza-like illness, tachycardia, nausea, throat irritation, erythema, and an anaphylactic reaction. In MS clinical trials, the incidence of infusion reactions in BRIUMVI-treated patients who received infusion reaction-limiting premedication prior to each infusion was 48%, with the highest incidence within 24 hours of the first infusion. 0.6% of BRIUMVI-treated patients experienced infusion reactions that were serious, some requiring hospitalization.

Observe treated patients for infusion reactions during the infusion and for at least one hour after the completion of the first two infusions unless infusion reaction and/or hypersensitivity has been observed in association with the current or any prior infusion. Inform patients that infusion reactions can occur up to 24 hours after the infusion. Administer the recommended pre-medication to reduce the frequency and severity of infusion reactions. If life-threatening, stop the infusion immediately, permanently discontinue BRIUMVI, and administer appropriate supportive treatment. Less severe infusion reactions may involve temporarily stopping the infusion, reducing the infusion rate, and/or administering symptomatic treatment.

Infections: Serious, life-threatening or fatal, bacterial and viral infections have been reported in BRIUMVI-treated patients. In MS clinical trials, the overall rate of infections in BRIUMVI-treated patients was 56% compared to 54% in teriflunomide-treated patients. The rate of serious infections was 5% compared to 3% respectively. There were 3 infection-related deaths in BRIUMVI-treated patients. The most common infections in BRIUMVI-treated patients included upper respiratory tract infection (45%) and urinary tract infection (10%). Delay BRIUMVI administration in patients with an active infection until the infection is resolved.

Consider the potential for increased immunosuppressive effects when initiating BRIUMVI after immunosuppressive therapy or initiating an immunosuppressive therapy after BRIUMVI.

Hepatitis B Virus (HBV) Reactivation: HBV reactivation occurred in an MS patient treated with BRIUMVI in clinical trials. Fulminant hepatitis, hepatic failure, and death caused by HBV reactivation have occurred in patients treated with anti-CD20 antibodies. Perform HBV screening in all patients before initiation of treatment with BRIUMVI. Do not start treatment with BRIUMVI in patients with active HBV confirmed by positive results for HB surface antigen (HBsAg) and anti-HB tests. For patients who are negative for HBsAg and positive for HB core antibody [HBcAb+] or are carriers of HBV [HBsAg+], consult a liver disease expert before starting and during treatment.

Progressive Multifocal Leukoencephalopathy (PML): PML is an opportunistic viral infection of the brain caused by the JC virus (JCV) that typically only occurs in patients who are immunocompromised, and that usually leads to death or severe disability. JCV infection resulting in PML has been observed in patients treated with anti-CD20 antibodies, including BRIUMVI, and other MS therapies.

If PML is suspected, withhold BRIUMVI and perform an appropriate diagnostic evaluation. Typical symptoms associated with PML are diverse, progress over days to weeks, and include progressive weakness on one side of the body or clumsiness of limbs, disturbance of vision, and changes in thinking, memory, and orientation leading to confusion and personality changes.

MRI findings may be apparent before clinical signs or symptoms; monitoring for signs consistent with PML may be useful. Further investigate suspicious findings to allow for an early diagnosis of PML, if present. Following discontinuation of another MS medication associated with PML, lower PML-related mortality and morbidity have been reported in patients who were initially asymptomatic at diagnosis compared to patients who had characteristic clinical signs and symptoms at diagnosis.

If PML is confirmed, treatment with BRIUMVI should be discontinued.

Vaccinations: Administer all immunizations according to immunization guidelines: for live or live-attenuated vaccines, at least 4 weeks and, whenever possible, at least 2 weeks prior to initiation of BRIUMVI for non-live vaccines. BRIUMVI may interfere with the effectiveness of non-live vaccines. The safety of immunization with live or live-attenuated vaccines during or following administration of BRIUMVI has not been studied. Vaccination with live virus vaccines is not recommended during treatment and until B-cell repletion.

Vaccination of Infants Born to Mothers Treated with BRIUMVI During Pregnancy: In infants of mothers exposed to BRIUMVI during pregnancy, assess B-cell counts prior to administration of live or live-attenuated vaccines as measured by CD19+ B-cells. Depletion of B-cells in these infants may increase the risks from live or live-attenuated vaccines. Inactivated or non-live vaccines may be administered prior to B-cell recovery. Assessment of vaccine immune responses, including consultation with a qualified specialist, should be considered to determine whether a protective immune response was mounted.

Fetal Risk: Based on data from animal studies, BRIUMVI may cause fetal harm when administered to a pregnant woman. Transient peripheral B-cell depletion and lymphocytopenia have been reported in infants born to mothers exposed to other anti-CD20 B-cell depleting antibodies during pregnancy. Advise females of reproductive potential to use effective contraception during BRIUMVI treatment and for 6 months after the last dose.

Reduction in Immunoglobulins: As expected with any B-cell depleting therapy, decreased immunoglobulin levels were observed. Decrease in immunoglobulin M (IgM) was reported in 0.6% of BRIUMVI-treated patients compared to none of the patients treated with teriflunomide in RMS clinical trials. Monitor the levels of quantitative serum immunoglobulins during treatment, especially in patients with opportunistic or recurrent infections, and after discontinuation of therapy, until B-cell repletion. Consider discontinuing BRIUMVI therapy if a patient with low immunoglobulins develops a serious opportunistic infection or recurrent infections, or if prolonged hypogammaglobulinemia requires treatment with intravenous immunoglobulins.

Liver Injury: Clinically significant liver injury, without findings of viral hepatitis, has been reported in the postmarketing setting in patients treated with anti-CD20 B-cell depleting therapies approved for the treatment of MS, including BRIUMVI. Signs of liver injury, including markedly elevated serum hepatic enzymes with elevated total bilirubin, have occurred from weeks to months after administration.

Patients treated with BRIUMVI found to have an alanine aminotransaminase (ALT) or aspartate aminotransferase (AST) greater than 3x the upper limit of normal (ULN) with serum total bilirubin greater than 2x ULN are potentially at risk for severe drug-induced liver injury.

Obtain liver function tests prior to initiating treatment with BRIUMVI, and monitor for signs and symptoms of any hepatic injury during treatment. Measure serum aminotransferases, alkaline phosphatase, and bilirubin levels promptly in patients who report symptoms that may indicate liver injury, including new or worsening fatigue, anorexia, nausea, vomiting, right upper abdominal discomfort, dark urine, or jaundice. If liver injury is present and an alternative etiology is not identified, discontinue BRIUMVI.

Most Common Adverse Reactions: The most common adverse reactions in RMS trials (incidence of at least 10%) were infusion reactions and upper respiratory tract infections.

Physicians, pharmacists, or other healthcare professionals with questions about BRIUMVI should visit www.briumvi.com.

ABOUT BRIUMVI PATIENT SUPPORT in the U.S.
BRIUMVI Patient Support is a flexible program designed by TG Therapeutics to support U.S. patients through their treatment journey in a way that works best for them. More information about the BRIUMVI Patient Support program can be accessed at www.briumvipatientsupport.com.

ABOUT MULTIPLE SCLEROSIS
Relapsing multiple sclerosis (RMS) is a chronic demyelinating disease of the central nervous system (CNS) and includes people with relapsing-remitting multiple sclerosis (RRMS) and people with secondary progressive multiple sclerosis (SPMS) who continue to experience relapses. RRMS is the most common form of multiple sclerosis (MS) and is characterized by episodes of new or worsening signs or symptoms (relapses) followed by periods of recovery. It is estimated that nearly 1 million people are living with MS in the United States and approximately 85% are initially diagnosed with RRMS.1,2 The majority of people who are diagnosed with RRMS will eventually transition to SPMS, in which they experience steadily worsening disability over time. Worldwide, more than 2.3 million people have a diagnosis of MS.1

ABOUT TG THERAPEUTICS
TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit

www.tgtherapeutics.com, and follow us on X (formerly Twitter)

@TGTherapeutics and on

LinkedIn.

BRIUMVI® is a registered trademark of TG Therapeutics, Inc.

Cautionary Statement
This press release contains forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward- looking statements contained in this press release. In addition to the risk factors identified from time to time in our reports filed with the U.S. Securities and Exchange Commission (SEC), factors that could cause our actual results to differ materially include the below.

Such forward looking statements include but are not limited to statements regarding the ULTIMATE I & II Phase 3 studies, the ULTIMATE KIDS I & II studies, the ENHANCE study, the ENABLE study and BRIUMVI as a treatment for relapsing forms of multiple sclerosis (RMS). Additional factors that could cause our actual results to differ materially include the following: the risk that the data from any studies evaluating BRIUMVI that we announce or publish may change, or the product profile of BRIUMVI may be impacted, as more data or additional endpoints are analyzed; the risk that data may emerge from future clinical studies or from adverse event reporting that may affect the safety and tolerability profile and commercial potential of BRIUMVI; the risk that any individual patient’s clinical experience in the post-marketing setting, or the aggregate patient experience in the post-marketing setting, may differ from that demonstrated in controlled clinical trials such as ULTIMATE I and II; the risk that BRIUMVI will not be commercially successful; our ability to expand our commercial infrastructure, and successfully market and sell BRIUMVI in RMS; the Company’s reliance on third parties for manufacturing, distribution and supply, and a range of other support functions for our commercial and clinical products, including BRIUMVI, and the ability of the Company and its manufacturers and suppliers to produce and deliver BRIUMVI to meet the market demand for BRIUMVI; the failure to obtain and maintain requisite regulatory approvals, including the risk that the Company fails to satisfy post-approval regulatory requirements; the uncertainties inherent in research and development and general political, economic and business conditions. Further discussion about these and other risks and uncertainties can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our other filings with the U.S. Securities and Exchange Commission.

Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at www.tgtherapeutics.com. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.

CONTACT:
Investor Relations
Email:[email protected]
Telephone: 1.877.575.TGTX (8489), Option 4

Media Relations
Email:[email protected]
Telephone: 1.877.575.TGTX (8489), Option 6

1. MS Prevalence. National Multiple Sclerosis Society website. https://www.nationalmssociety.org/About-the-Society/MS-Prevalence. Accessed October 26, 2020. 2. Multiple Sclerosis International Federation, 2013 via Data monitor p. 236.
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve “Project Vault” and Highlights Titanium's Strategic Importance to North American Defense Supply Chains stocknewsapi
SAGMF
VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, acknowledges the recent announcement by The White House and Donald Trump of “Project Vault,” a large-scale U.S. strategic stockpile initiative intended to strengthen domestic supply chains, advance national security priorities, and reduce reliance on foreign-controlled sources of critical minerals and raw materials.

Project Vault—announced in the Oval Office with participation from Export-Import Bank of the United States (“EXIM”) — establishes the U.S. Strategic Critical Minerals Reserve as an independently governed public-private partnership designed to store essential raw materials across U.S. facilities.

EXIM has approved a Direct Loan of up to US$10 billion to support Project Vault, providing long-term financing for a partnership between original equipment manufacturers and private-sector capital providers—an effort EXIM has positioned as strengthening U.S. production and processing capacity, insulating manufacturers from supply shocks, and advancing U.S. national economic security objectives.

The stockpile is the latest move by the Trump administration to build a Western supply chain to counter China’s dominance in critical minerals — especially when it comes to refining. Beijing sought to cut off exports of rare earths, a subset of critical minerals, last year during trade disputes with the U.S.

A Media Snippet accompanying this announcement is available by clicking on this link.

Preferential trade alignment and allied coordination on display at the Critical Minerals Ministerial in Washington, D.C.

The U.S. efforts to diversify and stabilize critical minerals supply chains are expanding beyond domestic stockpiling toward allied coordination. On February 4, U.S. Vice President JD Vance outlined plans aimed at organizing partners into a preferential trade framework for critical minerals, including mechanisms intended to promote market stability and reduce vulnerability to price undercutting and supply disruption.

Canada’s Foreign Affairs Minister Anita Anand was in Washington on Wednesday as the Trump administration made a case for international partners to join a preferential trade zone for critical minerals with forced price floors.

Canada and the U.S. Department of Defense already have a co-investment deal to accelerate Canadian mining development and strengthen critical minerals supply chains.

A Media Snippet accompanying this announcement is available by clicking on this link.

Titanium: A national defense critical mineral facing supply chain constraints

Titanium remains a cornerstone material for aerospace and defense platforms, infrastructure, and high-performance industrial uses, and continues to be a strategic concern for Western supply chains due to limited domestic sourcing and processing capacity. Titanium is deemed a critical metal by the U.S., EU and Canada and is essential for defense and aerospace applications due to its strength-to-weight ratio and corrosion resistance.

Titanium is characterized as a critical mineral for defense and aerospace, with supply-chain risk concentrated in titanium metal pathways (including aerospace-grade sponge capacity and certification) rather than in pigment markets. The vast majority – over 90% globally of mined titanium is processed into the pigment – a looming supply chain gap UK-headquartered market intelligence company Project Blue outlines in a recent report.

“Titanium is essentially a defence metal – it can be up to 20% or more of the markets for total titanium consumption that goes into defence. An F 15 can be up to 40% in weight of titanium. There’s some serious volume going in these jet planes,” Project Blue Founder and Director, Dr. Nils Backeberg

Saga Metals’ Project Focus: Critical Minerals and Titanium Exploration in Labrador

Saga Metals believes the evolving policy environment reinforces the strategic relevance of North American Critical Minerals projects that can support secure, resilient supply chains for defense, aerospace, and advanced manufacturing. The Company’s flagship Radar Ti-V-Fe Project is located in Labrador near the port community of Cartwright and is supported by existing infrastructure, including road access and proximity to tidewater logistics. Saga recently announced a 100% drilling success rate in 2025 with exceptional grades of titanium, vanadium, and iron in all 15 drill holes completed at the Radar Critical Minerals Project. The company is advancing towards a Mineral Resource Estimate and has completed four diamond drill holes in 2026 to start the year.

Mike Stier, CEO & Director of Saga Metals commented: “The U.S. government’s focus on critical mineral stockpiling reinforces the strategic importance of secure, allied sources of materials such as titanium—particularly for North American national security and defense-related supply chains. Saga Metals continues to advance its portfolio with a focus on critical minerals that support supply-chain security, advanced manufacturing, and future-facing technologies. We believe this policy momentum highlights the importance of investing in strategic mining projects that can help build resilience—diversifying supply, strengthening domestic and allied production capacity, and supporting stable investment conditions for the critical materials that power our economies and protect our industries.”

Key implications Saga Metals sees from Project Vault and allied initiatives

Saga Metals recognizes several key implications from Project Vault and the broader allied push toward critical-minerals security:

Rising strategic value of titanium and other critical metals in defense readiness, aerospace manufacturing, and industrial policy.Potential acceleration of investment in North American exploration, development, and processing capacity as governments prioritize secure supply.Expanded public-private cooperation to create resilient, domestically aligned supply chains and mitigate market disruption risk.Increased allied coordination on pricing stability, trade frameworks, and supply diversification to reduce dependency on concentrated refining and processing pathways. About Critical Minerals

Critical minerals are the foundation upon which modern technology is built. They are used in a wide range of essential products ranging from mobile phones and solar panels to electric vehicle batteries, medical devices and defense applications. Canada’s critical minerals list identifies 34 minerals and metals while the U.S.A identifies 60 minerals and metals as critical.

Investor Relations Agreement

Additionally, the Company and GRA Enterprises LLC DBA National Inflation Association ("NIA") entered into a consulting agreement (the "NIA Agreement") for investor relations and communication services. The NIA Agreement has an initial term of twelve (12) months, at an aggregate cost of USD$100,000 for the term. Following the initial term, the NIA Agreement can be extended by three (3) months for an additional USD$30,000, six (6) months for an additional USD$50,000 or one year for an additional USD$100,000. NIA will leverage its expansive distribution channels - including targeted email lists, website features, and blog content - to highlight the Company's growth story and project developments.

NIA, based in Mooresville, North Carolina, has a strong track record of investor communications for publicly traded companies. The Company will not issue any securities to NIA as compensation. NIA and its principals are at arm's length to the Company. NIA currently has no direct or indirect interest in the securities of the Company, or any right or intent to acquire such an interest.

For more information about NIA: Contact [email protected] or visit them at 112 Camp Lane, Mooresville, North Carolina, 28117.

Qualified Person

Paul J. McGuigan, P. Geo., is an Independent Qualified Person as defined under National Instrument 43-101 and has reviewed and approved the technical information disclosed in this news release.

About SAGA Metals Corp.

SAGA Metals Corp. is a North American mining company focused on the exploration and discovery of a diversified suite of critical minerals that support the North American transition to supply security. The Radar Ti-V-Fe Project comprises 24,175 hectares and entirely encloses the Dykes River intrusive complex, mapped at 160 km² on the surface near Cartwright, Labrador. Exploration to date, including 4,250 m of drilling, has confirmed a large, mineralized layered mafic intrusion hosting vanadiferous titanomagnetite (VTM) and ilmenite mineralization with strong grades of titanium and vanadium.

The Double Mer Uranium Project, also in Labrador, covers 25,600 hectares and features uranium radiometrics that highlight an 18km east-west trend, with a confirmed 14km section producing samples as high as 0.428% U3O8. Uranium uranophane was identified in several areas of highest radiometric response (2024 Double Mer Technical Report).

Additionally, SAGA owns the Legacy Lithium Property in Quebec's Eeyou Istchee James Bay region. This project, developed in partnership with Rio Tinto, has been expanded through the acquisition of the Amirault Lithium Project. Together, these properties cover 65,849 hectares and share significant geological continuity with other major players in the area, including Rio Tinto, Winsome Resources, Azimut Exploration, and Loyal Metals.

With a portfolio spanning key commodities critical to the clean energy future, SAGA is strategically positioned to play an essential role in critical mineral security.

On Behalf of the Board of Directors

Mike Stier, Chief Executive Officer

For more information, contact:

Rob Guzman, Investor Relations
SAGA Metals Corp.
Tel: +1 (844) 724-2638
Email: [email protected]
www.sagametals.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Disclaimer
This news release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipates”, “expects”, “believes”, and similar expressions or the negative of these words or other comparable terminology. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. In particular, this news release contains forward-looking information pertaining to the Company’s Radar Project and IR agreements listed herein. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, changes in the state of equity and debt markets, fluctuations in commodity prices, delays in obtaining required regulatory or governmental approvals, environmental risks, limitations on insurance coverage, inherent risks and uncertainties involved in the mineral exploration and development industry, particularly given the early-stage nature of the Company’s assets, and the risks detailed in the Company’s continuous disclosure filings with securities regulations from time to time, available under its SEDAR+ profile at www.sedarplus.ca. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law.
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Brixton Metals Defines New Exploration Targets at Thorn Through Geochemical Sampling stocknewsapi
BBBXF
VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce the results from its regional prospecting soil and rock sampling program and the remaining drill results from its 2025 field season at the wholly owned Thorn Project, located in northwest British Columbia, Canada. The company provides a corporate and project update.

Highlights

Soil and rock geochemical sampling conducted within the Camp Creek Corridor has resulted in the identification of multiple new exploration targets. Notably, at the Cirque East Target, porphyry-style mineralization was identified hosted in a monzonite intrusive unit, with assays returning up to 2.16% copper and 39 g/t silver.At the 95th South Target, high-grade silver mineralization was found in veins, yielding up to 642 g/t silver, 1.47% copper, 3.56% lead, and 1.97% zinc.At Brixton’s Annual General and Special Meeting held on February 4th, 2026, shareholders have approved, among other items, a ten for one share consolidation, subject to the approval of the TSX Venture Exchange, which will result in a new post consolidation share count of 71.3 million shares outstanding. The Company believes the current strong metals market, a tight float, and with all four of its gold, silver and copper projects being drilled this year will provide a greater opportunity for share price appreciation.
Chairman, CEO, Gary R. Thompson stated, “The definition of new exploration targets through geochemical sampling with boots on the ground has been an effective approach at the Thorn Project as we continue to identify new areas of mineralization. 2026 is shaping up to be an exciting year for Brixton as we unlock potential at Thorn by drilling this year. Meanwhile current drilling at the Langis Silver Project is progressing well. Ivanhoe Electric is drilling at Brixton’s Hog Heaven copper-gold porphyry Project under the Earn-in Agreement and Eldorado Gold plans to drill Brixton’s Atlin Goldfields Project under the Option Agreement. This year will be the first time ever that all four of our projects will be drilled in the same year, so it’s super exciting. Assays from Langis are anticipated in the coming weeks and months.”

Figure 1. Brixton Metals Project Locations.

Figure 2. Location of Targets at the Thorn Project.

Discussion

During the 2025 exploration season at the Thorn Project, Brixton Metals conducted an extensive regional prospecting program, collecting 770 soil samples and 195 rock samples across multiple target zones. Geochemical analysis of these samples identified several new porphyry exploration targets within the Camp Creek Corridor, including the Cirque East target. In addition, high-grade silver veins at the 95th South Target were mapped and sampled. Drilling activities for the season comprised 3,223 meters at Camp Creek, 6,272 meters at Trapper, 2,670 meters at Catalyst, and 601 meters at Tempest. This news release presents the remaining drillhole results for the Thorn Project at the Camp Creek and Trapper Targets.

Camp Creek Corridor Overview

The Camp Creek Corridor is a northwest-trending zone hosting multiple centers of porphyry-style mineralization. This corridor is interpreted to be perpendicular to the Camp Creek Fault, which may have served as a conduit for porphyry intrusions into both the Stuhini volcanic rocks and the granitic units of the Thorn Stock. Key mineralized systems within the corridor include the Camp Creek Cu-Mo-Au porphyry, along with the recently identified Catalyst Cu-Au (see News Release, dated October 30, 2025) and Tempest Cu-Au (see News Release, dated December 1, 2025) porphyries (Figure 3).

In 2025, soil and rock sampling expanded the surface footprint of the Catalyst and Tempest Targets and delineated additional porphyry-style prospects. Of particular note is the Cirque Target, drilled in 2024, which revealed copper mineralization associated with intrusive breccias (see News Release, dated September 17, 2024). Recent mapping and sampling east of the drilled area have confirmed porphyry-style alteration and outlined a footprint coincident with a one-kilometre-long leach cap. Rock-chip samples from this area returned up to 2.16% copper and 39 g/t silver (sample B137847; see Table 1). Intrusive rocks at Cirque-East are characterized by fine-grained monzonites hosting chalcopyrite and molybdenite within quartz veins. The observed Cu-Ag-Mo mineralization, together with granitic intrusive phases and the development of a leach cap, is typical of porphyry deposits. Ongoing work will focus on refining these field results and evaluating the area for potential drilling in the 2026 campaign.

Figure 3. Map illustrating exploration targets within the Camp Creek Corridor, including locations of historical and 2025 drill holes, copper distribution in soils from both recent and past geochemical surveys, and IP-chargeability polygons delineated during the 2025 field season.

About the 95th South Target

The 95th South Target (see Figure 2 for general location of this target) consists of a series of nearly parallel veins ranging from 30 cm to 2 meters in width, striking ENE-WSE (see Figure 4). These veins are composed of quartz-feldspar with variable amounts of galena, sphalerite, chalcopyrite, bornite and pyrite. Sampling has returned notable values, including up to 642 g/t silver, 1.47% copper, 3.56% lead, and 1.97% zinc (sample B137851), as well as 414 g/t silver (sample B137859). These polymetallic veins intrude a Triassic quartz-diorite, and in some instances, are accompanied by meter-wide alteration halos characterized by quartz-carbonate and localized sulphide mineralization. Further fieldwork in this area will focus on continuous sampling of these mineralized veins and on testing similar structures.

Figure 4. Map illustrating the principal mapped polymetallic veins and locations of rock samples collected from the 95th South Target.

Table 1. Selected rock samples from the 2025 field campaign at the Cirque East and 95th South Targets.

SampleTargetSample TypeAg
(g/t)Cu (ppm)Mo (ppm)Pb (ppm)Zn (ppm)B137827Cirque EastChip1.671020481769B137837Cirque EastChip2.961530212073B137838Cirque EastGrab2.436225642759B137843Cirque EastChip2.42164072686B137847Cirque EastChip39.3021600124136B13785195th SouthGrab642.0014700103560019700B13785695th SouthGrab172.001480016218016350B13785795th SouthChip21.60209042431188B13785895th SouthChip31.80505056217409B13785995th SouthChip414.0074191154076 The collected rocks are selected chip or grab samples of mineralized outcrops within each target area and do not represent the entire target.

Trapper Gold Target

Gold mineralization at Trapper is structurally controlled, trending northwest-southeast and dipping moderately to the north within the main drilling area. Mineralization is preferentially developed along the contact between Cretaceous (85.2 ± 1.2 Ma) quartz diorite and Triassic lapilli tuffs, with broad gold intervals largely hosted along these faulted contacts. Gold is associated with silver and base metal veins containing pyrite, galena, sphalerite, and locally chalcopyrite and bornite. During the 2025 field season, drilling at Trapper comprised 6,272 meters across 30 holes. Notably, drillhole THN25-348 was collared from the same pad as previously reported holes THN25-358 and THN25-359 (see News Release, dated December 16, 2025), with mineralized intervals detailed in Table 2.

Drilling at the Camp Creek High Sulfidation Target

The final drillholes completed in 2025 at the Camp Creek high-sulfidation target include THN25-367, THN25-368, THN25-369, and THN25-370 (see Table 2). These holes intersected mineralized sections ranging from meters to tens of meters, associated with polymetallic veins interpreted as the shallow, high-sulfidation expression of the deeper Camp Creek porphyry system. Drilling at Camp Creek covered 3,223 meters across 19 holes and successfully identified high-sulfidation polymetallic veins. Future drilling in this area will focus on further testing the extent and grade of these high-sulfidation veins and on evaluating similar interpreted structures.

Table 2. Select Assay Intervals in Holes THN25-348 at Trapper and holes THN25-367, THN25-368, THN25-369 and THN25-370 at Camp Creek.

Hole IDFromToIntervalGoldSilverCoppermetermetermeterg/tg/t%THN25-348111.00115.304.301.392.01- 288.00292.004.002.588.07- 313.50314.000.505.3027.60-       THN25-36798.00108.0010.000.90102.210.86including100.35105.805.451.42159.501.38THN25-368128.00137.709.700.3312.520.15including134.50135.601.100.8264.900.90THN25-369174.60175.200.600.5457.400.88 209.00213.924.920.5914.110.03THN25-370263.60264.641.040.2019.95- Assay values are weighted averages. Reported intervals are drilling length, and the true width of the mineralized intervals has not yet been determined

Table 3. Collar location for reported drillholes

Hole IDLocationEasting
(m)Northing
(m)Elevation
(m)AzimuthDipDepth
(m)  THN25-348Trapper630519648540012262-45324 THN25-367Camp Creek6281666491808773140-70143 THN25-368Camp Creek6282576492382859340-60194 THN25-369Camp Creek628257649238285960-60251 THN25-370Camp Creek628257649238285990-60299  Quality Assurance & Quality Control

Brixton Metals has established rigorous quality assurance and quality control procedures for both drill core and surface sampling. Core samples were typically collected at 1.5-meter intervals, with high-grade intervals sampled at 0.5 meters. Blank, duplicate (lab pulp), and certified reference materials were inserted at a combined rate of up to 15 percent. Core samples were split, bagged, secured, and sent directly to ALS Minerals preparation facilities in Whitehorse, Yukon or Langley, British Columbia, depending on laboratory availability. Rock samples, collected as grab or chip samples, followed similar protocols prior to laboratory analysis. ALS Minerals Laboratories is accredited to ISO 9001:2008 and ISO 17025 standards for laboratory procedures. Gold analyses were performed at ALS Laboratory Facilities in North Vancouver, British Columbia, using fire assay with atomic absorption finish, while silver, lead, copper, zinc, and 48 additional elements were analyzed by four acid digestion with ICP-MS finish. Overlimit gold values were determined by fire assay and gravimetric finish. Certified reference materials were sourced from CDN Resource Laboratories Ltd. in Langley, British Columbia, with standards inserted based on the type and abundance of mineralization observed. Non-mineralized siliceous landscaping rock was used as blank material. The Company’s QAQC protocols are available on its website.

Update on Thorn Project

Drilling at Brixton’s Thorn Project is expected to commence in May 2026. Drill results will be released as they become available.

Update on Drilling at Langis Silver Project

Brixton Metals is actively drilling its wholly owned high-grade Langis Silver Project, situated in the renowned, silver-rich Cobalt Camp of Ontario, roughly 500 kilometers north of Toronto. Thus far, in 2026, the Company has completed 3,000 meters of drilling across eight holes, with assay results pending. Results will be released as they are made available.

Update on Hog Heaven and Atlin Projects 

Brixton's Hog Heaven Project, in Montana, is under an Earn-in Option to Ivanhoe Electric and as the operator, Ivanhoe Electric has commenced drilling, in search of the causative copper-gold porphyry system. Brixton's Atlin Goldfields Project in British Columbia is under Option to Eldorado Gold where they plan to start drilling orogenic gold targets in May 2026. Drill results will be released as they become available. 

Qualified Person (QP)

Ms. Madeline Berry, P.Geo., is a Project Geologist for the Company who is a Qualified Person as defined by National Instrument 43-101. Ms. Berry has verified the referenced data and analytical results disclosed in this press release and has approved the technical information presented herein.

Corporate Update

The Company held its Annual General and Special Meeting February 4, 2026. All matters were approved at the Meeting by shareholders. New directors, Ryan Goodman and Kevin Chen, were elected to the Board of Directors and incumbent directors, Ian Ball, Cale Moodie and Gary Thompson, were re-elected to the Board of Directors. A share consolidation was approved by shareholders resulting in a ten for one share consolidation, subject to the approval of the TSX Venture Exchange, which will result in a new share count of 71,323,542 post consolidation. An amendment of the Company’s articles was approved to provide directors with more flexibility regarding amending the Company’s authorized share capital. Shareholders also re-approved the Company’s Stock Option Plan for the ensuing year.

The exercise price and the number of shares issuable under the Company's outstanding warrants and stock options will be proportionately adjusted to reflect the consolidation in accordance with the respective terms thereof. Fractional common shares will not be issued, and no cash will be paid in lieu of fractional post-consolidation common shares. The number of post-consolidation common shares to be received by a shareholder will be rounded down to the nearest whole common share. This proposed consolidation does not change a shareholder’s proportionate ownership interest in the Company.

The proposed consolidation has been approved and authorized by the Company’s board of directors. The consolidation is subject to approval by the TSX Venture Exchange. In particular, the Company will be required to meet the Exchange’s continued listing requirements upon completion of a consolidation. There is no guarantee that Exchange acceptance of a consolidation will be given or that the Company will meet the Exchange’s continued listing requirements upon completion.

A further news release will be issued announcing the effective date for the consolidation and a letter of transmittal will be mailed to the Company’s registered shareholders, which shareholders can use to exchange their current share certificates for certificates representing the consolidated number of shares. No action will be required to effect consolidation of beneficially held securities by non-registered shareholders, who hold securities of the Company through an intermediary.

The Company does not intend to change its name or current trading symbol in connection with the proposed consolidation.

About Brixton Metals Corporation

Brixton Metals is a Canadian exploration company focused on the advancement of its mining projects. Brixton wholly owns four exploration projects: Brixton’s flagship Thorn copper-gold-silver-molybdenum Project, the Hog Heaven copper-silver-gold Project in NW Montana, USA, which is optioned to Ivanhoe Electric Inc., the Langis and HudBay silver Projects in Ontario and the Atlin Goldfields Project located in northwest BC, which is optioned to Eldorado Gold Corporation. Brixton Metals Corporation shares trade on the TSX-V under the ticker symbol BBB, and on the OTCQB under the ticker symbol BBBXF. For more information about Brixton, please visit our website at www.brixtonmetals.com.

On Behalf of the Board of Directors

Mr. Gary R. Thompson, Chairman and CEO
[email protected]

For Investor Relations inquiries please contact: Mr. Michael Rapsch, Vice President Investor Relations. email: [email protected] or call Tel: 604-630-9707

Follow us on:
LinkedIn | Twitter/X | Facebook | Instagram

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, including statements that address potential quantity and/or grade of minerals, potential size and expansion of a mineralized zone, proposed timing of exploration and development plans, or other similar expressions. All statements, other than statements of historical fact included herein including, without limitation, statements regarding the use of proceeds. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the need for additional financing; operational risks associated with mineral exploration; fluctuations in commodity prices; title matters; and the additional risks identified in the annual information form of the Company or other reports and filings with the TSXV and applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. 

Links:

https://brixtonmetals.com/wp-content/uploads/2026/02/Fig-1-_NR_05Feb2026-projects-scaled.png

https://brixtonmetals.com/wp-content/uploads/2026/02/Fig-2-_NR_05Feb2026-targets.png

https://brixtonmetals.com/wp-content/uploads/2026/02/Fig-3-_NR_05Feb2026-Camp-Crk-scaled.png

https://brixtonmetals.com/wp-content/uploads/2026/02/Fig-4_NR_05Feb2026-95th-South-scaled.png
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Enwex ERCOT Onshore Wind Futures Now Live for Trading on Abaxx Exchange stocknewsapi
ABXXF
TORONTO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced that trading has commenced in Enwex ERCOT Onshore Wind (EWM) futures, extending Abaxx’s weather-indexed markets into the United States.

The Electric Reliability Council of Texas (ERCOT) has become one of the fastest-growing renewable power systems globally, with Texas leading the United States in installed wind capacity and total wind-generated electricity. The EWM contract gives market participants a focused hedge against weather-driven volume swings and grid-imposed curtailment, isolating wind-specific risk from broader power market drivers.

“Texas produces roughly a quarter of U.S. wind power, making ERCOT the most consequential wind market in the country,” said Joe Raia, Chief Commercial Officer of Abaxx Exchange. “Abaxx’s EWM contract establishes a forward curve that enables market participants to hedge utilization risk while supporting revenue stability for wind producers.”

Enwex ERCOT Onshore Wind (EWM) Futures are available for trading from 1000 to 2400 SGT, Monday to Friday, except for Singapore public holidays. View contract details, connected clearing and broker firms, and request market access at abaxx.exchange/resources/start-trading.

About Abaxx Technologies
Abaxx Technologies is building Smarter Markets: markets empowered by better tools, better benchmarks, and better technology to drive market-based solutions to the biggest challenges we face as a society, including the energy transition.

In addition to developing and deploying financial technologies that make communication, trade, and transactions easier and more secure, Abaxx is the majority shareholder of Abaxx Singapore, the owner of Abaxx Exchange and Abaxx Clearing, and the parent company of wholly owned subsidiary Abaxx Spot Pte. Ltd., the operator of Abaxx Spot.

Abaxx Exchange delivers the market infrastructure critical to the shift toward an electrified, low-carbon economy through centrally-cleared, physically-deliverable futures contracts in LNG, carbon, battery materials, and precious metals, meeting the commercial needs of today’s commodity markets and establishing the next generation of global benchmarks.

Abaxx Spot modernizes physical gold trading through a physically-backed gold pool in Singapore. As the first instance of a co-located spot and futures market for gold, Abaxx Spot enables secure electronic transactions, efficient OTC transfers, and is designed to support physical delivery for Abaxx Exchange’s physically-deliverable gold futures contract, providing integrated infrastructure to deliver smarter gold markets.

Adaptive Infrastructure closes critical gaps in post-trade infrastructure by providing a unified custodial foundation across environmental markets and digital title assets. Incorporated in Barbados and regulated by the Financial Services Commission of Barbados, the company delivers institutional-grade custody, settlement, and transfer agency services designed to reduce risk and improve reliability across asset classes.

For more information, visit abaxx.tech | abaxx.exchange | abaxxspot.com | basecarbon.com | smartermarkets.media

Cautionary Statement Regarding Forward-Looking Information

This press release includes certain “forward-looking statements” and “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “believe”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “may”, “will”, “plan”, “should”, “would”, “could”, “target”, “purpose”, “goal”, “objective”, “ongoing”, “potential”, “likely” or the negative thereof or similar expressions.

In particular, this press release contains forward-looking statements including, without limitation, statements regarding the expansion of Abaxx’s product suite, the timing and implementation of wind futures contracts offered by Abaxx and related benefits to market participants and the development of world energy markets. Forward-looking statements are based on the reasonable assumptions, estimates, analyses and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Such factors impacting forward-looking information include, among others: risks relating to the global economic climate; dilution; Abaxx’s limited operating history; future capital needs and uncertainty of additional financing; the competitive nature of the industry; currency exchange risks; the need for Abaxx to manage its planned growth and expansion; the effects of product development and need for continued technology change; protection of proprietary rights; the effect of government regulation and compliance on Abaxx and the industry; acquiring and maintaining regulatory approvals for Abaxx’s products and operations; the ability to list Abaxx’s securities on stock exchanges in a timely fashion or at all; network security risks; the ability of Abaxx to maintain properly working systems; reliance on key personnel; global economic and financial market deterioration impeding access to capital or increasing the cost of capital; and volatile securities markets impacting security pricing unrelated to operating performance. In addition, particular factors which could impact future results of the business of Abaxx include but are not limited to: operations in foreign jurisdictions; protection of intellectual property rights; contractual risk; third-party risk; clearinghouse risk; malicious actor risks; third- party software license risk; system failure risk; risk of technological change; dependence of technical infrastructure; changes in global weather patterns; changes in the price of commodities, capital market conditions, restrictions on labor and international travel and supply chains, and the risk factors identified in the Company’s most recent management’s discussion and analysis filed on SEDAR+. Abaxx has also assumed that no significant events occur outside of Abaxx’s normal course of business.

Abaxx cautions that the foregoing list of material factors is not exhaustive. In addition, although Abaxx has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, or intended. When relying on forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Abaxx has assumed that the material factors referred to in the previous paragraphs will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking statements and information contained in this press release represents the expectations of Abaxx as of the date of this press release and, accordingly, is subject to change after such date. Abaxx undertakes no obligation to update or revise any forward-looking statements and information, whether as a result of new information, future events or otherwise, except as required by law. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements and information. Cboe Canada does not accept responsibility for the adequacy or accuracy of this press release.
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) stocknewsapi
KURA
February 06, 2026 07:30 ET  | Source: Kura Oncology, Inc.

SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on February 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 69,750 shares of common stock to four (4) new employees under the Company’s 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Each stock option has an exercise price equal to $8.27 per share, the closing price of the Company’s common stock on February 2, 2026, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees’ continued service relationship with the Company through the applicable vesting dates. The stock options are subject to the terms and conditions of the Company’s 2023 Inducement Option Plan, as amended, and the terms and conditions of an applicable stock option agreement covering the grant.

About Kura Oncology
Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura developed and is commercializing KOMZIFTI™, the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit the Kura website at https://kuraoncology.com/ and follow us on X and LinkedIn.

Kura Contact

Investors and Media:
Greg Mann
858-987-4046
[email protected]
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Boeing stock price eyes a rebound as a new $80 billion tailwind emerges stocknewsapi
BA
Boeing stock price has pulled back in the past few weeks, moving from the year-to-date high of $254 to the current $236. Still, the company has some potential catalysts that may drive it higher in the coming weeks or months.

India and potential Boeing orders  Copy link to section

There are signs that Boeing’s business is expecting more orders in the coming months, a move that will see it narrow the backlog with Airbus.

In a statement, Piyush Goyal, India’s Commerce and Industry minister, said that the country was preparing to make an $80 billion order from Boeing. With services and engines included, he believes that the value of imports from the United States will be worth over $100 billion.

The minister said this as he commented on the recently announced deal between the US and India that reduced the tariff to 18%. Air India recently announced an order of of 30 737 MAX planes last month.

Another potential catalyst for Boeing is that Donald Trump plans to visit China in April to meet with Xi Jinping. Trump has always been a transactional person, and China will be keen to please him.

Therefore, there is a likelihood that Beijing will commit to making huge purchases from the United States. While agriculture will be discussed, there are chances that Beijing will ask its airlines to make huge orders from Boeing.

Such a move will be important for Boeing as Chinese companies have largely stayed on the sidelines since the US started a trade war with China during Trump’s first term.

Trump has brokered many Boeing orders in the past. For example, he received orders worth billions of dollars during his trip to the Middle East last year. These orders came from companies like Emirates, Qatar, and Saudia.

Boeing is making progress as the turnaround continues  Copy link to section

Meanwhile, Boeing is making substantial progress as the management executes its turnaround strategy.  For one, the safety issues that plagued the company have now ended as no jet has been involved in a Boeing-caused accident in the past few years.

The company has also started increasing its 737 MAX production, a trend that the management believes will continue in the foreseeable future.

Financial results released recently showed that the company’s revenue increased by 57% to $23 billion, while its annual total rose by 34% to over $89 billion. 

The company also made a big profit during the quarter, with the net earnings rising to over $8.2 billion. Its operating cash flow rose to over $1.3 billion.

Wall Street analysts are optimistic that Boeing’s business will continue doing well this year. The average estimate is that its revenue will come in at $22 billion this quarter, up by 13% YoY, while its revenue in the next two financial years will be $97 billion and $111 billion, respectively.

Boeing stock price technical analysis  Copy link to section

BA stock chart | Source: TradingViewThe daily timeframe chart shows that the Boeing share price has recovered in the past few months, moving from a low of $176 in November to a high of $254 in January.

It has retested the key support level at $228, completing a break-and-retest pattern, a common bullish continuation sign.

The stock remains above the 50-day and 100-day Exponential Moving Averages (EMA), while the Relative Strength Index (RSI) has moved to over 50.

Therefore, the most likely scenario is where it rebounds in the coming weeks and retests the important resistance level at $254. A move above that level will point to more gains, potentially to $300.
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Can Captain Michael Saylor Right The Bitcoin Ship? stocknewsapi
RB RC
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Spotify.

Getty Images

Seeking Alpha News Quiz

Up for a challenge? Test your knowledge on the biggest events in the investing world over the past week. Take the latest Seeking Alpha News Quiz and see how you stack up against the competition.

Reaching an all-time high above $126,000 in October 2025, Bitcoin (BTC-USD) has now lost more than half of its value, tumbling close to the $60,000 level overnight. The selloff is coinciding with many market fears, like the SaaSpocalypse, surging layoffs, and the unwinding of recent popular trades like precious metals. Bitcoin has also wiped out all its gains since the election of President Trump, who pledged to "ensure that the United States will be the crypto capital of the planet and Bitcoin superpower of the world."

Trouble brewing: Many Bitcoin investors are feeling the pain (if they're still HODLing), but no one more than Strategy (MSTR) founder Michael Saylor. He has spent years promoting Bitcoin as a primary reserve asset and strategic corporate treasury, accumulating 713,500 BTC through the issuance of convertible debt, preferred stock, and equity. The average cost paid for those BTC was $76,000, meaning the company is currently swimming in a whole lot of red ink. In fact, Strategy just posted a $17.5B net unrealized loss on its digital assets in Q4, with its stock plunging 17% during the session on Thursday, and that was before the deepening Bitcoin bloodbath that took place this quarter. Bitcoin gets a zero price target in wake of Burry warning

"If people in the rest of the world knew what I know, and they agreed with me, Bitcoin would go to $10M tomorrow," Saylor declared in a video back in May 2025, which has gone viral again given the turbulence surrounding the crypto. "Volatility was a gift to the faithful. It scares away the tourist. It scares away the lazy. It scares away the people that are already conventionally rich and have all the money. If you're a 20-something or 30-something and are willing to do the work... if you have more time than money... then the volatility of Bitcoin is a gift to you [with] 20 years of stacking opportunity."

Outlook: In the past, Strategy (MSTR) CEO Phong Le said the company could sell Bitcoin if it needed to fund dividend payments below 1x mNAV (market net asset value) and couldn't raise capital above that level. Additional worries surround funding and liquidity to pay off bond payments. If Strategy sells its BTC, it would send a distress signal to the market about the store of value upon which the firm is based. Meanwhile, if the company sells equity, it would dilute existing shareholders who chose to park their cash with Strategy instead of investing in Bitcoin as an underlying asset and staking it themselves. Note that Strategy's convertible debt is unsecured, so a Bitcoin crash can continue for quite a while before it becomes a serious problem, and would only lead to a worst-case scenario if a vanishing stock premium over the long term prevents the company from refinancing maturing debt. (6 comments)

Here's the latest Seeking Alpha analysis

What else is happening...

Today's Markets

In Asia, Japan +0.8%. Hong Kong -1.2%. China -0.3%. India +0.3%.
In Europe, at midday, London +0.2%. Paris flat. Frankfurt +0.7%.
Futures at 6:30, Dow +0.4%. S&P +0.5%. Nasdaq +0.7%. Crude flat at $63.28. Gold +0.4% to $4,909.90. Bitcoin -6% to $66,264.
Ten-year Treasury Yield +2 bps to 4.20%.

On The Calendar
2026-02-06 12:54 1mo ago
2026-02-06 07:30 1mo ago
Despite The Ho-Hum Dividend, SCHG Beat the S&P 500 by An Impressive 15% stocknewsapi
SCHG
The Schwab U.S. Large-Cap Growth ETF (NYSEARCA:SCHG) isn't designed to generate meaningful dividend income.
2026-02-06 12:54 1mo ago
2026-02-06 07:35 1mo ago
Otis Worldwide: Recent Share Price Weakness Improves The Long-Term Setup stocknewsapi
OTIS
Analyst’s Disclosure: I/we have a beneficial long position in the shares of OTIS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-02-06 12:54 1mo ago
2026-02-06 07:35 1mo ago
Tesla Stock Rises to End a Tough Week. How It Got Caught Up in the Tech Selloff. stocknewsapi
TSLA
Tesla stock has had a tough week, dropping almost 8%, though Thursday trading.
2026-02-06 12:54 1mo ago
2026-02-06 07:35 1mo ago
Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio. stocknewsapi
BIIB
Biogen says it expects revenue to fall in 2026 as its multiple sclerosis therapies continue to struggle.
2026-02-06 12:54 1mo ago
2026-02-06 07:40 1mo ago
Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RARE stocknewsapi
RARE
LOS ANGELES--(BUSINESS WIRE)--Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RARE.
2026-02-06 12:54 1mo ago
2026-02-06 07:44 1mo ago
FinecoBank Banca Fineco S.p.A. (FNBKY) Q4 2025 Earnings Call Transcript stocknewsapi
FCBBF
FinecoBank Banca Fineco S.p.A. (FNBKY) Q4 2025 Earnings Call February 6, 2026 4:00 AM EST

Company Participants

Alessandro Foti - CEO, GM & Executive Director
Paolo Grazia - Deputy GM & Head of Global Business
Lorena Pelliciari

Conference Call Participants

Enrico Bolzoni - JPMorgan Chase & Co, Research Division
Elena Perini - Intesa Sanpaolo Equity Research
Luigi De Bellis - Equita SIM S.p.A., Research Division

Presentation

Operator

Good morning. This is the Chorus Call conference operator. Welcome, and thank you for joining the FinecoBank 4Q 2025 Results Conference Call. [Operator Instructions].

At this time, I would like to turn the conference over to Mr. Alessandro Foti, CEO and General Manager of FinecoBank.

Alessandro Foti
CEO, GM & Executive Director

Thank you. Good morning, everyone, and thank you for joining our fourth quarter 2025 results conference call. In 2025, net profit was flat year-on-year at EUR 647 million and revenues at around EUR 1,317 million, supported by our nonfinancial income, investing up by around 10% year-on-year, thanks to the volume effect and the higher control of the value chain by Fineco Asset Management and brokerage is up by around 18% year-on-year, thanks to the enlargement of our active investors and stock of assets under custody. Operating costs well under control at around EUR 356 million, increasing by around 6% year-on-year by excluding costs related to the growth of the business. Cost/income ratio was equal to 27.1%, confirming operating leverage as a key strength of the bank.

Moving to our commercial results. The underlying step-up in our growth dynamics gets crystal clear month by month. This is underpinned by the positive tailwinds from structural trends, and we are leveraging on this solid momentum through and more efficient marketing. The results of this acceleration has been clearly visible in our most recent numbers. First of all, recorded our third record year
2026-02-06 12:54 1mo ago
2026-02-06 07:45 1mo ago
5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now stocknewsapi
ET MO PAA PFE VZ
Investors love dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.
2026-02-06 12:54 1mo ago
2026-02-06 07:47 1mo ago
Jeffs' Brands: KeepZone AI Announces Exclusive Agreement for the Reselling of Counter Underwater Systems for Drug Smuggling and Protecting Offshore Assets stocknewsapi
JFBR
Tel Aviv, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) -driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has entered into an exclusive reseller agreement (the “Agreement”) with DSIT Solutions Ltd. (“DSIT”), a global leader in underwater domain awareness and acoustic intelligence solutions.

KeepZone will help lead DSIT’s entry into the Mexican market to counter underwater drug smuggling and protect offshore assets, as part of DSIT’s strategic effort to support national authorities and critical infrastructure operators.

Drug trafficking organizations are increasingly shifting their operations underwater, as maritime security above the surface continues to tighten. Much like terrorist organizations that adapt when defensive layers are reinforced, criminal cartels exploit the underwater domain, using covert diver operations, hull-mounted drug packages, and semi-submersible or fully submersible vessels to evade detection. DSIT’s advanced underwater security systems are designed to counter this evolving threat by enabling early detection, classification, and response to covert underwater activity.

Pursuant to the Agreement, KeepZone will lead the introduction of DSIT’s advanced underwater security solutions to Mexican government agencies and energy operators, including systems for:

Detection of hostile or unauthorized diversIdentification of unmanned underwater vehicles (“UUVs”)Protection of ports, anchorages, and coastal assetsUnderwater protection of offshore oil & gas platforms (“Oil Rigs”) against sabotage, smuggling, and covert underwater intrusionSupport for maritime drug intervention and counter-smuggling operations
Together, KeepZone and DSIT may be able to support a truly multi-layered maritime security approach, above and below the waterline, with the potential to address a critical gap increasingly exploited by organized criminal networks.

Alon Dayan, Chief Executive Officer of KeepZone, commented: “By leading the deployment of DSIT’s underwater security technologies in Mexico, we believe we are enabling authorities and offshore operators to detect and deter threats operating where traditional surveillance cannot, beneath the surface.”

About Jeffs’ Brands

Jeffs’ Brands is a data-driven company that has recently pivoted into the global homeland security sector through its wholly-owned subsidiary, KeepZone AI Inc., following the entry into the definitive distribution agreement with Scanary Ltd., in December 2025. Jeffs’ Brands aims to deliver comprehensive, multi-layered security ecosystems for critical infrastructure worldwide, capitalizing on the homeland security market’s significant growth potential while leveraging its expertise in data-driven operations.

For more information on Jeffs’ Brands visit https://jeffsbrands.com.

About DSIT Solutions Ltd.

DSIT Solutions Ltd. specializes in underwater domain awareness, sonar, and acoustic intelligence systems designed to protect naval forces, critical maritime infrastructure, and offshore energy assets worldwide.

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, the Company is using forward-looking statements when discussing the anticipated benefits of the Agreement, KeepZone’s anticipated role in introducing DSIT’s solutions to the Mexican market, the potential effectiveness of underwater security technologies, the ability of the KeepZone and DSIT to support national authorities and critical infrastructure operators, the potential ability of KeepZone and DSIT to support a multi-layered maritime security approach above and below the waterline, and the possibility that such an approach may help address security gaps that could be exploited by organized criminal networks. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company’s ability to adapt to significant future alterations in Amazon’s policies; the Company’s ability to sell its existing products and grow the Company’s brands and product offerings; the Company’s ability to meet its expectations regarding the revenue growth and the demand for e-commerce; the overall global economic environment; the impact of competition and new e-commerce technologies; general market, political and economic conditions in the countries in which the Company operates; projected capital expenditures and liquidity; the impact of possible changes in Amazon’s policies and terms of use; the impact of the conditions in Israel; and the other risks and uncertainties described in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (“SEC”), on March 31, 2025, and the Company’s other filings with the SEC. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Michal Efraty
Adi and Michal PR- IR
Investor Relations, Israel
[email protected]
2026-02-06 12:54 1mo ago
2026-02-06 07:48 1mo ago
Philip Morris Posts Higher Profit, Revenue; Forecasts Continued Growth stocknewsapi
PM
Philip Morris International logged higher profit and revenue in the fourth quarter, while forecasting continued growth for years to come.
2026-02-06 12:54 1mo ago
2026-02-06 07:50 1mo ago
Why I Stopped Buying Rental Properties To Buy Dividend Stocks Instead stocknewsapi
AMLP BIZD SCHD VNQ WELL XLU
Rental properties are often pitched as better investments than dividend stocks. I strongly disagree. Dividend stocks are not only more rewarding, but they are also safer and help you optimize for your lifestyle and career. Here is why.
2026-02-06 11:54 1mo ago
2026-02-06 06:30 1mo ago
nVent Electric plc Fourth Quarter and Full Year 2025 Financial Results Available on Company's Website stocknewsapi
NVT
February 06, 2026 06:30 ET  | Source: nVent

LONDON, Feb. 06, 2026 (GLOBE NEWSWIRE) -- nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, reported fourth quarter and full-year 2025 financial results today through an earnings release posted on the company’s Investor Relations website at http://investors.nvent.com. The earnings release will be furnished with the Securities and Exchange Commission on a Form 8-K and is available here. The company will also hold a conference call with analysts and investors at 9:00 a.m. ET.

Conference Call and Webcast Details

The call can be accessed via webcast at http://investors.nvent.com or by dialing 1-833-630-1071 or 1-412-317-1832. Once available, a replay of the conference call will be accessible through February 20, 2026, by dialing 1-855-669-9658 or 1-412-317-0088, along with the access code 1131007.

About nVent
nVent is a leading global provider of electrical connection and protection solutions. We believe our inventive electrical solutions enable safer systems and ensure a more secure world. We design, manufacture, market, install and service high performance products and solutions that connect and protect some of the world's most sensitive equipment, buildings and critical processes. We offer a comprehensive range of systems protection and electrical connections solutions across industry-leading brands that are recognized globally for quality, reliability and innovation. Our principal office is in London and our management office in the United States is in Minneapolis. Our robust portfolio of leading electrical product brands dates back more than 100 years and includes nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE. Learn more at www.nvent.com.

nVent, CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE are trademarks owned or licensed by nVent Services GmbH or its affiliates.

Investor Contact
Tony Riter
Vice President, Investor Relations
nVent
763.204.7750
[email protected]

Media Contact
Kevin H. King
Vice President, Global Communications
nVent
763.291.0526
[email protected]
2026-02-06 11:54 1mo ago
2026-02-06 06:31 1mo ago
Mineros S.A. Announces 2026 Guidance: A Disciplined Approach to Production Growth and Strategic Expansion stocknewsapi
MNSAF
MEDELLÍN, Colombia--(BUSINESS WIRE)--Mineros S.A. (TSX:MSA, OTCQX:MNSAF, BVC:MINEROS) (“Mineros” or the “Company”) announces its production and cost guidance for 2026. The Company’s 2026 outlook reflects a dual-track strategy: maximizing near-term production to capitalize on the current gold price environment, while advancing the technical evaluations required for a multi-year growth trajectory.

STRATEGIC CAPITAL ALLOCATION: NEAR-TERM OPTIMIZATION

For 2026, Mineros is providing consolidated gold production guidance of 213,000 to 233,000 ounces of gold. This represents an increase of 10,000 ounces relative to 2025 guidance. This increase is the result of a disciplined focus on "quick-return" ounces, prioritizing capital investment toward brownfield projects and operational efficiencies that can be brought online rapidly to maximize free cash flow in a robust commodity market.

“Our 2026 guidance demonstrates a transition in our corporate lifecycle,” stated Daniel Henao, President and CEO of Mineros. “We are moving beyond a steady-state profile by allocating capital to projects with immediate accretive value. We are shifting our focus to creating shareholder value through disciplined growth that strengthens cash flow and enhances long-term returns. This 10,000-ounce increment is the first stage of a broader evolution for the Company.”

2026 OPERATIONAL & COST OUTLOOK

The Company’s production and cost guidance reflects a commitment to maintaining healthy margins despite global inflationary pressures.

Production and Cost Guidance

units

2026

Nechí Property (Colombia)

oz

83,000 – 93,000

AISC per ounce of gold sold (Company Owned Dredges)

$/oz

$1,820 - $1,920

AISC Margin (Contract Mining Partners)

%

11 - 14

Hemco Property (Nicaragua)

130,000 - 140,000

AISC per ounce of gold sold (Panama & Pioneer)

$/oz

$2,000 - $2,100

AISC Margin (Bonanza Mining Partners)

%

39 - 41

Consolidated

Gold production

oz

213,000 – 233,000

Cash Cost per ounce of gold sold

$/oz

$2,070 - $2,170

AISC per ounce of gold sold

$/oz

$2,370 - $2,470

Note to Guidance: The gold price assumed was $4,405. While our 2026 guidance is anchored in our primary gold reserves, the Company continues to optimize silver recovery at the Hemco processing plant. Although silver is not currently classified as either a Mineral Reserve or a Mineral Resource, we expect improvements to our ability to recover silver will provide a positive impact on our revenues and consolidated AISC. For reporting purposes, any silver recovered will be disclosed as gold equivalent (AuEq) production using the then-average price per ounce sold of each metal.

In 2026, the Hemco Property (Nicaragua) is expected to deliver solid performance with gold production guidance of 130,000–140,000 ounces. The Panama & Pioneer operations are expected to have an AISC range of $2,000–$2,100 per ounce, reflecting a disciplined cost framework. In addition, the Bonanza Mining Partners arrangement is expected to generate a 39%–41% AISC margin, supporting a resilient contribution profile.

For the Nechí Property (Colombia), Mineros is targeting steady gold output of 83,000–93,000 ounces in 2026. Company-owned dredges are expected to operate within an AISC range of $1,820–$1,920 per ounce, underpinned by continued operational focus and cost control. The contract mining partners are expected to deliver an AISC margin of 11%–14%, reinforcing a consistent and dependable cash generation profile.

CAPEX: FINANCING THE GROWTH HORIZON

The 2026 CAPEX budget is structured to balance sustaining requirements with high-impact growth initiatives.

Category

Investment (US$)

Strategic Objective

Growth CAPEX

$51.7 Million

Hemco plant expansion, Porvenir (Nicaragua) and La Pepa (Chile) technical studies

Sustaining CAPEX

$44.7 Million

Operational continuity and infrastructure renewal

Exploration

$17.3 Million

Resource-to-Reserve conversion

Greenfield exploration

Total CAPEX

$113.7 Million

NICARAGUA EXPANSION AND LONG-TERM SCALABILITY

Approximately 78% of the Company’s growth capital is directed toward Nicaragua, anchored by a $23 million project to scale the Hemco processing capacity from 1,800 to 2,500 tpd. This initiative is the first stage in a disciplined approach to increase production through organic capacity expansion.

Beyond these immediate gains, Mineros is evaluating the strategic installation of a 1,000 tpd mill already in the Company’s asset inventory. This project is viewed as a critical de-bottlenecking exercise intended to increase output in Nicaragua. By addressing these processing limits, the Company is laying the groundwork for a transition to significantly higher production capacity over the long term.

The Company is also focused on advancing the Porvenir Project through the final stages of permitting and technical optimization. The completion of the Hemco NI 43-101 update, scheduled for late in the first quarter of 2026, contains an update on the Porvenir Project’s at prefeasibility study (PFS), highlighting an optimized process plant with throughput capacity of 2,000 tpd. The Porvenir project already holds the environmental permit for mining operation, significantly de-risking the path to production.

EXPLORATION

Mineros’ exploration program (budgeted at $17.3 million) is designed to support near-term production growth while advancing a pipeline of opportunities across the portfolio. The Company plans 95,000 metres of drilling in 2026, with the focus being a 75,400 metres program at Hemco costing $11.0 million, predominantly focused on brownfield targets around existing operations and growth projects (including work at and near Porvenir), while selectively increasing greenfield exploration across the under-explored “Golden Triangle” district, an area defined by the historic mining towns of Bonanza, Rosita and Siuna; where the Company operates. The golden triangle is one of Central America’s most prolific mining regions, reported to have produced nine million ounces of gold, five million ounces of silver and 305 million pounds of copper.

In Colombia, Mineros expects to complete 13,000 metres of drilling at the Nechi Property at a cost of $4.1 million, and in Chile the Company will invest $2.2 million for 7,000 metres of drilling at La Pepa as it continues to de-risk the project and maintain strategic exposure to a high-potential exploration district.

Mineros plans to release its fourth quarter 2025 and year-end financial and operating results on Wednesday, February 18, 2026. Senior management will host a conference call on Thursday, February 19, 2025, at 9:00 AM Eastern Standard Time (9:00 AM Colombian Standard Time).

ABOUT MINEROS S.A.

Mineros is a leading Latin American gold mining company headquartered in Medellín, Colombia. The Company operates a diversified portfolio of assets in Colombia and Nicaragua and maintains a pipeline of development and exploration projects across the region, including the La Pepa Project in Chile.

With more than 50 years of operating history, Mineros maintains a longstanding focus on safety, sustainability, and disciplined capital allocation. Its common shares are listed on the Toronto Stock Exchange (MSA) and the Colombian Stock Exchange (MINEROS) and trade on the OTCQX® Best Market under the symbol MNSAF.

Election of Directors – Electoral Quotient System

The Company has received an exemption from the individual and majority voting requirements applicable to TSX-listed issuers. Compliance with such requirements would conflict with Colombian laws and regulations, which require directors to be elected from a slate of nominees under an electoral quotient system. Additional details are available in the Company’s most recent Annual Information Form, accessible on the Company’s website at www.mineros.com.co and on SEDAR+ at www.sedarplus.com.

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking information within the meaning of applicable securities laws. Forward-looking information includes statements regarding production for 2026, cash cost per ounce of gold sold, all-in sustaining cost per ounce of gold sold, capital expenditures, both sustaining and growth, exploration spend and the timing of any such expenditures.

Forward-looking information is based on management’s current expectations and assumptions as of the date of this release and is subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking information except as required by applicable securities law.

More News From Mineros S.A.
2026-02-06 11:54 1mo ago
2026-02-06 06:33 1mo ago
The Largest Write Off In Car Industry History stocknewsapi
STLA
Ford (NYSE: F) recently wrote off $19.5 billion due to the collapse of its EV business.
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
ARDENT HEALTH CLASS ACTION: Ardent Health, Inc. (ARDT) Accused of Misrepresentations About Its Revenue in Securities Lawsuit, Contact BFA Law by March 9 stocknewsapi
ARDT
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.

Investors have until March 9, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities. The class action is pending in the U.S. District Court for the Middle District of Tennessee. It is captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022.

Why is Ardent Health Being Sued for Securities Fraud?

Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. A critical aspect of Ardent Health's operations is the collection of accounts receivable and the framework by which Ardent Health determines the collectability of such accounts. According to the lawsuit, Ardent Health stated that it employed an active monitoring process to determine the collectability of its accounts receivable, and that this process included "detailed reviews of historical collections" as a "primary source of information."

As alleged, in truth, Ardent Health did not primarily rely on "detailed reviews of historical collections" in determining collectability of accounts receivable, but instead "utilized a 180-day cliff at which time an account became fully reserved." This allowed Ardent Health to report higher amounts of accounts receivable during the Class Period, and delay recognizing losses on uncollectable accounts. The lawsuit alleges that Ardent Health's purported misrepresentations are a violation of the federal securities laws.

Why did Ardent Health's Stock Drop?

On November 12, 2025, after market hours, Ardent Health revealed it had completed "hindsight evaluations of historical collection trends" that resulted in a $43 million decrease in revenue for the quarter. Ardent Health also revealed that it increased its professional liability reserves by $54 million because of "adverse prior period claim developments" resulting from a set of claims between 2019 and 2022 "as well as consideration of broader industry trends."

This news caused the price of Ardent Health stock to drop $4.75 per share, or more than 33%, from a closing price of $14.05 per share on November 12, 2025, to $9.30 per share on November 13, 2025.

Click here for more information: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.

What Can You Do?

If you invested in Ardent Health, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282897

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
BELLRING CLASS ACTION: BellRing Brands, Inc. (BRBR) Accused of Misrepresentations About Its Elevated Inventory in Securities Fraud Lawsuit, Contact BFA Law by March 23 stocknewsapi
BRBR
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.

If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

Investors have until March 23, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in BellRing securities. The class action is pending in the U.S. District Court for the Southern District of New York. It is captioned Denha v. BellRing Brands, Inc., No. 1:26-cv-00575.

Why is BellRing Being Sued for Securities Fraud?

BellRing develops, markets, and sells "convenient nutrition" products such as ready-to-drink ("RTD") protein shakes primarily under the brand name Premier Protein. During the relevant period, Defendants represented that sales growth reflected increased end-consumer demand, attributing results to "organic growth," "distribution gains," "incremental promotional activity," and "[s]trong macro tailwinds around protein" among other factors. At the same time, Defendants downplayed the impact of competition on demand, insisting BellRing was not experiencing any significant changes in competition, and that in the RTD category particularly, BellRing possessed a "competitive moat," given that "the ready-to-drink category is just highly complex" and the products are "hard to formulate."

As alleged, in truth, BellRing's reported sales during the Class Period were driven by its key customers stockpiling inventory and did not reflect increased end-consumer demand or brand momentum. Following the destocking, BellRing admitted that competitive pressures were materially weakening demand.

Why did BellRing's Stock Drop?

On May 6, 2025, BellRing's CFO revealed "several key retailers lowered their weeks of supply on hand, which is expected to be a mid-single-digit headwind to our third quarter growth," adding "[w]e now expect Q3 sales growth of low single digits." BellRing's CEO further revealed that retailers had been "hoarding inventory to make sure they didn't run out of stock on shelf" and "protecting themselves coming out of capacity constraints," but since there had been "several quarters of high in-stock rates," customers "felt comfortable about bringing [inventory] down. We thought this could happen."

This news caused the price of BellRing stock to drop $14.88 per share, or 19%, from a closing price of $78.43 per share on May 5, 2025, to $63.55 per share on May 6, 2025.

On August 4, 2025, after market hours, BellRing reported its 3Q 2025 financial results and "narrowed its fiscal year 2025 outlook for net sales." Then, during the Company's August 5, 2025 earnings call, BellRing's CEO attributed the narrowed guidance to "several other competitors" gaining space to sell their products with a large retailer and that "it is not surprising to see new protein RTDs enter[ed]" the convenient nutrition market.

This news caused the price of BellRing stock to drop $17.46 per share, or nearly 33%, from a closing price of $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025.

Click here for more information: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.

What Can You Do?

If you invested in BellRing, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282898

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
PLUG POWER CLASS ACTION: Plug Power Inc. (PLUG) Accused of Misrepresentations About Its DOE Funding in Securities Fraud Lawsuit, Contact BFA Law by April 3 stocknewsapi
PLUG
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ: PLUG) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Plug Power, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/plug-power-class-action-lawsuit.

Investors have until April 3, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Plug Power securities. The case is pending in the U.S. District Court for the Northern District of New York and is captioned Ortolani v. Plug Power Inc., et al., No. 1:26-cv-00165.

Why is Plug Power Being Sued for Securities Fraud?

Plug Power provides hydrogen fuel cell turnkey solutions for the electric mobility and stationary power markets and develops infrastructure such as hydrogen production plants. During the relevant period, Plug Power announced it had "closed a $1.66 billion loan guarantee" from the U.S. Dept. of Energy's Loan Program Office to "help finance the construction of up to six projects to produce and liquefy zero- or low-carbon hydrogen at scale throughout the United States."

As alleged, in truth, Plug Power materially overstated the likelihood that DOE loan funds would ultimately become available to Plug Power, and that Plug Power would ultimately construct the hydrogen production facilities necessary to receive those funds.

Why did Plug Power's Stock Drop?

On October 7, 2025, Plug Power announced the abrupt departure of its CEO, Andrew Marsh, and its President, Sanjay Shrestha. This news caused the price of Plug Power stock to drop $0.26 per share, or 6.3%, from a closing price of $4.13 per share on October 6, 2025, to $3.87 per share on October 7, 2025.

A month later, on November 10, 2025, Plug Power announced that it "suspended activities under the DOE loan program," which purportedly allowed the Company to "redeploy capital" to pursue an agreement with a U.S. data center developer to monetize electricity rights. This news caused the price of Plug Power stock to drop $0.09 per share, or 3.4%, from a closing price of $2.65 per share on November 7, 2025, to $2.56 per share on November 10, 2025, the next trading day.

Then, on November 13, 2025, The Washington Examiner reported that Plug Power "confirmed . . . that it suspended activities" on "its plans to construct six facilities to produce and liquefy zero or low-carbon hydrogen, putting at risk" the $1.66 billion DOE loan it closed in January. This news caused the price of Plug Power stock to drop $0.48 per share, or 17.6%, from a closing price of $2.49 per share on November 13, 2025, to $2.25 per share on November 14, 2025.

Click here for more information: https://www.bfalaw.com/cases/plug-power-class-action-lawsuit.

What Can You Do?

If you invested in Plug Power, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/plug-power-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, "Litigation Stars" by Benchmark Litigation, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/plug-power-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282904

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
WEALTHFRONT INVESTIGATION: Wealthfront Corporation (WLTH) Investigated for Misrepresentations About Its Home-Lending Business, Contact BFA Law If You Lost Money stocknewsapi
WLTH
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Wealthfront Corporation (NASDAQ: WLTH) for potential violations of the federal securities laws.

If you invested in Wealthfront, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/wealthfront-corporation-class-action.

Why is Wealthfront Being Investigated for Violations of the Federal Securities Laws?

Wealthfront is an online financial advisor that uses automated tools to provide investment and financial advice. On or around December 12, 2025, Wealthfront completed an initial public offering ("IPO") of more than 34 million shares of common stock at a price of $14.00 per share.

BFA is investigating whether Wealthfront violated the federal securities laws by making false and misleading statements to investors, including in the offering materials for its IPO.

Why did Wealthfront's Stock Drop?

On January 12, 2026, Wealthfront published its first quarterly results as a publicly traded company. The results included net deposit outflows of $208 million, a stark reversal from the $874 million in inflows the company experienced during the same period a year earlier. During the company's earnings conference call held the same day, CEO David Fortunato attributed the decline to falling interest rates and emphasized the strategic importance of Wealthfront's new home-lending business which he asserted would protect the company from downside risk should interest rates continue to fall. Also on the call, Fortunato revealed that he personally owns a 95.1% stake in Wealthfront's home-lending business and that the company may "revisit or revise the ownership structure." This news caused the price of Wealthfront stock to drop $2.12 per share, nearly 17%, from a closing price of $12.59 per share on January 12, 2026, to $10.47 per share on January 13, 2026.

Click here for more information: https://www.bfalaw.com/cases/wealthfront-corporation-class-action.

What Can You Do?

If you invested in Wealthfront, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/wealthfront-corporation-class-action

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/wealthfront-corporation-class-action

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282905

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
COREWEAVE CLASS ACTION: CoreWeave, Inc. (CRWV) Accused of Misrepresentations About Its Infrastructure Delays in Securities Fraud Lawsuit, Contact BFA Law by March 13 stocknewsapi
CRWV
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in CoreWeave, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coreweave-inc-class-action-lawsuit.

Investors have until March 13, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in CoreWeave securities. The case is pending in the U.S. District Court for the District of New Jersey and is captioned Masaitis v. CoreWeave, Inc., et al., No. 2:26-cv-00355.

Why is CoreWeave Being Sued for Securities Fraud?

CoreWeave is an AI-focused cloud computing company that builds and operates data centers offering high-performance GPU infrastructure. CoreWeave relies on multiple partners to develop its data centers and provide the infrastructure needed for its AI computing operations, including Core Scientific, a large digital infrastructure company. On July 7, 2025, CoreWeave announced a merger agreement with Core Scientific.

During the relevant period, CoreWeave repeatedly assured investors it could capitalize on the "robust" and "unprecedented" demand for its services given its "competitive strengths," including its ability to "deploy" AI infrastructure "at massive scale" and "rapidly scale our operations."

As alleged, in truth, CoreWeave overstated its ability to meet customer demand and concealed significant construction delays at its data centers.

Why did CoreWeave's Stock Drop?

On October 30, 2025, Core Scientific announced it did not receive enough shareholder votes to approve the merger with CoreWeave and, as a result, terminated the merger agreement. This news caused the price of CoreWeave stock to drop $8.87 per share, or more than 6%, from $139.93 per share on October 29, 2025, to $131.06 per share on October 30, 2025.

Then, on November 10, 2025, CoreWeave lowered guidance for revenue, operating income, capital spending, and active power capacity for 2025 due to "temporary delays related to a third-party data center developer who is behind schedule." This news caused the price of CoreWeave stock to drop $17.22 per share, or more than 16%, from $105.61 per share on November 10, 2025, to $88.39 per share on November 11, 2025.

Finally, on December 15, 2025, The Wall Street Journal reported that the "completion date" for a "huge data-center cluster" in Denton, Texas to be leased by OpenAI, "has been pushed back several months," and that the site builder, Core Scientific, had flagged delays at the site months earlier. The Wall Street Journal also reported that Core Scientific had flagged additional delays at sites in Texas and elsewhere "since at least February." This news caused the price of CoreWeave stock to drop $2.85 per share, or more than 3%, from $72.35 per share on December 15, 2025, to $69.50 per share on December 16, 2025.

Click here for more information: https://www.bfalaw.com/cases/coreweave-inc-class-action-lawsuit.

What Can You Do?

If you invested in CoreWeave, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/coreweave-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/coreweave-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282899

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
FERMI CLASS ACTION: Fermi Inc. (FRMI) Accused of Misrepresentations About Its $150 Million Customer Agreement in Securities Fraud Lawsuit, Contact BFA Law by March 6 stocknewsapi
FRMI
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI), certain of the Company's senior executives and directors, and underwriters of Fermi's Initial Public Offering after a significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Fermi, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/fermi-inc-class-action-lawsuit.

Investors have until March 6, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Fermi securities, as well as claims under Sections 11 and 15 of the Securities Act of 1933 on behalf of investors who purchased or acquired Fermi common stock pursuant and traceable to the Company's Initial Public Offering. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Lupia v. Fermi Inc., et al., No. 1:26-cv-00050.

Why is Fermi Being Sued for Violations of the Federal Securities Laws?

Fermi is an energy and AI infrastructure company that purportedly intends to build multiple, large scale nuclear reactors to support its own network of large, grid-independent data centers powered by nuclear and other energy to power AI companies. Fermi's first project is Project Matador, its flagship, first-of-its kind energy and AI infrastructure campus designed to provide dedicated power for AI workloads.

Fermi completed its IPO in October 2025. In the IPO Registration Statement, Fermi represented that it "entered into a letter of intent . . . with an investment grade-rated tenant (the 'First Tenant') to lease a portion of the Project Matador Site . . . for an initial lease term of twenty years." The Company also represented there was strong demand for Project Matador and that construction of the facility would be funded by "tenant payments" and "lease agreements." Following the IPO, Fermi announced that the First Tenant entered into an Advance in Aid of Construction Agreement, through which it would advance up to $150 million to Fermi to fund Project Matador construction costs.

As alleged, in truth, Fermi overstated tenant demand for Project Matador and misrepresented the agreement with the First Tenant.

Why did Fermi's Stock Drop?

On December 12, 2025, Fermi disclosed that "[o]n December 11, 2025, the First Tenant notified the Company that it is terminating the [Advance of Aid of Construction Agreement]" after "[t]he exclusivity period set forward in the letter of intent expired." Fermi also stated that it had "commenced discussions with several other potential tenants" and "continue[s] to negotiate the terms of a lease agreement at Project Matador" with the First Tenant. This news caused the price of Fermi stock to drop $5.16 per share, or more than 33%, from a closing price of $15.25 per share on December 11, 2025, to $10.09 per share on December 12, 2025.

Click here for more information: https://www.bfalaw.com/cases/fermi-inc-class-action-lawsuit.

What Can You Do?

If you invested in Fermi, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/fermi-inc-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/fermi-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282900

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:36 1mo ago
INTEGER CLASS ACTION: Integer Holdings (ITGR) Accused of Misrepresentations About Its Sales Outlook in Securities Lawsuit, Contact BFA Law by February 9 stocknewsapi
ITGR
New York, New York--(Newsfile Corp. - February 6, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.

If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

Investors have until February 9, 2026, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Integer common stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251.

Why is Integer Being Sued for Securities Fraud?

Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology ("EP") devices that map the heart's electrical activity to diagnose and treat arrhythmias.

During the relevant period, Integer repeatedly touted its EP sales growth and market position while overstating demand for its EP devices.

As alleged, in truth, demand for and revenue from Integer's EP products had fallen sharply-directly contradicting the Company's public assurances.

Why did Integer's Stock Drop?

On October 23, 2025, Integer disclosed that it lowered its 2025 sales guidance to a range between $1.840 billion and $1.854 billion, from a range between $1.850 billion and $1.876 billion, and well below analysts' estimates. The Company also revealed that it expected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. Integer also admitted that two of its EP devices experienced "slower than forecasted" adoption and that it expected the slower demand "to continue into 2026." This news caused the price of Integer stock to drop $35.22 per share, or more than 32%, from a closing price of $109.11 per share on October 22, 2025, to $73.89 per share on October 23, 2025.

Click here for more information: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

What Can You Do?

If you invested in Integer, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282901

Source: Bleichmar Fonti & Auld

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-06 11:54 1mo ago
2026-02-06 06:40 1mo ago
GrafTech Reports Fourth Quarter and Full Year 2025 Results stocknewsapi
EAF
Delivered on 2025 Strategic Priorities to Grow Sales Volume and Generate Substantial Cost Savings

BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)--GrafTech International Ltd. (NYSE: EAF) ("GrafTech," the "Company," "we," or "our") today announced its unaudited financial results for the quarter and year ended December 31, 2025.

Highlights

Sales volume was flat year-over-year for the fourth quarter of 2025; sales volume grew 6% on a full-year basis. Grew sales volume in the United States 83% year-over-year for the fourth quarter of 2025 and 48% on a full-year basis, reflecting our strategy to actively shift the geographic mix of our sales volume towards this key region. Achieved a 2% year-over-year reduction in cash cost of goods sold per metric ton ("MT") for the fourth quarter of 2025 and an 11% reduction on a full-year basis, reflecting our capability to control production costs at various levels of demand. Ended the fourth quarter of 2025 with total liquidity of $340 million, which reflects prudent cash management and provides stability as we navigate near-term, industry-wide challenges. Fourth Quarter 2025 Summary

Sales volume of 27.1 thousand MT Net sales of $116 million Net loss of $65 million, or $2.50 per share(1) Adjusted EBITDA(2) of negative $22 million, including a $12 million non-cash charge related to a lower of cost or market inventory valuation adjustment Net cash used in operating activities of $21 million Adjusted free cash flow(2) of negative $39 million CEO Comments

"Looking back on 2025, I am proud of how our team navigated a challenging environment with discipline and determination,” said Timothy Flanagan, Chief Executive Officer and President. “We achieved notable successes, including a 6% increase in our full-year sales volume despite a flat demand environment globally, led by 48% sales volume growth in the United States. In addition, we achieved an 11% year-over-year reduction in our cash cost of goods sold per metric ton for 2025. These impressive results reflect our ongoing commitment to meeting the needs of our customers and achieving operational excellence to control production costs. We ended 2025 with liquidity of $340 million, enabling us to maintain stability, despite the persistence of industry-wide challenges, and positioning GrafTech for future growth."

"As we enter 2026, we are encouraged to see signs of improving steel industry trends in our core regions," continued Mr. Flanagan. "Accordingly, we anticipate a slight increase in global (excluding China) demand for graphite electrodes in 2026. That said, competitive pricing pressures for graphite electrodes have intensified further of late, a dynamic that is neither sustainable for the graphite electrode industry nor supportive of the long-term health of the steel industry. A resilient steel sector depends on a strong graphite electrode industry with the ability to invest and grow alongside it. Given these dynamics, as a leader in the graphite electrode industry, we must continue to act decisively to support the long-term viability of our business and our industry. To that end, we are committed to identifying further opportunities to enhance efficiency, preserve optionality and position GrafTech for long-term value creation for our shareholders, customers, employees and all other stakeholders."

Fourth Quarter and Full Year 2025 Financial Performance

  (dollars in thousands, except per share amounts)

Year Ended

December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Net sales

$

116,457

$

143,998

$

134,217

$

504,134

$

538,782

Net loss

$

(65,116

)

$

(28,482

)

$

(49,476

)

$

(219,835

)

$

(131,165

)

Loss per share(1)

$

(2.50

)

$

(1.10

)

$

(1.92

)

$

(8.45

)

$

(5.09

)

Net cash (used in) provided by operating activities

$

(20,894

)

$

24,700

$

(26,417

)

$

(81,616

)

$

(40,093

)

Adjusted net loss(2)

$

(63,886

)

$

(26,788

)

$

(33,143

)

$

(167,076

)

$

(106,144

)

Adjusted loss per share(1)(2)

$

(2.45

)

$

(1.03

)

$

(1.28

)

$

(6.42

)

$

(4.12

)

Adjusted EBITDA(2)

$

(21,900

)

$

13,013

$

(6,859

)

$

(9,088

)

$

1,632

Adjusted free cash flow(2)

$

(39,265

)

$

18,376

$

(20,960

)

$

(114,500

)

$

(56,153

)

Net sales for the fourth quarter of 2025 were $116 million, a decrease of 13% compared to $134 million for the fourth quarter of 2024, primarily reflecting a year-over-year decrease in our weighted-average realized price. Sales volume for the fourth quarter of 2025 was comparable to the same period in 2024.

Net loss for the fourth quarter of 2025 was $65 million, or $2.50 per share, compared to a net loss of $49 million, or $1.92 per share, for the fourth quarter of 2024. Adjusted EBITDA(2) for the fourth quarter of 2025 was negative $22 million, compared to adjusted EBITDA(2) of negative $7 million for the fourth quarter of 2024, with the year-over-year change primarily reflecting the decline in weighted-average realized prices. This was partially offset by a 2% reduction in cash cost of goods sold per MT for the fourth quarter of 2025, compared to the same period in 2024.

For the fourth quarter of 2025, net cash used in operating activities was $21 million, compared to net cash used in operating activities of $26 million for the fourth quarter of 2024. Adjusted free cash flow(2) for the fourth quarter of 2025 was negative $39 million, compared to adjusted free cash flow(2) of negative $21 million for the fourth quarter of 2024, with the year-over-year change primarily reflecting the decline in adjusted EBITDA(2) and a year-over-year increase in capital expenditures for the fourth quarter. These factors were partially offset by a higher benefit from the net change in working capital in the fourth quarter of 2025, compared to the same period in 2024.

Net sales for the year ended December 31, 2025 decreased 6% compared to the prior year as higher sales volume was offset by a year-over-year decrease in our weighted-average realized price.

Net loss for the year ended December 31, 2025 was $220 million, or $8.45 per share, compared to a net loss of $131 million, or $5.09 per share, for the year ended December 31, 2024. Included in net loss for the year ended December 31, 2025 was a $43 million non-cash income tax expense related to the establishment of a full valuation allowance against the Company’s United States and Switzerland deferred tax assets.

Adjusted EBITDA(2) for the year ended December 31, 2025 was negative $9 million, compared to adjusted EBITDA of $2 million in the prior year. The year-over-year decline primarily reflected the impact of lower weighted-average realized prices, partially offset by an 11% reduction in cash costs on a per MT basis for the year ended December 31, 2025, compared to 2024.

Net cash used in operating activities for the year ended December 31, 2025 was $82 million, compared to net cash used in operating activities of $40 million for the year ended December 31, 2024. Adjusted free cash flow(2) for the year ended December 31, 2025 was negative $115 million, compared to adjusted free cash flow(2) of negative $56 million for the year ended December 31, 2024, with the year-over-year change primarily reflecting a lower benefit from the net change in working capital for the year ended December 31, 2025, compared to 2024, and the decline in adjusted EBITDA(2).

Operational and Commercial Update

Key Operating Metrics

Year Ended

December 31,

(in thousands, except percentages)

Q4 2025

Q3 2025

Q4 2024

2025

2024

Sales volume (MT)

27.1

28.8

27.2

109.2

103.2

Production volume (MT)

27.8

26.6

25.1

112.3

97.3

Production capacity (MT)(3)(4)

46.0

42.0

46.0

178.0

178.0

Capacity utilization(5)

60

%

63

%

55

%

63

%

55

%

Sales volume for the fourth quarter of 2025 was 27.1 thousand MT, compared to sales volume of 27.2 thousand MT for the fourth quarter of 2024. For the year ended December 31, 2025, sales volume was 109.2 thousand MT, resulting in year-over-year growth of 6% on a full-year basis. This was below our most recent guidance of an 8-10% year-over-year increase in sales volume for 2025, primarily reflecting our decision to forego certain volume opportunities where margins would be unacceptably low.

For the fourth quarter of 2025, our weighted-average realized price was approximately $4,000 per MT. This represented a 9% decrease compared to the fourth quarter of 2024 and, sequentially, a 5% decline compared to the third quarter of 2025, reflecting persistent competitive pressures across all of our principal commercial regions. The year-over-year decline further reflected the substantial completion in 2024 of long-term sales agreements entered into in prior years. These impacts were partially mitigated by our initiative to actively shift more sales volume to the United States, which remains the strongest region for graphite electrode pricing.

Production volume for the fourth quarter of 2025 was 27.8 thousand MT, resulting in a capacity utilization rate of 60% for the quarter. For the year ended December 31, 2025, production volume was 112.3 thousand MT, resulting in a capacity utilization rate of 63% for the full year.

Capital Structure and Liquidity

As of December 31, 2025, we had total liquidity of $340 million, consisting of cash and cash equivalents of $138 million, $102 million of availability under our revolving credit facility and $100 million of availability under our senior secured first lien delayed draw term loans, which continues to support our ability to manage through near-term, industry-wide challenges. As of December 31, 2025, we had gross debt(6) of $1,125 million, with substantially no maturities until December 2029, and net debt(7) of approximately $987 million.

Outlook

In 2025, global (excluding China) steel production was relatively flat compared to 2024, as geopolitical uncertainty, particularly as it relates to global trade and tariffs, had a significant impact on broader steel industry trends. In addition, steel exports from China reached a record high in 2025, further constraining steel production in the rest of the world.

As we enter 2026, industry analyst projections indicate a modest recovery in global (excluding China) steel demand is expected for the year. In the United States, where the steel industry has experienced relative stability, steel production is expected to increase further in the near-term, supported by favorable domestic trade policies. In the European Union, where the steel industry has been relatively challenged, we continue to see signs of a potential recovery. In addition to the anticipated growth in steel demand within the European Union in 2026, steel production in Europe is expected to be further supported by increased trade protections as we proceed through the year. Reflecting these dynamics, hot-rolled coil steel pricing is expected to increase in 2026 in most regions.

As we closely monitor these developments and assess their potential impact on the commercial environment for graphite electrodes, we currently project that global (excluding China) demand for graphite electrodes will increase slightly in 2026, compared to 2025, including projected demand increases within all of the key regions in which we operate.

For GrafTech, we expect to achieve a 5-10% year-over-year increase in our sales volume for 2026 on a full-year basis, as we continue to gain market share reflecting our compelling customer value proposition and our ongoing focus on delivering on the needs of our customers. Of our anticipated 2026 sales volume, to date, we have approximately 65% committed in our order book following the completion of the customer negotiations that occur in the fourth quarter of each year. Specific to the first quarter of 2026, we expect a year-over-year increase in our sales volume of approximately 10%.

While we are encouraged by our ongoing strong volume performance, industry-wide pricing levels remain unsustainably low. Challenging pricing dynamics, most notably aggressive competitor pricing behavior, increased further during the fourth quarter of 2025 and we expect that pressure to continue into 2026. As a result, we will continue to execute actions to accelerate our path to normalized levels of profitability and support our ability to invest in our business. This includes further optimizing our order book by continuing to shift the geographic mix of our sales volume to regions where there is an opportunity to capture higher average selling prices, particularly in the United States, while also maintaining our disciplined approach of foregoing volume opportunities where margins are unacceptably low.

As it relates to costs, we will continue to expand on our initiatives to improve our cost structure. With our 2025 cost performance, we have achieved a cumulative decline in our cash cost of goods sold per metric ton of 31% since the end of 2023. As we look to implement additional measures to enhance the efficiency of our production schedules and further optimize production costs, we expect to build on this achievement with a low single-digit percentage-point decline in our cash cost of goods sold per MT for 2026 compared to 2025.

Further, we will continue to prudently manage our working capital levels and capital expenditures. For 2026, reflecting our anticipated volume growth, we expect a modest increase in our net working capital levels for the full year, most notably in the first half of the year reflecting the timing of planned plant maintenance and other timing factors. We anticipate our full-year 2026 capital expenditures will be approximately $35 million, which we believe is an adequate level to maintain our assets at current utilization levels.

Longer term, we remain confident that the steel industry’s efforts to decarbonize will lead to increased adoption of the electric arc furnace method of steelmaking, driving long-term demand growth for graphite electrodes. We also anticipate the demand for petroleum needle coke, the key raw material we use to produce graphite electrodes, to accelerate driven by its utilization in producing synthetic graphite used in anodes for lithium-ion batteries that power electric vehicles and energy storage systems. We believe that the near-term actions we are taking, supported by an industry-leading position and our sustainable competitive advantages, including our substantial vertical integration into petroleum needle coke via our Seadrift facility, will optimally position GrafTech to benefit from that long-term growth.

Conference Call Information

In connection with this earnings release, you are invited to listen to our earnings call being held on February 6, 2026 at 10:00 a.m. (EST). The webcast and accompanying slide presentation will be available on our investor relations website at: http://ir.graftech.com. The earnings call dial-in number is +1 (800) 715-9871 toll-free in the United States or +1 (646) 307-1963 for international calls, conference ID: 4082619. Archived replays of the conference call and webcast will be made available on our investor relations website at: http://ir.graftech.com. GrafTech also makes its complete financial reports that have been filed with the Securities and Exchange Commission ("SEC") and other information available at: www.GrafTech.com. The information on our website is not part of this release or any report we file with or furnish to the SEC.

About GrafTech

GrafTech International Ltd. is a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. The Company has a competitive portfolio of low-cost, ultra-high power graphite electrode manufacturing facilities, with some of the highest capacity facilities in the world. We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, our key raw material for graphite electrode manufacturing. This unique position provides us with competitive advantages in product quality and cost.

____________________ (1)

Loss per share represents diluted loss per share. Adjusted loss per share represents diluted adjusted loss per share. All share and per share data for all periods presented reflect the 1-for-10 reverse stock split, which became effective on August 29, 2025.

(2)

A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States of America ("GAAP").

(3)

Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary.

(4)

Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; and Pamplona, Spain.

(5)

Capacity utilization reflects production volume as a percentage of production capacity.

(6)

Gross debt reflects the notional value of our outstanding debt and excludes unamortized debt discount and issuance costs.

(7)

A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents (December 31, 2025 gross debt of $1,125 million less December 31, 2025 cash and cash equivalents of $138 million).

Cautionary Note Regarding Forward-Looking Statements

This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our current views with respect to, among other things, financial projections, plans and objectives of management for future operations, future economic performance and short-term and long-term liquidity. Examples of forward-looking statements include, among others, statements we make regarding future estimated volume, pricing and revenue, and anticipated levels of capital expenditures and cost of goods sold. You can identify these forward-looking statements by the use of forward-looking words such as “will,” “may,” “plan,” “estimate,” “project,” “believe,” “anticipate,” “expect,” “foresee,” “intend,” “should,” “would,” “could,” “target,” “goal,” “continue to,” “positioned to,” “are confident,” or the negative versions of those words or other comparable words. Any forward-looking statements contained in this press release are based upon our historical performance and on our current plans, estimates and expectations considering information currently available to us. The inclusion of this forward-looking information should not be regarded as a representation by us that the future plans, estimates, or expectations contemplated by us will be achieved. Our expectations and targets are not predictions of actual performance and historically our performance has deviated, often significantly, from our expectations and targets. These forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity. Accordingly, there are or will be important factors that could cause our actual results to differ materially from those indicated in these statements. We believe that these factors include, but are not limited to: our dependence on the global steel industry generally and the electric arc furnace steel industry in particular; the cyclical nature of our business and the selling prices of our products, which may remain at depressed levels or further decline in the future, and may continue to experience prolonged periods of reduced profitability and net losses or adversely impact liquidity; the sensitivity of our business and operating results to economic conditions, including any recession, and the possibility others may not be able to fulfill their obligations to us in a timely fashion or at all; the possibility that we may be unable to implement our business strategies in an effective manner, including our ability to effectively increase or maintain existing prices and shift sales to regions with higher average selling prices; continued overcapacity of the global graphite electrode industry, which may further adversely affect graphite electrode prices; the competitiveness of the graphite electrode industry; our dependence on the cost and availability of manufacturing inputs, including raw materials, such as decant oil, petroleum needle coke, energy and freight, and disruptions in availability for such inputs; our primary reliance on one facility in Monterrey, Mexico for the manufacturing of connecting pins; the cost of electric power and natural gas, particularly in Europe; our manufacturing operations are subject to hazards; the legal, compliance, economic, social and political risks associated with our substantial operations in multiple countries; the possibility that fluctuation of foreign currency exchange rates could materially harm our financial results; the possibility that our results of operations could further deteriorate if our manufacturing operations were substantially disrupted for an extended period, including as a result of equipment failure, climate change, regulatory issues, natural disasters, public health crises, such as a global pandemic, political crises or other catastrophic events; the risks and uncertainties associated with litigation, arbitration, and like disputes, including disputes related to contractual commitments; our dependence on third parties for certain construction, maintenance, engineering, transportation, warehousing and logistics services; the possibility that we are subject to information technology systems failures, cybersecurity incidents, network disruptions and breaches of data security, including with respect to our third-party suppliers and business partners; the possibility that we are unable to recruit or retain key management and plant operating personnel or successfully negotiate with the representatives of our employees, including labor unions; the sensitivity of long-lived assets on our balance sheet to changes in the market; our dependence on protecting our intellectual property and the possibility that third parties may claim that our products or processes infringe their intellectual property rights; the impact of inflation and our ability to mitigate the effect on our costs; the impact of macroeconomic and geopolitical events on our business, results of operations, financial condition and cash flows, and the disruptions and inefficiencies in our supply chain that may occur as a result of such events; uncertain shifts in domestic and foreign trade policies and the possibility that the imposition of current, new or increased custom duties and tariffs and trade barriers in the countries in which we, our customers and our suppliers operate could adversely affect our ability to compete, operations, results of operations and financial condition; risks associated with strategic transactions, including acquisitions, divestitures, joint ventures, equity investments, and debt issuances, that could adversely affect our business, operating results and financial condition; the possibility that our indebtedness could limit our financial and operating activities or that our cash flows may not be sufficient to service our indebtedness; any current or future borrowings may subject us to interest rate risk; risks and uncertainties associated with our ability to access the capital and credit markets could adversely affect our results of operations, cash flows and financial condition; the possibility that disruptions in the capital and credit markets could adversely affect our customers and suppliers; the possibility that restrictive covenants in our financing agreements could restrict or limit our operations; and changes in health, safety and environmental regulations applicable to our manufacturing operations and facilities.

These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and other filings with the SEC. The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Except as required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release, in our Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.

Non‑GAAP Financial Measures

In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted net loss, adjusted loss per share, free cash flow, adjusted free cash flow, net debt and cash cost of goods sold per MT are non-GAAP financial measures.

We define EBITDA, a non‑GAAP financial measure, as net loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA, a non-GAAP financial measure, as EBITDA adjusted by any pension and other post-employment benefit ("OPEB") expenses, rationalization and rationalization-related expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, stock-based compensation expense, proxy contest expenses and Tax Receivable Agreement adjustments. Adjusted EBITDA is the primary metric used by our management and our Board of Directors to establish budgets and operational goals for managing our business and evaluating our performance.

We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities.

We define adjusted net loss, a non‑GAAP financial measure, as net loss, excluding the items used to calculate adjusted EBITDA and further excluding debt modification costs, less the tax effect of those adjustments and non-cash income tax expense related to the establishment of a deferred tax valuation allowance. We define adjusted loss per share, a non‑GAAP financial measure, as adjusted net loss divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net loss and adjusted loss per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.

We define free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less capital expenditures. We define adjusted free cash flow, a non-GAAP financial measure, as free cash flow adjusted by payments made for debt modification costs. We use free cash flow and adjusted free cash flow as critical measures in the evaluation of liquidity in conjunction with related GAAP amounts. We also use these measures when considering available cash, including for decision-making purposes related to dividends and discretionary investments. Further, these measures help management, the Board of Directors, and investors evaluate the Company's ability to generate liquidity from operating activities.

We define net debt, a non-GAAP financial measure, as gross debt minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.

We define cash cost of goods sold per MT, a non-GAAP financial measure, as cost of goods sold less depreciation and amortization, less cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes and less rationalization-related expenses, with this total divided by our sales volume measured in MT. We believe this is an important measure as it is used by our management and Board of Directors to evaluate our costs on a per MT basis.

In evaluating these non-GAAP financial measures, you should be aware that in the future, we may incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of these non-GAAP financial measures should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider these non-GAAP financial measures alongside other measures of financial performance and liquidity, including our net loss, loss per share, cash flow from operating activities, cost of goods sold and other GAAP measures.

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share data)

(Unaudited)

  December 31,

2025

December 31,

2024

ASSETS

Current assets:

Cash and cash equivalents

$

138,427

$

256,248

Accounts and notes receivable, net of allowance for doubtful accounts of $3,271 as of December 31, 2025 and $7,114 as of December 31, 2024

73,235

93,576

Inventories

224,692

231,241

Prepaid expenses and other current assets

48,180

55,732

Total current assets

484,534

636,797

Property, plant and equipment

986,946

910,247

Less: accumulated depreciation

497,016

427,548

Net property, plant and equipment

489,930

482,699

Deferred income taxes

9,318

53,139

Other assets

45,007

51,639

Total assets

$

1,028,789

$

1,224,274

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current liabilities:

Accounts payable

$

67,017

$

72,833

Accrued income and other taxes

8,047

9,642

Other accrued liabilities

53,127

55,432

Tax Receivable Agreement



2,022

Total current liabilities

128,191

139,929

Long-term debt

1,094,706

1,086,915

Other long-term obligations

40,388

48,559

Deferred income taxes

25,132

23,971

Tax Receivable Agreement long-term



3,802

Stockholders’ deficit:

Preferred stock, par value $0.01, 30,000,000 shares authorized, none issued





Common stock, par value $0.01, 300,000,000 shares authorized, 25,820,110 and 25,726,420 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively

2,582

2,572

Additional paid-in capital

759,710

755,338

Accumulated other comprehensive loss

(8,972

)

(43,359

)

Accumulated deficit

(1,012,948

)

(793,453

)

Total stockholders’ deficit

(259,628

)

(78,902

)

Total liabilities and stockholders’ deficit

$

1,028,789

$

1,224,274

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except per share data)

(Unaudited)

  Three Months Ended

December 31,

Year Ended

December 31,

2025

2024

2025

2024

Net sales

$

116,457

$

134,217

$

504,134

$

538,782

Cost of goods sold

128,805

131,698

501,496

533,757

Lower of cost or market inventory valuation adjustment

11,989

12,962

18,315

24,878

Gross loss

(24,337

)

(10,443

)

(15,677

)

(19,853

)

Research and development

1,609

1,387

6,475

5,706

Selling and administrative expenses

13,241

13,075

54,914

46,510

Rationalization expenses







3,156

Operating loss

(39,187

)

(24,905

)

(77,066

)

(75,225

)

Other (income) expense, net

(2,212

)

200

(4,049

)

(1,569

)

Interest expense

24,281

37,575

104,057

85,313

Interest income

(1,448

)

(1,226

)

(6,632

)

(5,701

)

Loss before income taxes

(59,808

)

(61,454

)

(170,442

)

(153,268

)

Income tax expense (benefit)

5,308

(11,978

)

49,393

(22,103

)

Net loss

$

(65,116

)

$

(49,476

)

$

(219,835

)

$

(131,165

)

Basic loss per common share:

Net loss per share

$

(2.50

)

$

(1.92

)

$

(8.45

)

$

(5.09

)

Weighted average common shares outstanding

26,043,244

25,796,851

26,004,964

25,766,825

Diluted loss per common share:

Net loss per share

$

(2.50

)

$

(1.92

)

$

(8.45

)

$

(5.09

)

Weighted average common shares outstanding

26,043,244

25,796,851

26,004,964

25,766,825

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

  Three Months Ended

December 31,

Year Ended

December 31,

2025

2024

2025

2024

Cash flow from operating activities:

Net loss

$

(65,116

)

$

(49,476

)

$

(219,835

)

$

(131,165

)

Adjustments to reconcile net loss to cash used in operations:

Depreciation and amortization

15,799

16,110

61,643

62,245

Deferred income tax (benefit) expense

2,010

(15,891

)

42,792

(27,634

)

Non-cash stock-based compensation expense

1,518

1,589

4,952

6,035

Non-cash interest expense

1,947

1,550

7,791

(2,028

)

Lower of cost or market inventory valuation adjustment

11,989

12,962

18,315

24,878

Other adjustments

(2,858

)

(3,891

)

8,525

(7,348

)

Net change in working capital*

13,817

10,543

25

40,254

Change in Tax Receivable Agreement



87

(5,824

)

(5,330

)

Net cash used in operating activities

(20,894

)

(26,417

)

(81,616

)

(40,093

)

Cash flow from investing activities:

Capital expenditures

(18,371

)

(12,792

)

(38,885

)

(34,309

)

Proceeds from the sale of fixed assets

256



554

100

Net cash used in investing activities

(18,115

)

(12,792

)

(38,331

)

(34,209

)

Cash flow from financing activities:

Proceeds from Initial First Lien Term Loan due 2029



175,000



175,000

Principal payments on long-term debt



(137

)



(137

)

Debt issuance and modification costs



(18,945

)



(18,945

)

Payments for taxes related to net share settlement of equity awards



(36

)

(230

)

(118

)

Principal payments under finance lease obligations

(31

)

(24

)

(111

)

(82

)

Net cash (used in) provided by financing activities

(31

)

155,858

(341

)

155,718

Net change in cash and cash equivalents

(39,040

)

116,649

(120,288

)

81,416

Effect of exchange rate changes on cash and cash equivalents

(168

)

(1,807

)

2,467

(2,046

)

Cash and cash equivalents at beginning of period

177,635

141,406

256,248

176,878

Cash and cash equivalents at end of period

$

138,427

$

256,248

$

138,427

$

256,248

* Net change in working capital due to changes in the following components:

Accounts and notes receivable, net

$

14,683

$

(6,682

)

$

23,825

$

4,519

Inventories

6,445

18,727

(8,589

)

68,832

Prepaid expenses and other current assets

6,750

6,296

487

9,106

Income taxes payable

568

1,067

(123

)

(1,549

)

Accounts payable and accruals

(508

)

9,165

(18,270

)

(39,501

)

Interest payable

(14,121

)

(18,030

)

2,695

(1,153

)

Net change in working capital

$

13,817

$

10,543

$

25

$

40,254

NON-GAAP RECONCILIATIONS

(Dollars in thousands, except per share and per MT data)

(Unaudited)

The following tables reconcile our non-GAAP financial measures to the most directly comparable GAAP measures:

  Reconciliation of Net Loss to Adjusted Net Loss

Year Ended

December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Net loss

$

(65,116

)

$

(28,482

)

$

(49,476

)

$

(219,835

)

$

(131,165

)

Diluted loss per common share:

Net loss per share

$

(2.50

)

$

(1.10

)

$

(1.92

)

$

(8.45

)

$

(5.09

)

Weighted average shares outstanding

26,043,244

25,933,254

25,796,851

26,004,964

25,766,825

Adjustments, pre-tax:

Pension and OPEB plan expenses(1)

(3,109

)

719

967

(1,129

)

2,270

Rationalization expenses(2)









3,156

Rationalization-related expenses(3)









2,655

Foreign currency remeasurement(4)

867

41

(507

)

2,254

(1,949

)

Stock-based compensation expense(5)

1,518

1,012

1,589

4,952

6,035

Proxy contest expenses(6)









752

Tax Receivable Agreement adjustment(7)





87

(3,791

)

124

Debt modification costs(8)





18,369

6,293

18,369

Total non-GAAP adjustments pre-tax

(724

)

1,772

20,505

8,579

31,412

Valuation allowance adjustment(9)







(42,624

)



Income tax impact on non-GAAP adjustments(10)

(1,954

)

78

4,172

(1,556

)

6,391

Adjusted net loss

$

(63,886

)

$

(26,788

)

$

(33,143

)

$

(167,076

)

$

(106,144

)

Reconciliation of Loss Per Share to Adjusted Loss Per Share

Year Ended

December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Loss per share

$

(2.50

)

$

(1.10

)

$

(1.92

)

$

(8.45

)

$

(5.09

)

Adjustments per share:

Pension and OPEB plan expenses(1)

(0.12

)

0.03

0.04

(0.04

)

0.09

Rationalization expenses(2)









0.12

Rationalization-related expenses(3)









0.10

Foreign currency remeasurement(4)

0.03



(0.02

)

0.08

(0.07

)

Stock-based compensation expense(5)

0.06

0.04

0.06

0.19

0.23

Proxy contest expenses(6)









0.03

Tax Receivable Agreement adjustment(7)







(0.14

)



Debt modification costs(8)





0.72

0.24

0.71

Total non-GAAP adjustments pre-tax per share

(0.03

)

0.07

0.80

0.33

1.21

Valuation allowance adjustment(9)







(1.64

)



Income tax impact on non-GAAP adjustments per share(10)

(0.08

)



0.16

(0.06

)

0.24

Adjusted loss per share

$

(2.45

)

$

(1.03

)

$

(1.28

)

$

(6.42

)

$

(4.12

)

Reconciliation of Net Loss to Adjusted EBITDA

Year Ended
December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Net loss

$

(65,116

)

$

(28,482

)

$

(49,476

)

$

(219,835

)

$

(131,165

)

Add:

Depreciation and amortization

15,799

16,499

16,110

61,643

62,245

Interest expense

24,281

24,517

37,575

104,057

85,313

Interest income

(1,448

)

(1,383

)

(1,226

)

(6,632

)

(5,701

)

Income taxes

5,308

90

(11,978

)

49,393

(22,103

)

EBITDA

(21,176

)

11,241

(8,995

)

(11,374

)

(11,411

)

Adjustments:

Pension and OPEB plan expenses(1)

(3,109

)

719

967

(1,129

)

2,270

Rationalization expenses(2)









3,156

Rationalization-related expenses(3)









2,655

Foreign currency remeasurement(4)

867

41

(507

)

2,254

(1,949

)

Stock-based compensation expense(5)

1,518

1,012

1,589

4,952

6,035

Proxy contest expenses(6)









752

Tax Receivable Agreement adjustment(7)





87

(3,791

)

124

Adjusted EBITDA

$

(21,900

)

$

13,013

$

(6,859

)

$

(9,088

)

$

1,632

Reconciliation of Net Cash (Used in) Provided by Operating Activities to Free Cash Flow and Adjusted Free Cash Flow

Year Ended
December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Net cash (used in) provided by operating activities

$

(20,894

)

$

24,700

$

(26,417

)

$

(81,616

)

$

(40,093

)

Capital expenditures

(18,371

)

(6,324

)

(12,792

)

(38,885

)

(34,309

)

Free cash flow

(39,265

)

18,376

(39,209

)

(120,501

)

(74,402

)

Debt modification costs(11)





18,249

6,001

18,249

Adjusted free cash flow

$

(39,265

)

$

18,376

$

(20,960

)

$

(114,500

)

$

(56,153

)

Reconciliation of Cost of Goods Sold to Cash Cost of Goods Sold per MT

Year Ended
December 31,

Q4 2025

Q3 2025

Q4 2024

2025

2024

Cost of goods sold

$

128,805

$

132,041

$

131,698

$

501,496

$

533,757

Less:

Depreciation and amortization(12)

14,229

14,905

14,466

55,224

55,602

Cost of goods sold - by-products and other(13)

5,672

7,840

6,094

30,512

32,801

Rationalization-related expenses(3)









2,655

Cash cost of goods sold

108,904

109,296

111,138

415,760

442,699

Sales volume (in thousands of MT)

27.1

28.8

27.2

109.2

103.2

Cash cost of goods sold per MT

$

4,019

$

3,795

$

4,086

$

3,807

$

4,290

(1)

Net periodic benefit cost for our pension and OPEB plans, including a mark-to-market adjustment, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year.

(2)

Severance and contract termination costs associated with the cost rationalization and footprint optimization plan announced in February 2024.

(3)

Other non-cash costs, primarily inventory and fixed asset write-offs, associated with the cost rationalization and footprint optimization plan announced in February 2024.

(4)

Non-cash losses (gains) from foreign currency remeasurement of non-operating assets and liabilities of our non-U.S. subsidiaries where the functional currency is the U.S. dollar.

(5)

Non-cash expense for stock-based compensation awards.

(6)

Expenses associated with our proxy contest.

(7)

Prior to the second quarter of 2025, represents expense adjustment for future payment to our sole pre-Initial Public Offering ("IPO") stockholder for tax assets that have been utilized. In the second quarter of 2025, represents the write-off of the remaining liability for pre-IPO tax assets that are not expected to be realized.

(8)

Debt modification costs related to the December 2024 debt transactions, which are recognized in interest expense on the Consolidated Statements of Operations.

(9)

Represents non-cash income tax expense recorded in the second quarter of 2025 related to the establishment of a full valuation allowance against the Company’s United States and Switzerland deferred tax assets.

(10)

Represents the tax impact on the non-GAAP adjustments.

(11)

Cash payments of debt modification costs related to the December 2024 debt transactions, which are recognized in interest expense on the Consolidated Statements of Operations and recognized in net cash used in operating activities on the Consolidated Statements of Cash Flows.

(12)

Reflects the portion of depreciation and amortization that is recognized in cost of goods sold.

(13)

Primarily reflects cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes.

More News From GrafTech International Ltd.
2026-02-06 11:54 1mo ago
2026-02-06 06:40 1mo ago
Broker initiates coverage of Capita with a 'buy' call stocknewsapi
AZN
Capita PLC (LSE:CPI) received a boost after Shore Capital Markets initiated coverage of the UK outsourcing group with a Buy rating, arguing that the company’s turnaround plan could support a return to positive free cash flow and higher margins.

The broker set a fair value estimate of £5.30 a share, above the current price of 389p, and said the market was not yet pricing in the group’s full recovery potential.

Shore Capital said Capita’s strategy to return to growth and “ultimately positive cash flows” offered upside from what it described as a normalisation of the group’s profile after years of restructuring.

The analysts said the business was starting from low margins, which created operating leverage as fixed cash costs were absorbed, while a wide range of outcomes reflected both the risks and the opportunity.

Shore Capital said it expected Capita to transition to positive adjusted free cash flow from this year and to strengthen margins over the medium term as it converted its opportunity pipeline into firm orders.

The broker highlighted the Contact Centre division as central to the investment case, saying its recovery would be critical to delivering the group’s target of rebuilding adjusted operating margins to 6–8% from 4% in 2024.

If Capita succeeds in its plan, Shore Capital said adjusted operating profit could ultimately recover to £163m from £96m in 2024, with free cash flow returning to inflows after prolonged outflows.

The shares were flat at 375p.
2026-02-06 11:54 1mo ago
2026-02-06 06:41 1mo ago
Tesla is training its AI technology in China, local media reports stocknewsapi
TSLA
By Reuters

February 6, 202611:41 AM UTCUpdated 10 mins ago

A man walks by at a store of the electric vehicle (EV) maker Tesla, in Beijing, China March 24, 2025. REUTERS/Florence Lo Purchase Licensing Rights, opens new tab

CompaniesBEIJING, Feb 6 (Reuters) - Tesla (TSLA.O), opens new tab is operating an artificial intelligence training centre in China focusing on local application and assisted driving, Chinese media outlet Cailianshe reported on Friday, citing the company's Vice President Tao Lin.

Learn about the latest breakthroughs in AI and tech with the Reuters Artificial Intelligencer newsletter. Sign up here.

Reporting by Yukun Zhang and Ryan Woo; Editing by Toby Chopra

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-02-06 11:54 1mo ago
2026-02-06 06:43 1mo ago
Atmus Filtration Technologies Appoints Heath Sharp to Its Board of Directors stocknewsapi
ATMU
NASHVILLE, Tenn.--(BUSINESS WIRE)--Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU), a global leader in the filtration industry, today announced the appointment of Heath Sharp to its Board of Directors.

“Sharp brings more than 30 years of hands-on leadership across manufacturing, product development and commercial execution, with a career built on scaling industrial businesses internationally,” said Steph Disher, CEO and President of Atmus. “As a seasoned global industrial leader, Sharp joins the Board during a key time when we are well positioned for Atmus’ next phase of growth.”

Sharp currently serves as Chief Executive Officer and Managing Director of Reliance Worldwide Corporation, where he has led the company’s evolution from a regionally focused manufacturer into a global, publicly listed leader in water control systems and plumbing solutions.

“We’re excited to welcome Heath Sharp to the Atmus Board at a moment when operational excellence and smart, global execution matter more than ever,” said Steve Macadam, Chair of the Atmus Board of Directors. “Heath is a proven industrial operator and engineer who has spent decades building manufacturing capability, advancing product innovation and scaling a business internationally. His perspective is shaped by leading teams across multiple markets and will be a strong complement to the Board as Atmus continues to expand its global footprint and execute on its long‑term growth strategy.”

For Atmus, Sharp’s background offers a practical, operator’s perspective on building global platforms, particularly in areas that matter most to the Company today: manufacturing excellence, product innovation and disciplined commercial expansion. His experience leading teams across Australia, the United States and the United Kingdom brings valuable insight into operating effectively across diverse markets and cultures.

“Atmus has a clear purpose and a strong platform, and I’m impressed by the company’s focus on building capabilities in innovation, manufacturing strength and customer-driven execution at a global scale,” said Sharp. “I look forward to working with the Board and leadership team to help Atmus continue to grow and deliver for customers and shareholders.”

With Sharp’s appointment, the Atmus Board has increased from seven to eight directors. He will serve as a Class III director through the Company’s next Annual Meeting of Stockholders and has been named to the Board’s Audit Committee and Nominating and Governance Committee.

About Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU) is a global leader in filtration and media solutions. With more than 65 years of innovation and engineering expertise to deliver high-performance filtration solutions, Atmus operates through two business segments: Power Solutions, which serves global on-and-off highway equipment markets through its trusted Fleetguard® brand; and Industrial Solutions, which addresses high-growth end markets – including commercial and industrial HVAC, data centers and power generation environments – through its Koch Filter® brand. Headquartered in Nashville, Tenn., Atmus employs nearly 5,000 people worldwide who are committed to creating a better future by protecting what is important. Learn more at https://www.atmus.com.

More News From Atmus Filtration Technologies Inc.
2026-02-06 11:54 1mo ago
2026-02-06 06:43 1mo ago
Apple Scales Back AI Health Coach Plans stocknewsapi
AAPL
By PYMNTS  |  February 6, 2026

 | 

Apple Inc. is scaling back plans for an AI-based health coach, a retreat that underscores the difficulty of turning health tracking into a paid service. The shift matters for Apple’s wearables and services goals.

Bloomberg reported on Feb. 5 that Apple has wound down the initiative, code-named Mulberry, citing people familiar with the matter. Apple referred to the effort internally as Health+. Instead of launching the coach as a standalone offering, Apple plans to roll out some of the planned features inside the Health app over time. Apple declined to comment.

The move followed a leadership shift in Apple’s health organization, Bloomberg said. Services chief Eddy Cue took over the division after longtime executive Jeff Williams retired at the end of last year. Cue has told colleagues Apple needs to move faster, and he has pointed to rivals such as Oura and Whoop as offering more compelling features. Cue is also weighing changes to Apple Fitness+, the company’s $9.99-a-month guided workout subscription.

Bloomberg said Apple had delayed the coach more than once, first targeting iOS 26 and later pushing it to iOS 27, scheduled for September. The service was designed to generate health reports and provide AI-driven recommendations using surveys and assessments, paired with Apple Watch data and external lab reports. Apple built a content studio in Oakland, California, to produce videos for the Health app. Bloomberg said Apple will repurpose some of that video content and features such as suggestions based on existing Health app data, potentially as soon as this year. Another feature still in the works uses an iPhone camera to analyze how a person walks.

Competition is rising. Bloomberg said Samsung is gaining traction in health tracking, and OpenAI has launched “ChatGPT Health” to analyze data and provide feedback. Apple is also working on an AI chatbot for health questions and expects a future Siri chatbot to handle more advanced health queries, Bloomberg reported.

In a 2024 Apple press release, Apple health vice president Sumbul Desai said: “At Apple, we believe that technology can help you live a healthier life, and we’re excited to enable incredible new health capabilities.”

Advertisement: Scroll to Continue

In PYMNTS’ recent Apple coverage, we reported on “Apple Brings Tap to Pay to 9 New European Countries,” and its recent earnings announcement which focused on AI and iPhones sales.
2026-02-06 11:54 1mo ago
2026-02-06 06:44 1mo ago
YIT Oyj (YITYY) Q4 2025 Earnings Call Transcript stocknewsapi
YITYY
YIT Oyj (YITYY) Q4 2025 Earnings Call February 6, 2026 3:00 AM EST

Company Participants

Essi Nikitin - Vice President of Investor Relations
Heikki Vuorenmaa - Chairman of Group Management Team, CEO, President & Interim EVP of Residential Finland Segment
Markus Pietikainen - Interim CFO, Member of Group Management Team and SVP, Treasury and M&A

Conference Call Participants

Svante Krokfors - Nordea Markets, Research Division
Anssi Raussi - SEB, Research Division

Presentation

Essi Nikitin
Vice President of Investor Relations

Hi, everyone. Welcome to YIT's Financial Statements Bulletin 2025 Webcast. My name is Essi Nikitin, and I'm heading the Investor Relations at YIT. The results will be presented to you by our CEO, Heikki Vuorenmaa; and Interim CFO, Markus Pietikainen.

Without further ado, I will hand over to Heikki to go through the latest developments in the company. Please go ahead, Heikki.

Heikki Vuorenmaa
Chairman of Group Management Team, CEO, President & Interim EVP of Residential Finland Segment

Thank you very much, Essi, and welcome, everyone, to today's webcast. Today, we will have a comprehensive agenda ahead of us. First, we review our full year '25 performance. Then we will take the deep dive into the fourth quarter and following up on providing some additional details regarding the news related to earlier today.

But let's begin with the overview of the full year. So the first year of our strategy that we introduced 2024 is now behind. We made progress across the several targets, areas, including our adjusted operating profit margin, return on capital employed, gearing and the customer and employee NPS levels.

Our financial position continued to strengthen. It was supported by improved financing terms and EUR 120 million reduction in the net debt. The business segments delivered different types of performance throughout the year.

In the Residential Finland, the inventory of unsold
2026-02-06 11:54 1mo ago
2026-02-06 06:44 1mo ago
Hims & Hers falls 8% after Novo's legal threat. Here's the latest stocknewsapi
HIMS
The stock of Hims & Hers dropped in premarket trading early Friday after a legal threat from Novo Nordisk.

The online teleheath company announced on Thursday plans to launch a cheaper, copycat version of Novo's weight loss pill, prompting Novo to take legal action.

Hims stock spiked as much as 15% on the news in Thursday trading, but quickly pared gains and ended the session down 3.8% at a 12-month low after Novo said the action was "illegal." Shares fell another 6.7% in premarket trading Friday.

Hims said it will launch a Wegovy-style pill containing the same active ingredient as the original brand, semaglutide, for as little as $49 for the first month when customers sign up for a subscription. After the first month, the price will rise to $99.

That's significantly lower than the $149 Novo Nordisk sells its starting dose for on its direct-to-consumer website NovoCare.

Hims & Hers stock has been volatile over the past year.

Hims is launching its pill even though semaglutide has patent protection in the U.S. until 2032.

The telehealth firm's business flourished when it started selling compounded semaglutide in an injectable format, using a loophole in U.S. regulation that allows competitors to sell a drug protected by intellectual property laws if the drug is in short supply.

In the early days of the Wevovy jab, demand significantly outstripped supply, but Novo Nordisk has since invested heavily in manufacturing capacity and resolved the supply issues. There are no shortages reported for the pill version.

Hims says that its versions are "personalized" in dosage, and therefore legal. Novo says the action is illegal and a risk to patient safety.

"This is another example of Hims & Hers' historic behaviour of duping the American public with knock-off GLP-1 products, and the FDA has previously warned them about their deceptive advertising of GLP-1 knock-offs," Novo said in a statement Thursday.

Hims is a volatile stock, inherently tied to its perceived ability to sell weight loss drugs like its Wegovy copy. Shares have hit highs of $69 and lows of $23 in the past 12 months.

Leerink Partners analyst Michael Cherny, who rates Hims stock at "Market Perform," suggested the telehealth provider could also consider launching copycat versions of Eli Lilly's weight loss drugs. Lilly didn't respond to a CNBC request for comment.

Meanwhile, Barclays analyst James Gordon called the $49 Wegovy copy a "new concern" for Novo.

"While compounded alternatives may attract cost-sensitive patients in the near term, questions remain about their regulatory sustainability and clinical consistency," he added.
2026-02-06 11:54 1mo ago
2026-02-06 06:45 1mo ago
Miami International Holdings Reports Trading Results for January 2026 stocknewsapi
MIAX
MIAX Exchange Group reports 25.1% year-over-year increase in multi-list options ADV

, /PRNewswire/ -- Miami International Holdings, Inc. (MIAX) (NYSE: MIAX), a technology-driven leader in building and operating regulated financial markets across multiple asset classes, today reported January 2026 trading results for its U.S. exchange subsidiaries — MIAX®, MIAX Pearl®, MIAX Emerald® and MIAX Sapphire® (collectively, the MIAX Exchange Group), and MIAX Futures™.

January 2026 Highlights

MIAX Exchange Group average daily volume (ADV) reached 11.1 million contracts, a 25.1% year-over-year (YoY) increase and a 20.6% increase from December 2025 MIAX Exchange Group market share reached 17.6%, a 5.5% increase YoY and a 2.8% increase from December 2025 MIAX Futures ADV reached 7,359 contracts, a 51.9% increase from December 2025 Additional MIAX Exchange Group and MIAX Futures trading volume and market share information is included in the table below. Summary statistics including trading volume and market share by business segment, as well as rolling three-month average revenue per contract and capture rates are available on the MIAX website at https://ir.miaxglobal.com/volume-rpc-reports.

Average Daily Trading Volume (ADV) (1)

Year-to-Date Comparison

Jan-26

Jan-25

% Chg

Dec-25

% Chg

Jan-26

Jan-25

% Chg

U.S. Multi-list Options

Trading Days

20

20

22

20

20

U.S. Equity Options Industry ADV (000's)

63,025

53,135

18.6 %

53,703

17.4 %

63,025

53,135

18.6 %

MIAX Exchange Group Options ADV (000's)

11,100

8,870

25.1 %

9,201

20.6 %

11,100

8,870

25.1 %

MIAX Exchange Group Options Market Share

17.6 %

16.7 %

5.5 %

17.1 %

2.8 %

17.6 %

16.7 %

5.5 %

U.S. Equities

U.S. Equities Industry ADV (Millions)

19,436

15,438

25.9 %

15,879

22.4 %

19,436

15,438

25.9 %

MIAX Pearl ADV (Millions)

161

195

-17.3 %

120

34.6 %

161

195

-17.3 %

MIAX Pearl Market Share

0.8 %

1.3 %

-34.3 %

0.8 %

9.9 %

0.8 %

1.3 %

-34.3 %

MIAX Futures Exchange 

Trading Days

20

21

22

20

21

MIAX Futures ADV

7,359

15,577

-52.8 %

4,843

51.9 %

7,359

15,577

-52.8 %

1)  Calculated as total volume for the period divided by total trading days for the period.

About MIAX
Miami International Holdings, Inc. (NYSE: MIAX) is a technology-driven leader in building and operating regulated financial markets across multiple asset classes and geographies. MIAX operates eight exchanges across options, futures, equities and international markets including MIAX® Options, MIAX Pearl®, MIAX Emerald®, MIAX Sapphire®, MIAX Pearl Equities™, MIAX Futures™, The Bermuda Stock Exchange (BSX) and The International Stock Exchange (TISE). MIAX also owns Dorman Trading, a full-service Futures Commission Merchant. To learn more about MIAX, please visit www.miaxglobal.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are based on management's current expectations and are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements. Additional risks and uncertainties that may cause actual results to differ materially include the risks and uncertainties listed in Miami International Holdings, Inc.'s (together with its subsidiaries, the Company) public filings with the Securities and Exchange Commission. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise.

All third-party trademarks (including logos and icons) referenced by the Company remain the property of their respective owners. Unless specifically identified as such, the Company's use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between the owners of these trademarks and the Company. Any references by the Company to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

MIAX Contacts:

Investors
[email protected] 

Media
[email protected] 

SOURCE MIAX
2026-02-06 11:54 1mo ago
2026-02-06 06:45 1mo ago
Canada Nickel Announces US$32 Million Bridge Loan Facility with Auramet International, Inc. stocknewsapi
CNIKF
, /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) today announced that the Company has entered into a US$32 million bridge loan facility with Auramet International, Inc. ("Auramet") which is expected to close on or before February 9, 2026. Proceeds from the facility provide additional funding to advance the Company's flagship Crawford Nickel Sulphide Project and to repay the existing loan with Ber Tov Capital Corporation ("BT Capital"), signed on May 9, 2025.

Mark Selby, CEO, said, "We are pleased to have the continued support of Auramet, our longstanding financing partner, through this US$32 million bridge facility. This funding ensures we remain well-capitalized to advance the Crawford Nickel Sulphide Project towards construction by year-end 2026 as we complete funding discussions with government and project partners."

Loan Facility

The bridge loan facility will be due May 9, 2026, will carry an interest rate of 1.00% per month, and be subject to a 2.5% arrangement fee. At closing, Auramet will also receive 1,750,000 1-year warrants having an exercise price equal to a 5% premium to the 5-day volume weighted average price of the common shares of the Company on the TSX Venture Exchange for the five consecutive trading days ending on the trading day immediately prior to the closing date. The loan will be subject to such terms and conditions including certain specified positive and negative covenants that are customary for a transaction of this nature. The warrants and the underlying shares will be subject to a four-month hold period under applicable Canadian securities laws. The proceeds will be used for working capital purposes and to repay the existing loan with BT Capital. The closing of the loan facility is subject to customary conditions including the approval of the TSX Venture Exchange.

About Auramet

Auramet is a private company established in 2004 by seasoned professionals who have assembled a global team of industry specialists with over 350 years combined industry experience. It is one of the largest physical precious metals merchants in the world and has provided over $1.3 billion in term financing facilities to date. Auramet offers a full range of services including physical metals trading, metals merchant banking (including direct lending), and project finance advisory services to all participants in the precious metals supply chain. 

About Canada Nickel Company

Canada Nickel Company Inc. is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high growth electric vehicle and stainless-steel markets. Canada Nickel Company has applied in multiple jurisdictions to trademark the terms NetZero NickelTM, NetZero CobaltTM, NetZero IronTM and is pursuing the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.canadanickel.com. 

For further information, please contact:

Mark Selby
CEO
Phone: 647-256-1954
Email: [email protected]   

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain information that may constitute "forward-looking information" under applicable Canadian securities legislation. Forward looking information includes the ability of the Company to deliver nickel required to feed the high growth electric vehicle and stainless steel markets, and the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Readers should not place undue reliance on forward looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual 2 results, performance or achievements of Canada Nickel to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. There are no assurances that Crawford will be placed into production. Factors that could affect the outcome include, among others: inability to repay the loan or comply with the covenants set out in the loan agreement; the actual results of development activities; project delays; inability to raise the funds necessary to complete development; general business, economic, competitive, political and social uncertainties; future prices of metals or project costs could differ substantially and make any commercialization uneconomic; availability of alternative nickel sources or substitutes; actual nickel recovery; conclusions of economic evaluations; changes in applicable laws; changes in project parameters as plans continue to be refined; accidents, labour disputes, the availability and productivity of skilled labour and other risks of the mining industry; political instability, terrorism, insurrection or war; delays in obtaining governmental approvals, necessary permitting or in the completion of development or construction activities; mineral resource estimates relating to Crawford could prove to be inaccurate for any reason whatsoever; additional but currently unforeseen work may be required to advance to the feasibility stage; and even if Crawford goes into production, there is no assurance that operations will be profitable. Although Canada Nickel has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and Canada Nickel disclaims any obligation to update any forward looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Canada Nickel Company Inc.
2026-02-06 11:54 1mo ago
2026-02-06 06:46 1mo ago
Best Income Stocks to Buy for February 6th stocknewsapi
CZNC JOYY WASH
Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 6

JOYY Inc. (JOYY - Free Report) : This social media platform company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% the last 60 days.

This Zacks Rank #1 company has a dividend yield of 6.2%, compared with the industry average of 0.0%.

Washington Trust Bancorp, Inc. (WASH - Free Report) : This bank holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% the last 60 days.

This Zacks Rank #1 company has a dividend yield of 6.1%, compared with the industry average of 2.4%.

Citizens & Northern Corporation (CZNC - Free Report) : This bank holding company for Citizens & Northern Bank has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% the last 60 days.

This Zacks Rank #1 company has a dividend yield of 4.7%, compared with the industry average of 2.4%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.
2026-02-06 11:54 1mo ago
2026-02-06 06:47 1mo ago
A tech wreck has rattled markets. Why this battered S&P 500 sector could be primed for a bounce. stocknewsapi
IVV SPLG SPXL SPY SSO UPRO VOO
HomeMarketsNeed to KnowNeed to KnowA popular software ETF is now at extremely oversold levels, according to one measurePublished: Feb. 6, 2026 at 6:47 a.m. ET

Shares of many tech plays have been sent to the dump. Photo: issouf sanogo/Agence France-Presse/Getty ImagesHard to believe, but amid the recent shellacking meted out to parts of the technology sector — on fears AI will eat software and jitters about gazillion-dollar capex pledges — the S&P 500 is only down 2.6% from its record high.

Perhaps it feels worse because the stock market dip has been accompanied by intense volatility in precious metals and a crypto collapse.
2026-02-06 11:54 1mo ago
2026-02-06 06:48 1mo ago
Ethan Allen Interiors: Valuation, Fundamentals Are More Synchronized stocknewsapi
ETD
HomeStock IdeasLong IdeasConsumer 

SummaryEthan Allen Interiors remains resilient amid inflation and housing headwinds, leveraging operational efficiency and robust liquidity.ETD targets affluent homeowners, enabling pricing power and stable retail net sales despite weaker order volumes and macro challenges.A strong balance sheet with zero debt and high cash reserves supports sustainable dividends, with a 5.7% regular dividend yield and potential for special payouts.I reiterate my buy rating, as valuation offers upside and technicals show early signs of rebound despite prevailing bearish trends.Morsa Images/DigitalVision via Getty Images

It has been nearly four months since my previous coverage of Ethan Allen Interiors Inc. (ETD). From my cautious stance before, I was a bit too early to shift to an optimistic approach. The stock

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-02-06 11:54 1mo ago
2026-02-06 06:50 1mo ago
New Strong Sell Stocks for February 6th stocknewsapi
AKZOY MPC NVGS
This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.

Copyright 2026 Zacks Investment Research 101 N Wacker Drive, Floor 15, Chicago, IL 60606

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.

Visit Performance Disclosure for information about the performance numbers displayed above.

Visit www.zacksdata.com to get our data and content for your mobile app or website.

Real time prices by BATS. Delayed quotes by Sungard.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.

This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
2026-02-06 11:54 1mo ago
2026-02-06 06:52 1mo ago
K92 Mining Reports Surface Contractor Fatality stocknewsapi
KNTNF
VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQB: KNTNF) deeply regrets to report that on February 3, 2026, a contractor supporting roadwork activities near the Kumian Creek Contractor Camp, located approximately 1.5 km NE of the process plant and 8 km NE of the underground mine, suffered a fatal injury following an isolated incident on surface.

K92 Mining’s Emergency Services responded immediately to the incident, and the appropriate authorities were notified. A comprehensive investigation is underway by the contractor and relevant authorities, with full support from K92. K92 has temporarily paused this contractor’s activities at site to facilitate this process. K92 is working closely with its contractors and employees to provide the necessary support and counselling during this extremely challenging time. Safety and adherence to industry best practices remain K92’s highest priorities.

Underground mining and processing activities have not been impacted, and minimal impact is expected to project construction timelines.

John Lewins, K92 Chief Executive Officer and Director, stated, “On behalf of K92 Mining, we are deeply saddened by this incident and we extend our heartfelt sympathies and sincere condolences to the family, friends, and colleagues of the deceased during this extremely difficult time.”

About K92

K92 Mining Inc. is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine. The Company declared commercial production from Kainantu in February 2018, is in a strong financial position, and is working to become a Tier 1 mid-tier producer through ongoing plant expansions. A maiden resource estimate on the Blue Lake copper-gold porphyry project was completed in August 2022. K92 is operated by a team of mining company professionals with extensive international mine-building and operational experience.

On Behalf of the Company,

John Lewins, Chief Executive Officer and Director

For further information, please contact David Medilek, P.Eng., CFA, President and Chief Operating Officer at +1-604-416-4445

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Such forward-looking statements include, without limitation: (i) the results of the Kainantu Mine Definitive Feasibility Study, including the Stage 3 Expansion, a new standalone 1.2 million tonnes-per-annum process plant and supporting infrastructure; (ii) statements regarding the expansion of the mine and development of any of the deposits; (iii) the Kainantu Stage 4 Expansion, operating two standalone process plants, larger surface infrastructure and mining throughputs; and (iv) the potential extended life of the Kainantu Mine.

All statements in this news release that address events or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as “expect”, “plan”, “anticipate”, “project”, “target”, “potential”, “schedule”, “forecast”, “budget”, “estimate”, “intend” or “believe” and similar expressions or their negative connotations, or that events or conditions “will”, “would”, “may”, “could”, “should” or “might” occur. All such forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control, that may cause our actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, without limitation, Public Health Crises, including the epidemic or pandemic viruses; changes in the price of gold, silver, copper and other metals in the world markets; fluctuations in the price and availability of infrastructure and energy and other commodities; fluctuations in foreign currency exchange rates; volatility in price of our common shares; inherent risks associated with the mining industry, including problems related to weather and climate in remote areas in which certain of the Company’s operations are located; failure to achieve production, cost and other estimates; risks and uncertainties associated with exploration and development; uncertainties relating to estimates of mineral resources including uncertainty that mineral resources may never be converted into mineral reserves; the Company’s ability to carry on current and future operations, including development and exploration activities at the Arakompa, Kora, Judd and other projects; the timing, extent, duration and economic viability of such operations, including any mineral resources or reserves identified thereby; the accuracy and reliability of estimates, projections, forecasts, studies and assessments; the Company’s ability to meet or achieve estimates, projections and forecasts; the availability and cost of inputs; the availability and costs of achieving the Stage 3 Expansion or the Stage 4 Expansion; the ability of the Company to achieve the inputs the price and market for outputs, including gold, silver and copper; failures of information systems or information security threats; political, economic and other risks associated with the Company’s foreign operations; geopolitical events and other uncertainties, such as the conflicts in Ukraine, Israel and Palestine; compliance with various laws and regulatory requirements to which the Company is subject to, including taxation; the ability to obtain timely financing on reasonable terms when required; the current and future social, economic and political conditions, including relationship with the communities in Papua New Guinea and other jurisdictions it operates; other assumptions and factors generally associated with the mining industry; and the risks, uncertainties and other factors referred to in the Company’s Annual Information Form under the heading “Risk Factors”.

Estimates of mineral resources are also forward-looking statements because they constitute projections, based on certain estimates and assumptions, regarding the amount of minerals that may be encountered in the future and/or the anticipated economics of production. The estimation of mineral resources and mineral reserves is inherently uncertain and involves subjective judgments about many relevant factors. Mineral resources that are not mineral reserves do not have demonstrated economic viability. The accuracy of any such estimates is a function of the quantity and quality of available data, and of the assumptions made and judgments used in engineering and geological interpretation, Forward-looking statements are not a guarantee of future performance, and actual results and future events could materially differ from those anticipated in such statements. Although we have attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other factors that cause actual results to differ materially from those that are anticipated, estimated, or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
2026-02-06 11:54 1mo ago
2026-02-06 06:52 1mo ago
EnerSys: Showing Margin Power But Waiting For Volume Growth stocknewsapi
ENS
EnerSys delivered resilient Q3 results, with strong margin protection and cash flow despite weak volumes in Motive Power and Transportation. ENS benefits from disciplined cost reductions, a clean balance sheet, and robust free cash flow, supporting share repurchases and dividends. Exposure to secular growth in data centers, aerospace & defense, and advanced batteries positions ENS for upside as cyclical headwinds abate.
2026-02-06 10:54 1mo ago
2026-02-06 04:39 1mo ago
This Fund Just Sold GATX Stock but Kept a More Than $200 Million Stake stocknewsapi
GATX
This global railcar leasing firm serves industrial clients with a diversified fleet and long-term asset management solutions.

GAMCO Investors, Inc. reduced its holding in GATX Corporation (GATX +0.84%), selling 28,902 shares in the fourth quarter for an estimated $4.76 million based on quarterly average pricing, according to a February 5 SEC filing.

What happenedAccording to a filing published February 5 GAMCO Investors, Inc. sold 28,902 shares of GATX Corporation (GATX +0.84%) in the fourth quarter. The estimated transaction value was approximately $4.76 million, calculated using the average unadjusted closing price for the quarter. The fund’s quarter-end position value in GATX declined by $11.28 million, a change driven by both share sales and fluctuations in the stock’s price.

What else to knowThis was a partial sale; GATX now comprises 1.95% of 13F reportable AUM.

Top five holdings after the filing:

NYSE:MLI: $214.36 million (2.1% of AUM)NYSE:GATX: $203.12 million (2.0% of AUM)NYSE:CR: $196.42 million (1.9% of AUM)NYSE:MSGS: $158.65 million (1.5% of AUM)NYSE:HRI: $158.28 million (1.5% of AUM)As of February 4, GATX shares were priced at $186.63, up 14.9% over the past year and well outperforming the S&P 500’s roughly 14% gain in the same period.

Company overviewMetricValueRevenue (TTM)$1.70 billionNet Income (TTM)$312.80 millionDividend Yield1.30%Price (as of 2/4/26)$186.63Company snapshotGATX Corporation leases railcars, locomotives, aircraft spare engines, and liquefied gas-carrying vessels; provides railcar maintenance and regulatory compliance services.The company generates revenue primarily through long-term leasing contracts and asset management for third parties, complemented by value-added maintenance and repair services.It serves customers in the petroleum, chemical, food/agriculture, and transportation sectors across North America and international markets.GATX Corporation is a leading global railcar leasing company with a fleet of railcars and a diversified portfolio of transportation assets. The company leverages its scale, asset expertise, and long-standing customer relationships to deliver reliable leasing solutions and ancillary services. Its strategic focus on asset utilization and operational efficiency supports consistent financial performance and positions it as a key partner to industrial and logistics clients worldwide.

What this transaction means for investorsPosition trimming at this stage says more about portfolio discipline than conviction loss. GATX has already delivered much of what long-term investors typically want from an asset-heavy compounder: visible cash flows, strong pricing power, and high utilization across its core fleets. Rail North America ended the third quarter with utilization near 99%, while renewal lease rates rose more than 22%, locking in longer-term cash flow visibility at attractive economics.

The business continues to throw off durable earnings even in a choppier macro environment. Through the first nine months of 2025, GATX generated $6.46 in diluted EPS and reaffirmed full-year guidance of $8.50 to $8.90. That consistency helps explain why the stock has quietly outperformed over the past year while many industrial peers have struggled to defend margins.

The sale also needs to be viewed in context. GATX remains one of the portfolio’s largest holdings at roughly 2% of reported assets, alongside other capital-intensive names with predictable cash flows. With all this in mind, the move here looks less like an exit and more like a rebalance after a solid performance. The firm is set to report full-year earnings later this month.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Mueller Industries. The Motley Fool recommends Herc. The Motley Fool has a disclosure policy.